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Regulation of melanogenesis in conditionally immortalised mouse melanocytes expressing a 
temperature-sensitive SV40 large T antigen 
Sharon Prince 
Department of Anatomy and Cell Biology, Medical School, University of Cape Town, Observatory 7925 
Cape Town, South Africa 
February, 1999 
The transformation of a normal melanocyte to a malignant melanoma involves a series of poorly 
understood genotypic and phenotypic alterations. In vitro models of melanoma formation generated by 
transforming mouse melanocytes with exogenous oncogenes have revealed that this process is frequently 
accompanied by a loss of pigmentation. The aim of this study was to establish, and to make use of. unique 
cell lines to gain further insight into the mechanism(s) by which oncoproteins alter melanocyte 
differentiation. Primary cultures of mouse epidermal and dermal melanocytes were infected with a 
retrovirus carrying a temperature-sensitive mutant SV40 large T antigen. Six immortalised cell lines thus 
generated were analysed by northern and western blots and by enzymatic assays at the permissive 
temperature of the oncoprotein. Three epidermal and two dermal melanocyte clones remained pigmented 
and expressed tyrosinase, TRP-1 and -2 genes and the proteins encoded by them. In addition they 
expressed the mi gene and the c-kit receptor. 
In contrast, one dermal melanocyte clone (DMEL-3) gradually depigmented: this was accompanied by 
enhanced growth and down-regulation of melanocyte-specific gene expression. At the non-permissive 
temperature of the oncoprotein, proliferation ceased and DMEL-3 cells repigmented with a time-dependent 
increase in melanocyte-specific gene expression. Moreover, mi gene expression was down-regulated in the 
DMEL-3 cell line at the permissive temperature and was re-expressed at the non-permissive temperature. 
These results provided direct evidence for the role of the SV40 large T antigen in melanocyte de-
differentiation and emphasized the pivotal role of Mi in this process. Northern blot analysis of DMEL-3 cells 
cultured at the permissive and non-permissive temperatures revealed that there were no detectable levels 
of Pax3 transcripts at either temperature. In addition, Pax3 expression was absent in the highly pigmented 
DMEL-2 and melan-a cell lines. These results suggest that Pax3 is not required for mi expression and that 
it is unlikely to be a target of the T antigen-mediated repression of mi. 
To explore the possibility that other melanocyte markers are also altered as a consequence of alterations 
in mi expression, the DMEL-3 cells were examined for changes in the a-MSH and c-kit receptors. Melanin 
synthesis and tyrosinase activity assays showed that alterations in mi expression did not correlate to 
responsiveness to a-MSH, suggesting that the MSH receptor gene is not regulated by Mi. Furthermore, 
northern blot analysis showed that DMEL-3 cells did not express c-kit at either the permissive or non-
permissive temperature, suggesting that Mi does not regulate c-kit expression. 
x 
To address the possible role of RB family members in melanocyte differentiation, it was investigated 
whether melanocyte differentiation is accompanied by an increase in their mRNAs and protein levels. 
Northern blot analysis strongly suggested that expression of the RB1, p130 and p107 is not altered when 
DMEL-3 cells were induced to differentiate at the non-permissive temperature.· The results from western 
blot anaysis were inconclusive and require further investigations. 
Finally, the pigmented cell lines established in the present study provided a unique opportunity to 
investigate the stimulatory effect of TPA on melanogenesis because growth curves showed that the cells 
become TPA-independent. The results showed that stimulation of melanogenesis by TPA in a pigmented 
melanocyte line, DMEL-2, resulted in an increase in tyrosinase, TRP-1 and TRP-2 proteins and mRNAs. 
Additionally, TPA increased mi gene expression which suggests that Mi is necessary for the TPA-triggered 
signalling cascade that induces expression of the tyrosinase gene family. These results disclose, for the 
first time, a mechanistic link between TPA and the transcriptional induction of pigmentation. 
CHAPTER 1: INTRODUCTION AND AIMS 
1.1 Introduction 
Melanoma is a highly aggressive and increasingly common form of cancer. Despite several 
important advances, the mechanisms underlying the transformation of the melanocyte to a 
malignant melanoma remains poorly understood. The discovery of oncogenes and an 
understanding of their ability to convert normal cells (both in vivo and in culture) into either an 
immortalised or a transformed state has paved the way for understanding this process. 
Several groups of researchers have transformed murine melanocytes in vitro with constitutively 
expressed oncogenes and have described properties of the resulting cells. The predominant 
finding has been that melanocytes transformed with a variety of oncogenes including, v-Ha-ras, 
v-neu , E1A, v-myc, SV40 large T antigen or polyoma middle T antigen acquire growth autonomy 
from the exogenous mitogen, TPA and show loss of differentiation markers such as, melanin 
production (melanogenesis) (Donatien et al., 1996; Dooley et al., 1988; Dotto et al. , 1989; 
Halaban et al. , 1996; Wilson et al., 1989; Yavuzer et al. , 1995). Similar results were reported for 
melanocytes transformed by either ectopic expression of basic fibroblast growth factor (bFGF) or 
chemical carcinogens. 
The observation that melanocyte de-differentiation frequently accompanies transformation has 
raised the possibility that these two processes may be regulated by a common mechanism. As 
suggested by Yavuzer et al. (1995) there may, for example, be a common factor controlling 
melanocyte differentiation and a subset of genes essential to growth control. Such a factor may 
therefore act as a common target for the different transforming agents. This possibility has 
interested both pigment cell biologists and oncologists because it seems likely that studies 
attempting to elucidate the molecular mechanisms by which transforming agents derail pigment 
formation will shed light on the molecular basis for the regulation of melanocyte differentiation 
and transformation. Alternatively, it can be predicted that understanding melanocyte 
transformation will require a detailed understanding of the differentiation programme of 
melanocytes. However, despite several advances in these areas of research they remain poorly 
understood and in vitro systems are needed to link melanocyte transformation more directly to 
differentiation. 
Conditional temperature-sensitive mutants of viral oncoproteins provide an appropriate means 
for establishing in vitro systems which can be used to study both melanocyte transformation and 
the direct effect(s) of the transforming agent on melanocyte differentiation. Temperature-
sensitive oncogenes have an advantage in that cells expressing these genes grow well at the 
2 
perm1ss1ve temperature and when they are grown at the non-permissive temperature the 
transforming agent is inactivated and, in principle, the cells should acquire the morphological 
and biochemical characteristics of differentiated cells. 
The broad aim of this thesis was to establish melanocyte lines expressing a temperature-
sensitive mutant SV40 large T antigen and to use these cell lines as in vitro models for: 
i) obtaining large populations of differentiated melanocytes for studying the regulation of 
melanogenesis; 
ii) addressing the question of whether oncoproteins (transforming agents) play a direct role in 
altering melanocyte differentiation; 
iii) investigating whether any of the cellular proteins known to be inactivated by the SV40 large 
T antigen play a role in melanocyte differentiation. 
The purpose of this review is to provide a general overview of the current understanding of the 
regulation of melanogenesis (biochemical differentiation) and to introduce key areas of research 
that have bearing on the aims of this thesis. 
1.2 Melanocyte differentiation and melanogenesis 
Melanocytes, together with the retinal pigment epithelium (RPE), are responsible for skin, hair 
and eye colour. Skin and hair follicle melanocytes originate during development as melanoblasts 
in the neural crest. The melanoblasts migrate along a dorso-lateral pathway to the epidermis 
before populating the skin and hair follicles, differentiating into dendritic, pigment-producing 
melanocytes. The most obvious marker of mature melanocytes is the synthesis of melanin within 
specialised intracellular organelles, the melanosomes. The biochemical process of 
melanogenesis involves a series of enzymatic steps in which tyrosine is converted into either 
eumelanin (black and/or brown) or phaeomelanin (red and/or yellow). This is a complex process 
since it involves numerous genes: genes coding for enzymes involved in catalysing the 
conversion of tyrosine into melanin as well as genes coding for the structural components of the 
melanosome. A scheme outlining the current understanding of the enzymatic steps involved in 
the conversion of tyrosine to melanin is presented in Fig 1.1. 
At least three melanocyte-specific enzymes are involved in the production of eumelanin, namely 
tyrosinase, tyrosinase-related protein 1 and 2 (TRP-1 and TRP-2, or dopachrome tautomerase, 
DCT). These enzymes constitute the tyrosinase protein family, and while they are structurally 
similar they have evolved distinct catalytic activities. Tyrosinase (EC 1.14.18.1) is the key 
enzyme in the melanogenic pathway and its action is rate limiting. Tyrosinase catalyzes the first 
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(DOPA)· and its subsequent oxidation to DOPAquinone {Korner and Pawelek, 1982; Tripathi et 
al. , 1992). DOPAquinone undergoes rapid cyclization and rearrangement to sequentially form 
leucoDOPAchrome and then DOPAchrome. This semi-stable intermediate can either undergo a 
slow, spontaneous decarboxylation to yield 5,6-dihydroxyindole (DHI}, or be enzymatically 
converted into the stable carboxylated diphenol 5,6-dihydroxyindole-2-carboxylic acid (DHICA) 
by OCT (EC 5.3.2.3) (Kroumpouzos et al., 1994; Tsukamoto et al., 1992; Yokoyama et al. , 
1994). Both DHI and DHICA are oxidized again, leading to the formation of reactive quinonic 
intermediates and, eventually, to the melanin polymer. Tyrosinase catalyses the oxidation of 5,6-
dihydroxyindole to indole-5,6 quinone {Korner and Pawalek, 1982). TRP-1 appears to be DHICA 
oxidase, which acts in the conversion of DHICA into 5,6-quinone 2-carboxylic acid (Jimenez-
Cervantes et al., 1994; Kobayashi et al., 1994a, 1994b). 
Several other factors are thought to play a role in the biosynthesis of melanin but their specific 
functions have not yet been clarified. These factors include, for example, the Pmel 17/silver 
gene family (Kim and Wistow, 1992; Kwon et al., 1991; Kwon et al., 1994; Mochii et al. , 1988; 
Turque et al. , 1996; Weterman et al., 1995), the pink-eyed dilution (p) protein (Donatien and 
Orlow, 1995; Gardner et al. , 1992; Rinchick et al., 1993; Rosemblat et al., 1994; Sviderskaya et 
· al. , 1997), MART-1/Melan-A protein (Coulie et al. , 1994; de Vries et al. , 1997; Kawakami et al. , 
1994), endogenous melanogenic inhibitors (Chakraborty et al. , 1989; Hatta et al., 1988; 
Kameyama et al. , 1989), catalases (Halaban and Moellmann, 1990), peroxidases (d'lschia et al., 
1991 ; Gesualdo et al., 1997) and the proteins encoded by the melanocortin receptor 1 (MC1R) 
(Chhaijlani and Wikberg , 1992; Mountjoy et al. , 1992) and Agouti genes (Bultman et al. , 1992; 
Wilson et al., 1995). 
The next section of this review will focus on the tyrosinase gene family because the molecular 
mechanisms involved in their regulation is crucial for melanogenesis. Over the last decade, the 
genes encoding the three tyrosinase family members have been isolated from human (Bouchard 
et al. , 1994; Cohen et al. , 1990; Kwon et al. , 1987), mouse (Jackson et al. , 1992; Shibahara et 
al., 1986; Yamamoto et al. , 1987) and chicken (April et al., 1996; 1998a; 1998b) and details of 
each family member are briefly discussed below. 
1.3 The tyrosinase gene family 
The existence of a tyrosinase gene family first became apparent when attempts to isolate the 
mouse gene for tyrosinase led to the identification of three related cDNAs that mapped to 
different chromosomal loci. Although each family member encodes a distinct enzyme involved in 
melanin biosynthesis, they share an amino acid homology of 40% and have a number of 
structural features in common (Jackson et al. , 1994). 
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Tyrosinase is encoded at the Tyr/TYR (previously called the albino (c)) locus and mutations at 
this locus result in partial or complete loss of melanin production (Jackson and Bennett, 1990; 
Shibahara et al., 1990; Yokoyama et al., 1990). Northern blot analysis indicates that the 
processed tyrosinase transcripts are between 2 and 2.5 kb and alternatively spliced forms may 
be present (Kelsall et al., 1997; Porter and Mintz, 1991). These transcripts cannot be translated 
into catalytically competent proteins, but nothrng is known about their function. Tyrosinase, a 
multifunctional, copper-containing glycoprotein has three enzyme activities in the melanin 
biosynthesis pathway (see Fig 1.1 ). Newly synthesized tyrosinase has a molecular weight of 55 
kDa which increases to around 65-75 kDa (or even up to 80 kDa) following its N-glycosylation in 
the Golgi complex (Chen et al., 1995; Hearing and Tsukamoto, 1991). 
The gene encoding tyrosinase-related protein 1 maps to the Tyrp1 /TYRP1 (previously called the 
brown (b)) locus (Chintamaneni et al., 1991 ; Jackson, 1988). Mutations at the mouse Tyrp1 
locus may result in a brown, rather than a black coat (Jackson et al., 1990), while in humans 
TYRP1 mutations have been associated with type 3 oculocutaneous albinism (OCA) (Boissy et 
al., 1996; Manga et al., 1997; Spritz, 1994). The primary transcript is between 2.1 kb and 3.3 kb 
(Shibahara et al. , 1986; Boissy et al. , 1996) and the mature glycosylated TRP-1 protein has a 
molecular weight of about 75 kDa (Halaban and Moellmann, 1990; Hearing and Tsukamoto, 
1991). The enzymatic function of TRP-1 in the melanin biosynthesis pathway has been a subject 
of much controversy. Several functions have been proposed and disputed, including a low level 
tyrosinase activity (Jimenez et al., 1989), a catalase/hydrogen peroxidase (Halaban and 
Moellmann, 1990) as well as a DOPAchrome tautomerase (Winder et al., 1993). It has now been 
shown that the principal activity of mouse TRP-1 is DHICA oxidase (Jimenez-Cervantes et al. , 
1994; Kobayashi et al., 1994a, 1994b). 
The gene encoding tyrosinase-related protein 2 maps to the OCT (previously called the slaty 
(s/t)) locus (Bouchard et al. , 1994; Jackson et al. , 1992; Sturm et al., 1994). While mutations at 
the mouse OCT locus may result in a grey (slaty) rather than a black coat (Budd and Jackson, 
1995), there is currently no known human disorder associated with the human OCT locus. 
Mammalian transcripts vary from 2.3 to 4.5 kb (Bouchard et al. , 1994; Yokoyama et al., 1994) 
and the molecular weight of the fully processed protein is about 75 to 80 kDa (Tsukamoto et al., 
1992). 
1.4 Regulation of the tyrosinase gene family 
The promoter regions of the tyrosinase, TRP-1 and TRP-2 genes from a number of organisms 
have been sequenced and compared. Such comparisons have revealed the presence of an 11 
6 
bp promoter element, termed the M-box, which is conserved in the promoters of the three 
tyrosinase family genes in both mouse and human (Budd and Jackson, 1995; Jackson et al. , 
1991 ; Lowings et al. , 1992; Morrison et al. , 1994; Sturm et al. , 1995). The M-box contains a core 
CATGTG E-box motif and functional analyses have shown it to be an important component of 
the minimum promoter sequences required for melanocyte-specific expression of the tyrosinase 
gene family members in mammals. The CATGTG motif matches with the CANNTG E-box motif, 
which is the consensus sequence for binding of the basic/helix-loop-helix/leucine zipper (bHLH-
Zip) transcription factor family (Reviewed by Lopez, 1995). This family of transcription factors 
includes amongst others, TFE3, TFEB, the proto-oncogene, myc, the regulators of myc function , 
Mad, Max, and Mxi 1, as well as USF (upstream stimulatory factor), and MyoD-related factors. 
These proteins bind to DNA as homodimers or heterodimers. DNA binding is mediated via the 
basic domain, dimerization occurs via the HLH domain and is stabilized by the Zip domain. 
The presence of the E-box motif in the tyrosinase, TRP-1 and TRP-2 promoters suggested that 
this motif might provide a binding site for a melanocyte-specific transcription factor. A potential 
candidate with a bHLH-Zip domain was cloned and shown to map to the mouse microphthalmia 
locus (m1) (Hodgkinson et al. , 1993; Hughes et al. , 1993). Mice with mutations at the mi locus 
have defects in neural crest-derived melanocytes, including lack of pigmentation in the coat, eye 
and inner ear (reviewed by Moore, 1995). Most of them also result in microphthalmia, due to 
defects in the pigmented epithelial layer of the eye. Similarly, the human homologue of the mi 
gene, microphthalmia-associated transcription factor (MITF) , is mutated in patients with a 
pigmentation and deafness disorder termed Waardenburg Syndrome type 2 (Hughes et al., 
1994; Tassabehji et al., 1994). 
Cloning of the cDNA sequences encoding mouse Mi and the human MITF (Hodgkinson et al. , 
1993; Hughes et al., 1993; Tachibana et al. , 1994) has facilitated investigations into the potential 
of the Mi protein to function as a melanocyte-specific transcription factor. In situ hybridisation 
analyses on sections of mouse embryos show that mi gene expression is restricted to several 
cell types including melanoblasts of the developing eye, skin and inner ear (Hodgkinson et al. , 
1993). The protein encoded by mi is required for melanocyte differentiation (Hodgkinson et al. , 
1993; Opdecamp et al. , 1997) and has been shown to bind the M-box of the tyrosinase (Bentley 
et al. , 1994; Bertolotto et al. , 1996; Ganss et al. , 1994; Yasumoto et al. , 1997), TRP-1 (Bertolotto 
et al. , 1998a; Yavuzer et al. , 1995) and TRP-2 (Bertolotto et al. , 1998a; Yasumoto et al. , 1997) 
promoters in vitro. Co-transfection assays demonstrated that reporter gene expression driven by 
either a tyrosinase, TRP-1 or an M-box containing the SV40 promoter, is increased in the 
presence of a Mi/MITF expression plasmid. Mutation of the M-box, or either one of two other 
elements containing an E-box motif in the tyrosinase promoter, or deletion of the M-box from the 
I 
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TRP-1 promoter significantly reduced this transactivation (Bentley et al. , 1994; Ganss et al. , 
· 1994; Hemesath et al. , 1994; Yasumoto et al., 1994; Yasumoto et al. , 1995; Yavuzer et al. , 
1995). 
The question of whether Mi is involved in the transactivation of the TRP-2 promoter, however, 
remains unclear. Bertolotto et al. (1998a) have shown that co-transfection of mouse B 16 
melanoma cells with a TRP-2 reporter construct and an expression plasmid encoding mi results 
in transactivation of the TRP-2 promoter. However similar studies in which human melanoma 
cells were co-transfected with MITF and either tyrosinase, TRP-1 or TRP-2 promoters linked to a 
reporter gene suggest that unlike the other two members of the tyrosinase gene family, the TRP-
2 promoter is unresponsive to MITF (Yasumoto et al., 1997). Bertolotto et al. (1998a) explained 
the discrepancy between their results and that of Yasumoto et al. (1997) as resulting from either 
specific behaviours of human versus mouse microphthalmia or by the different cellular contexts 
used in their respective experiments. 
Ectopic expression of a number of different oncogenes in melanocytes frequently results in de-
pigmentation and a co-ordinated down-regulation of tissue-specific gene expression. To explore 
the potential of Mi to act as a melanocyte-specific transcription factor, Yavuzer et al. (1995) 
investigated if Mi was the target for E1A-mediated down-regulation of melanocyte-specific gene 
transcription in E1A-transformed melanocytes. Using quantitative RT-PCR they found that mi 
expression is reduced up to SO-fold in these cells as compared with untransformed controls. This 
reduction in mi expression is likely to be responsible for the concomitant decrease of tyrosinase 
and TRP-1 gene expression, since these genes are re-expressed in the presence of ectopic mi 
expression. Halaban et al. (1996) provided additional evidence to show that mi is downregulated 
in melanocytes rendered amelanotic by the oncogenes E1A, ras and neu as well as by the 
aberrant expression of basic fibroblast growth factor (bFGF). 
The possibility of Mi functioning as a melanocyte-specific transcription factor was further 
underscored by studies in which transfection of MITF cDNA converted NIH/3T3 fibroblasts to 
cells with a melanocyte-like morphology. These cells also exhibit specific induction of tyrosinase 
and TRP-1 gene expression (Tachibana et al., 1996). The particular line of NIH/3T3 cells used in 
this experiment already expresses the TRP-2 gene and its expression was not altered by MITF 
expression. 
The above results together with the mi phenotype and the fact that mi is tissue-restricted makes 
Mi an attractive candidate as a regulator of pigmentation gene expression. Further progress 
towards a better understanding of the mechanism by which Mi regulates the pigmentation genes 
I 
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clearly depends on the identification of potential dimerization partners, Mi-interacting proteins as 
well as investigation into the mechanism(s) by which Mi is itself regulated. 
1.5 Regulation of Mi 
Fuse et al. (1996) cloned and characterized the human genomic DNA segment containing a 
melanocyte-type exon and its 5'-flanking region of the MITF gene. They showed, using transient 
expression assays, that the 5'-flanking region of 2.3 kb is able to confer preferential expression 
of a luciferase gene in pigment cells. The promoter region of the MITF gene was found to 
contain potential cis-acting elements, such as GATA boxes, a cyclic AMP-response element and 
an interleukin-6-responsive element. However, there were no CATGTG motifs in this promoter 
region and co-transfection with an MITF cDNA did not lead to the increase in expression of any 
MITF-luciferase fusion genes. This suggests that the melanocyte-type promoter of the MITF 
gene is not autoregulated and that the regulatory elements involved in the melanocyte-specific 
promoter function of the MITF gene may be different from that of the tyrosinase-gene family. 
Recently, Watanabe et al. (1998) provided convincing evidence to suggest that PAX3, whose 
mouse homologue is expressed prior to mi in the neural crest of mouse embryos, is a 
transcriptional activator of MITF expression. PAX3, a transcription factor with a paired domain 
and homeodomain, is mutated in patients suffering from Waardenburg syndrome type 1 and 3 
and these individuals exhibit incomplete pigmentation and hearing impairment. Using co-
transfection assays, they show that a reporter gene driven by the MITF promoter region is 
transactivated in Hela cells in the presence of wild-type PAX3 but not mutant PAX3 cDNAs 
encoding proteins with mutations in their paired domain and homeodomain. Furthermore, they 
demonstrate that transactivation of the MITF promoter requires the presence of a 26-bp region 
that was shown to contain a consensus sequence for binding to the palindromic PAX3 
homeodoman and the paired domain. 
Bm-2, a POU domain transcription factor, expressed in premelanoblasts, melanocytes and 
melanoma cells, has also been implicated in transcriptional regulation of mi expression. 
However, the regulation of mi by Brn-2 has not been clearly demonstrated and remains 
controversial. Angus et al. (1995) provide evidence that Brn-2 can function as a transcriptional 
activator of mi. They introduced anti-sense Brn-2 into a melanoma cell line and the resulting 
cells failed to express Brn-2 and concurrently lost expression of tyrosinase, TRP-1 , TRP-2 and 
mi. In contrast, Eisen et al. (1995) reported that in co-transfection assays, the levels of Mi-
activated expression of the tyrosinase promoter were repressed in the presence of increasing 
amounts of a Brn-2 expression vector. 
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Additional evidence for Brn-2 acting as a negative regulator was provided by studies in which a 
dominant-positive form of Brn-2 was stably introduced by retrovi"ruses into melanocytes (Goding 
and Fisher, 1997). The resulting melanocyte cell lines failed to express mi and also lost 
expression of tyrosinase, TRP-1 and TRP-2 which could be reversed by re-expressing mi from a 
·second retrovirus. The ability of Brn-2 to repress mi expression was confirmed by co-transfection · 
assays in which overexpression of either the wild-type or dominant-positive form of Brn-2 could 
repress mi promoter activity in melanocytes. Finally, when the mouse TRP-1 promoter was used 
to target ectopic expression of Brn-2 to the retinal pigment epithelium, the resultant transgenic 
mice developed a microphthalmic phenotype, consistent with loss of mi expression. 
In addition to Mi being regulated at a transcriptional level, Mi was also reported to undergo post-
translational modifications that may link its activity to signal transduction pathways. Germline 
mutations at loci encoding either Mi, or the cytokine receptor c-Kit, or its ligand Steel factor (SI) 
result in similar defects in melanocyte development suggesting a relationship between these 
factors. Hemesath et al. (1998) have recently described a biochemical link between Kit signalling 
. and the activity of Mi. They showed that when a human melanoma cell line (501 mel) was 
stimulated with SI, mitogen-activated protein kinase (MAPK) was activated, which in turn 
phosphorylated Mi at a consensus target serine. Using a luciferase reporter linked to the 
tyrosinase promoter, this phosphorylation was shown to upregulate Mi transactivation of the 
tyrosinase gene promoter. These results, therefore, demonstrate that Mi is phosphorylated by 
MAPK in response to c-Kit activation and that this leads to upregulation of Mi transcriptional 
activity. 
In a very recent report Price et al. (1998a) examined the mechanism by which Mi is activated by 
the above pathway. They treated c-kit-expressing melanoma cells (501 mel) with SI factor and 
demonstrated that the transcriptional coactivator p300/CBP selectively associates with MAPK-
phosphorylated Mi and that p300/CBP coactivates Mi transcriptional activity in a manner 
dependent upon this phosphorylation. 
1.6 Regulation of melanogenesis by extracellular factors 
Several agents have been found to regulate melanogenesis in mammalian melanocytes and 
melanoma cells in vitro and in vivo. These agents include cAMP elevating agents such as 
forskolin, isobutylmethylxanthine (IBMX) and a melanocyte stimulating hormone (a-MSH), UV 
irradiation. the endothelins 1, 2 and 3 (lmokawa et al. , 1995; lmokawa et al. , 1996; Reid et al. , 
1996; Vada et al. , 1991) and phorbol esters such as 12-0-tetradecanoyl-phorbol-13-acetate 
(TPA). An understanding of the mechanism by which these stimuli regulate melanogenesis has 
only recently begun to be understood. This section is limited to a review of the effect(s) of a-
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MSH and TPA on melanogenesis because they have bearing on areas to which this thesis aims 
to contribute. 
1.6.1 The stimulation of melanogenesis by a-MSH and cAMP 
Melanocytes express the MSH receptor which responds to a-MSH to convey signals that are 
thought to modulate growth and differentiation. Evidence accumulated over many years from 
several laboratories strongly suggests that in mammals, a-MSH and the a-MSH receptor are 
involved in enhancing eumelanogenesis by stimulating the enzymatic activity of tyrosinase. 
Because the regulation of melanin synthesis was thought for a long time to occur at the level of 
tyrosinase, most studies have focused on how this enhanced enzyme activity may come about 
and several mechanisms have been proposed. For example, while there is evidence that pre-
existing tyrosinase enzyme is activated by a-MSH (Halaban et al. , 1983), there is also strong 
evidence that a-MSH upregulates tyrosinase gene expression (Kuzumaki et al., 1993) as well as 
tyrosinase protein translation (Aroca et al., 1993). 
More recently, TRP-1 and TRP-2 were shown to control distal steps of eumelanin synthesis, 
suggesting that a-MSH might also regulate TRP-1 and TRP-2 activity and/or expression. 
However, the regulation of these two tyrosinase family members by a-MSH has not been clearly 
demonstrated since the hormone appears to elicit different transcriptional responses in different 
mouse melanoma cell lines. Whereas Aroca et al. (1993), using JB/MS cells, found that a-MSH 
only upregulated tyrosinase, but had no effect on TRP-1 and TRP-2 transcription, Kuzumaki et 
al. (1993), using B16-F1 cells reported that a-MSH upregulated both tyrosinase and TRP-1 gene 
expression. 
Recent work by Bertolotto et al. (1996, 1998a) demonstrated that stimulation of melanogenesis 
by cAMP-elevating agents (forskolin, a-MSH and IBMX) in 816 melanoma cells results in an 
increase in the amount of tyrosinase, TRP-1 and TRP-2 proteins and mRNAs. In addition, using 
reporter constructs containing the 2.2 kb, 1.1 kb or 0.6 kb fragments 5' of the transcriptional start 
sites of the mouse tyrosinase, TRP-1 and TRP-2 genes respectively, they show that cAMP-
elevating agents stimulate the transcriptional activity of the promoters of these genes. Deletion 
and mutation analysis showed that the M-box plays a key role in the regulation of tyrosinase, 
TRP-1 and TRP-2 promoter activity by cAMP. Finally, they provide data to suggest that by 
increasing mi expression, cAMP increases the binding of Mi to the M-box, resulting in 
transcriptional activation of the tyrosinase, TRP-1 and TRP-2 gene promoters. The authors 
therefore hypothesize that microphthalmia is involved in the regulation of the tyrosinase, TRP-1 
and TRP-2 promoters by cAMP. 
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In a subsequent study Bertolotto et al. (1998b) investigated this possibility as well as the 
mechanism by which cAMP regulates microphthalmia function. They showed that cAMP 
upregulates the transcription of the microphthalmia gene through a classical cAMP response 
element that is functional only in melanocytes. Furthermore, using a dominant-negative mutant 
of microphthalmia, they demonstrate that microphthalmia is required for the cAMP effect on the 
tyrosinase promoter. In a similar study, Price et al. (1998b) obtained results that confirmed those 
of Bertolotto et al. (1998b) . 
1.6.2 The regulation of melanogenesis by 12-0-tetradecanoyl-phorbol-13-acetate (TPA) 
TPA is a non-physiological agent that is used routinely for establishing long-term cultures of 
mammalian melanocytes (Bennett et al. , 1987; Eisinger and Marko, 1982; Halaban et al. , 1986; 
Tamura et al. , 1987). Withdrawal of TPA from the culture medium of these cells leads to 
senescence and a loss of pigmentation. TPA is therefore an effective melanocyte mitogen and is 
capable of stimulating melanogenesis in normal mammalian melanocytes. In contrast, 
melanocytes transformed with a variety of exogenous oncogenes or chemical carcinogens, lose 
their pigmented phenotype and their growth is TPA-independent. These transformed 
melanocytes cannot be stimulated to synthesize melanin upon addition of TPA into their culture 
medium (Dotto et al. , 1989; Melber et al. , 1989). Human and some mouse melanoma cells in 
culture are also to a certain extent growth inhibited in the presence of TPA (Arita et al., 1994; 
Becker et al. , 1990; Halaban et al. , 1986; Herlyn et al. , 1987; Oka et al. , 1996). However, reports 
in the literature about the melanogenic effects mediated by TPA in melanoma cells are 
inconsistent and both inhibitory and stimulatory effects have been reported. The reason for 
these different responses to TPA remains unclear. It is, however, likely that alterations in TPA-
responsive signalling occurs during transformation of melanocytes. In order to explore the 
effects of TPA on melanogenesis in greater depth, a brief summary of signalling by TPA is 
outlined below. 
The major intracellular target for TPA is protein kinase C (PKC) (Nishizuka, 1989). PKC 
represents a multigene family of serine- and threonine-specific kinases that play crucial roles in 
signal transduction pathways that are involved in diverse cellular functions, including 
differentiation, growth control , tumor promotion and cell death. The PKC family is subdivided into 
three groups: the classical PKC members (a., 13 , y) are Ca2+ and diacylglycerol (DAG)-dependent, 
the novel PKCs (&, E, 11 and 0) are Ca2+-independent but DAG-dependent and the atypical PKCs 
(l; and A) are not activated by Ca2+ and DAG in vitro (reviewed in Livneh and Fishman, 1997). 
Each member of the PKC family is thought to execute distinct cellular functions since they show 
differences in their structure, mechanisms of activation and tissue expression (Nishizuka, 1988; 
Asaoka et al. , 1992). 
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TPA binds to and directly activates both classical and novel members of the PKC family (but not 
atypical PKCs) in a manner analogous to that of DAG. When activated,. PKC phosphorylates 
specific serine or threonine residues on target proteins that vary depending on the cell type. An 
important consequence of the activation of PKC, in many cells, is the stimulation of gene 
transcription which occurs via at least two known pathways (Alberts et al. , 1994, see fig . 1.2). In 
one pathway, PKC activation leads to the phosphorylation of hc-8, an inhibitor protein, that is 
complexed to NF-KB, a transcription factor, in the cytoplasm. Upon phosphorylation of IK-8, NF-
KB is released so that it can migrate into the nucleus and stimulate the transcription of specific 
genes, for example the interleukins. In the other pathway, PKC activates a phosphorylation 
cascade that leads to the phosphorylation of a pivotal protein kinase, MAPK, which in tum 
phosphorylates and activates nuclear transcription factors. The effects of activated PKC are, 
therefore, mediated by specific regulatory proteins that interact with distinct cis-acting elements 
in the 5'-flanking region of the target gene. For example, MAPK phosphorylates and activates 
TCF-Elk that activates transcription of c-fos. Among other functions, c-fos forms part of the AP-1 
(activating protein-1) complex that binds to AP1 sites in gene promoters. Alternatively, MAPK 
can directly phosphorylate transcription factors which result in stimulation of their transactivation 
activity. 
As mentioned earlier, reports in the literature about the effect of TPA on melanogenesis in 
melanoma cells are inconsistent, in that both inhibitory and stimulatory effects have been 
reported. TPA was reported to enhance melanin synthesis in mouse 591 and 816 melanoma 
cells (Brooks et al. , 1980; Friedmann et al., 1990) and human 5K23 and HO melanoma cells 
(Brooks et al., 1980; Huberman et al., 1979), whereas Mufson et al. (1979) reported that TPA 
delayed, although it did not permanently block, melanin synthesis in 816 melanoma cells. In 
contrast, other studies have reported that TPA inhibited melanogenesis in mouse 591 (Fuller et 
al. , 1990) and 816 melanoma cells (Ando et al. , 1995; Kuzumaki et al. , 1993). The molecular 
mechanisms for the inhibitory effect of TPA in these melanoma cells were shown in part to be 
mediated by a decrease in tyrosinase (Ando et al. , 1995; Fuller et al., 1990; Kuzumaki et al., 
1993) and TRP-1 (Kuzumaki et al. , 1993) mRNA levels. These results suggest that repression of 
tyrosinase and TRP-1 gene expression by TPA possibly involves a regulatory site common to 
their promoters. 
While analysis of the 5' flanking sequence in the mouse and human tyrosinase gene revealed 
putative AP-1 sites, there are no AP-1 binding consensus sequences in the promoter region of 
the TRP-1 gene (Jackson et al., 1991). It would therefore appear that the AP-1 site may not be 



















ACTIVATED TRANSCRIPTION OF 
GENES 1 ANO 2 
Fig. 1.2. Two intracellular pathways by which activated C-kinase can activate the 
transcription of specific genes. In one (red arrows) C-kinase activates a phosphorylation 
cascade that leads to the phosphorylation of a pivotal protein kinase called MAP-kinase, 
which in tum phosphorylates and activates the gene regulatory protein Elk-1 . Elk-1 is bound 
to a short DNA sequence (called serum response element, SRE) in association with another 
DNA-binding protein (called serum response factor, SRF). In the other pathway (green 
arrows) C-kinase activation leads to the phosphorylation of hc-B, which releases the gene 
regulatory NF-KB so that it can migrate into the nucleus and activate the transcription of 
specific genes (from Alberts et al. , 1994). 
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evidence to show that the M-box, and not the AP-1 sites, in the mouse tyrosinase promoter was 
the target for TPA-mediated inhibition. In a previous study they found that forskolin , a cAMP-
elevating agent, stimulated melanogenesis by increasing the transcriptional activity of the 
tyrosinase promoter (8ertolotto et al. , 1996). They demonstrated that nuclear extracts from 
forskolin-treated 816 melanoma cells that were exposed to 160 nM TPA for 3 hours, showed 
decreased binding of Mi to the M-box (8ertolotto et al. , 1998c). The authors proposed that TPA 
decreases Mi binding to the M-box of the tyrosinase promoter, thereby leading to reduced 
tyrosinase expression and the inhibition of melanogenesis. This can be explained by TPA either 
regulating Mi expression or by inducing post-translational modifications of Mi that affect its 
binding to the M-box of the tyrosinase promoter. Indeed, a post-translational mechanism by 
which TPA regulates Mi activity has been reported by Hemesath et al. (1998). They 
demonstrated that treatment of a human melanoma cell line (501 mel) with 16 nM (10 ng/ml) 
TPA for 8 min, results in activation of MAPkinase, which in turn phosphorylates Mi at a 
consensus target serine. This phosphorylation was shown to upregulate Mi transactivation of the 
tyrosinase gene promoter. The apparent difference in the effect of TPA on transcriptional 
regulation in the 816- and 501 mel melanoma cell lines could have resulted from differences in 
human versus mouse melanoma cell lines or the concentrations of TPA, since Hemesath et al. 
(1998) used 10-fold less than that used by 8ertolotto et al. (1998c). 
The reason for the different effects of TPA on melanogenesis in melanoma cells is not known, 
but the following possibilities are worth noting. Firstly, depending on the concentration of TPA 
used in the culture medium of cells, it can exert opposite effects on PKC. High concentrations of 
TPA can initially activate PKC but longer exposures of cells to these concentrations lead to a 
depletion of certain PKC isoforms (Nishizuka, 1988; Oka et al. , 1995). Thus, conflicting results 
can be obtained depending on the concentration of TPA used and/or the length of time that the 
cells are exposed to TPA. Alternatively, it is possible that the differential effect of TPA on 
melanogenesis in different melanoma cell lines results from changes in the expression of certain 
PKC isoforms during the development of melanoma. For example, while it has not been clearly 
demonstrated which isoform mediates the effects of TPA on melanogenesis, Park et al. (1993) 
provided compelling data to suggest that PKC J3 may be involved. Their data show that the PKC 
J3 regulates human melanogenesis through activation of tyrosinase. However, PKC J3 is not 
expressed in 816 melanoma cells (Oka et al. , 1993) and is frequently absent in human 
melanoma cells (Oka et al. , 1996; Yamanishi and Meyskens, 1994). In the absence of this PKC 
isozyme, TPA may act on other PKC isozymes which mediate an inhibitory effect on 
melanogenesis in these cell lines. Given the phenotypic heterogeneity observed among different 
melanoma cell lines, it would be reasonable to suggest that these cell lines are not particularly 
suitable for studies aimed at elucidating the effect of TPA on melanogenesis. 
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The results of studies on the effect of TPA on melanocyte differentiation, including 
melanogenesis, have been more consistent in normal mammalian melanocytes. Exposure of 
normal human melanocytes to TPA has been reported to stimulate tyrosinase activity (Abdel-
Malek et al. , 1992; Chao-Hsing and Hsing-Su, 1991 ; Halaban et al., 1983) and melanin 
synthesis (Melber et al., 1989; Friedman et al. , 1990). Bennett et al. (1987) also showed that an 
immortal line of mouse melanocytes are visibly pigmented and dendritic in the presence of TPA. 
Without TPA, these cells became flat and isometric, without dendrites. Similar results were also 
reported by Melber et al. (1989) for normal human melanocytes. 
In addition, TPA was found to be essential in inducing melanocyte progenitors in mouse neural 
crest cultures to differentiate (Murphy et al., 1992; Kidson , pers. comm.). Murphy et al. (1992) 
reported tnat exposure of mouse neural crest cells to TPA in culture, resulted in pigmented 
(melanin_ synthesis) and DOPA-positive (tyrosinase activity) melanocytes. Subsequently, 
endothelins were found to substitute for TPA in such a system (Reid et al. 1996). Although it is 
still unclear what physiologic molecule TPA is mimicking, this provided strong evidence that TPA 
may mimic endothelin signalling and that endothelinsfTPA is an essential melanocyte 
differentiation factor. 
Further evidence in support of this possibility comes from studies which have shown that 
endothelins, like TPA, exert stimulatory effects on melanocyte growth and differentiation. 
Endothelins are strong mitogens for human melanocytes and endothelin-1 (ET-1) has been 
shown to increase tyrosinase activity and melanogenesis through binding to a receptor on 
melanocytes (Yada et al. , 1991). Hara et al. (1995) also reported that when added to cultured 
melanocytes, ET-1 enhances melanocyte dendricity. Swope et al. (1995) also found that ET-1 
could replace TPA in the growth medium that they use routinely for culturing normal human 
melanocytes. Furthermore, binding of endothelins to their G protein-coupled receptor on 
melanocytes activate the Ca2·-messenger system, which involves both calmodulin and protein 
kinase C. 
It is, therefore, clear that TPA provides a powerful tool for investigating the differentiation 
process of melanocytes because it substitutes for an endogenous growth/differentiation factor. 
However, detailed investigations on the stimulatory effects of TPA on normal melanocyte 
differentiation have, in part, been hindered because TPA itself is a prerequisite for expanding 
these cells in culture. 
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1.7 In vitro systems for studying melanocyte differentiation 
The growing interest in the molecular mechanisms regulating melanocyte differentiation has 
prompted investigators to develop in vitro systems to study this process. Until most recently, 
investigations were restricted to studies on melanoma cells because they readily give rise to cell 
lines in culture. However, melanoma cells are often highly heterogeneous and differ from normal · 
cells. Most melanoma cells which grow without growth factors in culture, exhibit a fibroblastic or 
epithelioid morphology and are often amelanotic, even if the original tumor was highly pigmented 
(Houghton et al., 1987). They therefore have limited use in the study of 'normal' melanogenesis. 
The establishment of in vitro methods for isolating and culturing normal mammalian melanocytes 
marked a major breakthrough in this area. TPA was found to be an effective mitogen and is now 
used routinely for culturing normal melanocytes. While primary cultures of normal melanocytes 
have several advantages for the study of melanogenesis, they have three major disadvantages: 
(1) normal mouse melanocyte cultures senesce within 3 weeks (Bennett et al., 1987) and normal 
human melanocytes will grow for only a limited period in culture and then senesce (Bennett et 
. al. , 1985; Eisinger and Marko, 1982; Herlyn et al., 1987); (2) normal melanocytes have low 
proliferative potential and it is, therefore, difficult to obtain large numbers of cells, limiting 
biochemical and molecular analyses; and (3) DNA transfer by transfection or retroviral infection 
techniques is difficult to carry out in primary cells. 
In principle, immortalised melanocyte lines offer a solution to the difficulties experienced with 
using melanoma cell lines and/or primary melanocytes. Two strategies have been adopted to 
obtain such cell lines: spontaneous immortalisation and the use of oncogenes. 
Rodent cells readily generate spontaneously immortalised cell lines in culture and as a result 
melanocyte lines from wild-type and black mice have been established (reviewed by Bennett 
and Sviderskaya, 1998). Similarly, melanocyte lines have also been established from mice that 
carry germline mutations at loci that encode genes involved in pigmentation (reviewed by 
Bennett and Sviderskaya, 1998). These cell lines have represented an important resource for 
genetic and molecular studies of normal and abnormal pigmentation. They are particularly useful 
in complementation studies which can assist with the characterisation of the genes encoded at 
the loci for which they carry a mutation. A limitation of spontaneously immortalised melanocyte 
lines is that their isolation can take a long time and depends largely on chance. 
The ability of oncogenes to convert normal cells (both in culture and in vivo) either into an 
immortalised or transformed state could provide an alternative to spontaneously immortalised 
cell lines. Unlike rodent cells, normal diploid human cells do not readily generate spontaneously 
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immortalised cell lines in culture. However, expression of viral oncogenes in primary normal 
human melanocytes have been reported to extend their life span. Albino et al. (1986) showed 
that when v-Ha- or v-ki-ras oncogenes were introduced and expressed in cultured human 
melanocytes the resulting cells were initially diploid, pigmented and maintained an obligatory 
growth requirement for TPA. However, following six months of culture some cells emerged that 
underwent complete transformation, acquiring phenotypic characteristics of malignant 
melanoma, chromosomal changes and TPA-independence (Albino et al. , 1992). 
Zepter et al. (1995) infected cultured normal human melanocytes with a retroviral vector 
encoding the SV40 large T antigen. The resulting cells were morphologically indistinguishable 
from their normal counterparts and expressed the tyrosinase gene. Moreover, these T antigen-
expressing melanocytes proliferated in the absence of TPA and required reduced levels of 
exogenous bFGF, indicating growth factor independence. Interestingly, these cells eventually 
underwent senescence. It should be noted that in another report in which the SV40 large T 
antigen was introduced into normal human melanocytes, the resulting cells were reported to be 
unpigmented, growth inhibited by TPA and to have undergone transformation (Melber et al. , 
1989). None of the above studies were therefore able to obtain stably-pigmented cell lines from 
human melanocytes. 
Exogenous oncogenes have also been expressed constitutively in immortal murine 
melanocytes. Cells expressing oncogenes v-Ha-ras (Donatien et al. , 1996; Dotto et al. , 1989; 
Wilson et al. , 1989), v-myc, v-neu (Dotto et al., 1989), adenovirus E1a (Dotto et al., 1989; 
Halaban et al. , 1996; Yavuzer et al., 1995) or polyoma middle T (Dooley et al., 1988) all showed 
changes in their differentiated properties. The changes include morphological alterations 
(Donatien et al. , 1996; Dotto et al. , 1989), loss of expression of the enzymes responsible for 
melanin synthesis, including tyrosinase, TRP-1 and TRP-2 proteins (Donatien et al., 1996) and 
inhibition of transcription of the genes coding for tyrosinase and TRP-1 (Halaban et al. , 1996; 
Yavuzer et al., 1995) with concomitant loss of pigmentation. In addition these cell lines loss their 
growth dependence on TPA. 
In general, the above cell lines behaved like transformed cells since they also gained the ability 
to grow in suspension (in semisolid medium) and some were able to form tumors in mice. While 
most of the cell lines established above were produced primarily to study melanocyte growth 
control in relation to melanoma, they have revealed a possible connection between 
transformation and differentiation. Studies directed at understanding the molecular mechanisms 
by which oncoproteins can inhibit melanogenesis could, therefore, provide a more indirect but 
equally effective strategy for identifying the molecular mechanism(s) regulating melanogenesis. 
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However, the above cell lines are irreversibly transformed and it may be difficult to separate the 
effect of the oncoprotein on melanogenesis from the transforming process. To date, there have 
been no reports in the literature of melanocyte cell lines obtained by overexpressing 
oncoproteins in normal primary mouse melanocytes in culture. It would be of interest to see if 
oncoproteins exert the same effects on melanocyte differentiation in normal primary 
melanocytes as described for immortal cells. 
In another approach, transgenic (Tyr-SV40E) mice were generated with an integrated fusion 
gene containing the SV40 early-region sequences, including the large T antigen and small t 
transforming genes, under the control of the pigment cell-specific mouse tyrosinase promoter 
(Bradl et al. , 1991). Several mouse strains were described which had reduced coat pigmentation 
that roughly reflected the relative numbers of transgene copies (Bradl et al., 1991). Larue et al. 
(1993) cultured skin melanocytes from young Tyr-SV40E mice with no apparent skin lesions 
from hemizygous donors with low, medium and high numbers of transgene copies. The resulting 
cell lines readily became transformed, with loss of pigment and tyrosinase expression. 
Importantly, the rate at which these changes occurred was directly related to the numbers of 
integrated transgene copies in the cells. This suggests that the effect of the SV40 large T 
antigen on both the growth and pigmentation of melanocytes is dose-dependent. These cell 
lines and the Tyr-SV40E mouse strains provide potential models of melanoma progression but 
are probably limited in the study of melanogenesis. 
The use of conditional temperature-sensitive (ts) mutants of viral oncogenes provide a novel 
approach to (a) exploring the molecular mechanisms by which oncoproteins alter pigmentation 
and (b) obtaining large populations of differentiated melanocytes for studying melanogenesis. 
Temperature-sensitive oncogenes have an advantage in that the cells grow well at the 
permissive temperature; however, when the cells are grown at the non-permissive temperature 
they lose their transformed properties and acquire the morphological and biochemical 
characteristics of differentiated cells. For example, ts mutants of polyoma and SV40 viruses 
encode a large T antigen which is transforming at the permissive temperature of 33°C but 
inactivated at the non-permissive temperature of 39°C. The growth and differentiation of cell 
lines established by these ts mutant oncogenes can thus be regulated by simply shifting the 
temperature at which the cells are cultured . 
1.8 SV40 large T antigen 
Simian virus 40 (SV40) is an oncogenic DNA virus belonging to the papovavirus group. The 
early region of the SV40 virus encodes two proteins, large (T) and small (t) tumor antigens. Both 
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these proteins can play a role in the oncogenic potential of this virus. The large T antigen has 
been shown to interfere with differentiation, as well as to immortalise primary cells in culture. 
When present at a sufficiently high concentration or when co-expressed with other genes, the 
large T antigen can also enhance transformation of primary cells (reviewed in Tooze, 1981). 
The SV40 large T antigen, a predominantly nuclear phosphoprotein, has multiple biochemical 
properties and plays a pivotal role in lytic growth of the virus and in transformation of cells. 
Genetic and biochemical evidence indicates that specific portions of the T antigen molecule are 
essential for individual T antigen functions (see Fig. 1.3). (For review, see Manfredi and Prives, 
1994). A large number of mutants, both deletion and missense, have now been identified and 
have clearly shown that the replication and transformation functions of SV40 large T antigen can 
be separated. For example, biochemical analysis has demonstrated that the ability to bind 
specifically to the SV40 origin of replication , the ability to hydrolyze ATP, and the helicase 
activity of SV40 large T antigen are not necessary for T antigen-mediated transformation 
(Aubom et al., 1989; Manos and Gluzman, 1985; Prives et al. , 1983). 
Extensive studies have demonstrated that specific regions of SV40 large T antigen interacts with 
a variety of cellular proteins including p53 (Lane and Crawford, 1979; Linzer and Levine, 1979), 
pRB (DeCaprio et al., 1988; Ewen et al., 1989), p107 (Dyson et al., 1989a), p130 (Hannon et al. , 
1993), p185 (Kohrman and lmperiale, 1992), p300/CBP (Avantaggiati et al. , 1996; Eckner et al. , 
1996), the key replication enzyme, DNA polymerase a (Domreiter et al. , 1990; Gannon and 
Lane, 1987; Smale and Tjian, 1986), the transcription factor AP-2 (Mitchell et al. , 1987), the heat 
shock protein, hsp-70 (Sawai and Butel, 1989), and the TATA box binding protein , TBP (Gruda 
et al. , 1993). To date, four regions of SV40 large T antigen have been shown to be important in 
the ability of the T antigen to transform cells. These regions, identified by letters A-D, are shown 
schematically in Fig. 1.3. Regions B and D are responsible for binding to the tumor suppressor 
proteins, pRb and p53, respectively, that normally regulate cell proliferation. T antigen is thought 
to induce transformation of cells by binding to and inactivating these proteins. The nuclear 
localization region, C, has been shown to be important for transformation of primary cells and a 
remaining region, A, at the amino terminus, has been shown to bind to p300, a transcription co-
activator. Two other regions, a zinc finger motif and a hydrophobic region embedded within 
region D, appear to be involved in the general stability of T antigen and therefore mutations in 
these residues indirectly affect transformation. 
Studies on the biological activity of the SV40 large T antigen have provided a wealth of 
information about the cellular mechanisms involved in normal cell growth and the malfunction of 
these mechanisms during neoplastic transformation. The emerging picture is that the formation 
of a complex between the products of viral oncogenes and cellular growth suppressor proteins is 
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Fig. 1.3. Regions of SV40 large T antigen that are involved in its oncogenic activity. The 
numbers that are indicated above the schematic diagram represent the amino-acid residues 
of SV40 large T antigen (out of 708 total amino acids). Four transforming regions are 
identified by letter. (A) Amino acids 1-82 is the region of binding to DNA polymerase a and to 
the cellular protein p300. (B) Amino acids 101 -118 are the region of binding to pRb and p107. 
(C) Amino acids 126-132 are the nuclear localization signal. The binding site for the heat 
shock protein, p73, resides in amino acids 1-178, spanning regions A, B, and C. (D) Amino 
acids 351-450 and 533~26 are the region of binding to p53 as well as DNA polymerase a. 
Two other regions involved in the general stability of the protein are also indicated. Amino 
acids 302-318 is a zinc finger motif and amino acids 571-589 are a hydrophorbic region 





associated with an increased propensity toward neoplastic transformation. Studies of such 
interactions has led to a clearer understanding of the role of tumor suppressor proteins in cell 
cycle regulation. The SV40 large T antigen has also been shown to interfere with cellular 
differentiation but very little is known about the mechanism(s) underlying this effect and whether 
it is mechanistically related to its transforming ability. A growing body of evidence, however, 
suggests that the large T antigen exerts its effect on cell proliferation and differentiation by 
binding, and thus inactivating, a set of regulatory proteins, notably those belonging to the 
retinoblastoma family of growth suppressors. Since a central interest of the present study is the 
effect of oncoproteins on melanocyte differentiation, the following section of this review will 
focus on the role of the retinoblastoma gene product in regulating cell growth and differentiation. 
1.9 Dual roles of the retinoblastoma protein in cell cycle regulation and differentiation 
Cell differentiation is a coordinated process that includes cell cycle exit and the expression of 
unique genes to specify tissue identity. While there is much knowledge on each separate step of 
differentiation, the mechanisms that coordinate cell cycle and tissue-specific events are still not 
known. 
RB 1 was the first tumor suppressor gene to be cloned (Dryja et al., 1986; Friend et al., 1986; 
Lee et al., 1987), and as a consequence has been studied intensively within the context of cell 
cycle regulation and oncogenesis. However, in addition to its role in regulation of the cell cycle, 
there is mounting evidence that the retinoblastoma gene product (pRb) also plays a role in cell 
differentiation. Whether pRb plays a role in differentiation by simply allowing cells to withdraw 
from the cell cycle or whether it plays a more direct role in tissue-specific gene expression during 
differentiation has begun to be explored. Because these two processes are almost inextricably 
linked, the above question has been difficult to resolve. However, recent evidence suggests that 
in some cell systems, pRb has distinct roles in cell cycle exit and terminal differentiation. For 
clarity, the next section will deal separately with pRb's role in these two processes. 
1.9.1 pRb in cell cycle progression and cell cycle exit 
RB1 is a member of a family of genes that encode cell cycle-regulatory proteins. The two other 
members, p107 (Ewen et al., 1991) and p130 (Hannon et al. , 1993; Li et al., 1993), encode 
proteins that are closely related to pRb in both sequence and function. Each pRb family protein 
can induce a G1-specific cell cycle arrest when overexpressed in tumor cells (Claudio et al., 
1994; Hinds et al., 1992; Zhu et al., 1993). This specific effect is dependent upon two highly 
conserved domains, termed the A and B boxes or the 'pocket' which are separated by a non-
conserved spacer region. pRb, p107 and p130 may act as negative regulators of cell 
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proliferation through interaction with the E2F transcription factors (Zhu et al., 1993; Claudio et 
al. , 1994; Qin et al. , 1995). E2F is a multigene family with at least five members that 
heterodimerise with another set of transcription factors (DP-1 , DP-2 and DP-3) in various 
combinations to form functionally active DNA-binding complexes (reviewed by LaThangue, 
1994; Ormondroyd et al. , 1995). 
pRb, p107, and p130 are phosphorylated in a cell cycle-dependent manner (Beijersbergen et al., 
1995; Buchkovich et al., 1989; Chen et al., 1989; Decaprio et al. , 1992; Mayol et al. , 1995; Xiao 
et al. , 1996). During early G1 phase, hypophosphorylated pRb binds to E2F and represses its 
ability to activate transcription. In response to mitogenic stimuli, the cells progress into S phase 
as pRb becomes increasingly phosphorylated through the action of cyclin-dependent kinases. 
This causes pRb to dissociate from E2F, which can then regulate transcription of the S phase 
genes which are its targets (for review see Nevins, 1993). E2F, as mentioned earlier, also forms 
complexes with p130 and p107 but t~eir times of appearance during the cell cycle differ (for 
review see Herwig and Strauss, 1997). The predominant E2F complex in quiescent cells is 
p130:E2F, whereas p107:E2F is detected in cells as they enter the S phase. The specific roles 
of the p107 and p130 proteins in the cell cycle and growth arrest are still unclear. 
Several viral oncoproteins, including simian virus 40 large T antigen (Decaprio et al. , 1988), 
adenovirus E1A (Whyte et al. , 1988) and the human papilloma virus-16 (HPV) protein E7 (Dyson 
et al., 1989b; Murger et al. , 1989) interact with the hypophosphorylated form of pRb and its 
relatives p107 and p130 by binding to their pocket domains (for review see Herwig and Strauss, 
1997). In this way viral oncoproteins promote growth by sequestering the retinoblastoma family 
proteins (reviewed by Nevins, 1992) and thus disrupting the growth inhibitory E2F:pRb, 
E2F:p107 and E2F:p130 complexes. This leads to the liberation of tra11scriptionally active E2F 
species which triggers S phase entry and uncontrolled proliferation. 
1.9.2 pRb and cellular differentiation 
The first evidence for a role of pRb in differentiation came from studies of RB1 knockout mice 
which die in utero at a stage when many highly specialized cell types begin to form (Clarke et al. , 
1992; Jacks et al. , 1992; Lee et al. , 1992). Erythrocytes retain their nuclei and neuronal cells in 
the developing hind brain and spinal ganglia fail to differentiate further into mature neurons 
(Jacks et al. , 1992; Lee et al., 1992; Lee et al. , 1994). pRb is seemingly not required for the 
differentiation of every cell type however, since certain cell types in RB1-deficient embryos have 
already begun differentiating by day 14.5 of embryonic development when these mice die. For 
example the formation of the somites, cardiac and skeletal muscle, bone, and several other 
tissues have already been initiated in RB_,_ mice at this time. 
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Further evidence in support of a role for pRb in cell differentiation has come from in vitro studies. 
The collective observations suggest that differentiation is accompanied by an increase in 
transcription of the RB1 gene, changes in the phosphorylation status of pRb and complex 
formation between pRb and transcription factors that are involved in regulating cellular 
differentiation. These studies are described in detail below. 
To begin to decipher the role of the RB1 gene in differentiation, some investigators have 
examined whether cell differentiation correlates to changes in the phosphorylation status of the 
pRb protein. In several systems examined, it was found that an early event in differentiation was 
the dephosphorylation of pRb. For example, Chen et al. (1989), using western blot analysis, 
reported that induction of differentiation in several human leukemia cell lines by treatment with 
the phorbol ester, TPA, or retinoic acid (RA), leads to dephosphorylation of pRb. They further 
showed that in cells which were unable to differentiate in response to TPA and RA, no change in 
pRb phosphorylation pattern was observed. Hypophosphorylation of pRb was therefore 
. associated with cell differentiation. Of significance was the observation that dephosphorylation 
of pRb occurs after the addition of differentiation inducers at a time when the cells are not 
morphologically differentiated and can still divide. Chen et al. (1989) therefore suggest that pRb 
dephosphorylation is not merely a consequence of cell cycle arrest. In other systems examined, 
however, decreased phosphorylation of pRb during differentiation correlated with cell cycle 
arrest in GO/G1 (Mihara et al. , 1989; Resnitzky et al. , 1992). In these systems, prevention of pRb 
phosphorylation and the resulting proliferation block imposed by pRb therefore appear to be 
essential for subsequent cell differentiation. 
As mentioned earlier, increased RB1 mRNA expression has also been associated with 
differentiation (Coppola et al. , 1990). For example, Coppola et al. (1990) studied three mouse 
cell lineages (erythroid, muscle and B cell) to determine whether there is a correlation between 
RB1 gene expression and differentiation. They found that when mouse erythroleukemia cells are 
induced to differentiate with either dimethyl sulfoxide (DMSO) or hexamethylene bisacetimide 
(HMBA) the process is associated with an increase in expression of RB1 mRNA. Similarly, 
increased expression of RB 1 mRNA was found in myoblasts induced by mitogen depletion to 
become differentiated myotubes. This increase of RB1 mRNA was shown to correlate to an 
increase in expression of a muscle specific gene, a-actin. Furthermore, Coppola et al. (1990) 
show that in a 8-cell lineage, RB1 expression is low in pre-8 and B cell lines but high in 
plasmacytomas, which represent late stages of B cell differentiation. Thus, in all three lineages 
studied, late stages of differentiation were associated with increased amounts of RB1 mRNA. 
Other studies have provided more direct evidence for pRb's role in differentiation. Chen et al. 
(1996a) investigated the possibility that pRb regulates the activity of NF-IL6, a member of the 
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CAAT/enhancer-binding protein (C/EBP) family of transcription factors, which functions in the 
generation and maintenance of differentiation in hematopoeitic cells. They demonstrate that 
wild-type pRb interacts, through its SV40 large T antigen-binding domains, with the nuclear 
factor NF-IL6. This interaction was shown to occur in monocyte/macrophage precursors 
precisely when the cells differentiate and continues in terminally specialized cells. Furthermore, 
they show that pRb directly activates NF-IL6 by enhancing its binding to cognate DNA 
sequences and by increasing transcription of a gene containing NF-IL6-binding elements in its 
promoter sequence. 
In a different but analogous cell culture system, a correlation was observed between the process 
of adipocyte differentiation and the positive regulation of the transcription factor C/EBPl3 by pRb 
(Chen et al., 1996b). C/EBPs transactivate the promoters of several adipocyte-specific genes 
during the differentiation of preadipocytes, including the fatty acid-binding protein 422/aP2 
(references within Chen et al., 1996b). Chen et al. (1996b) showed that while embryonic lung 
fibroblasts (ELFs) prepared from RB+1+ mice spontaneously differentiated to a fat-laden 
phenotype, RB-1- ELFs from an embryo in the same litter did not. To test whether RB1 
expression is the key factor in determining the potential of ELFs to differentiate into fat-laden 
. cells, they transfected RB-1- fibroblasts with plasmids containing wild-type or point mutant RB 1 
cDNA. The fibroblasts transfected with the plasmid expressing wild-type RB1 differentiated into 
fat-laden cells in response to hormonal treatment. In contrast, they show that untransfected 
fibroblasts and those transfected with mutant RB1 failed to differentiate along the same lineage. 
Furthermore, they showed that the process of adipocyte differentiation is regulated by the direct 
interaction between pRb, through its SV40 large T antigen-binding domains, and the family of 
transcription factors known as C/EBPs. This interaction activates C/EBPs to regulate the 
transcription of genes involved in adipocyte differentiation. 
Previous studies in ex vivo culture systems have also shown that pRb may be important for 
muscle differentiation (Gu et al., 1993). During differentiation of muscle cells, pRb accumulates 
in the nucleus and forms complexes with bHLH myogenic transcription factors such as MyoD 
and myogenin (Gu et al., 1993). Gu et al. (1993) showed that pRb and MyoD directly bind to 
each other in vitro and in vivo, through a region that involves the pocket domain of pRb and the 
basic-helix-loop-helix domain of MyoD. Moreover, this pRb:MyoD interaction is essential for both 
the ability of MyoD to activate muscle cell-specific transcription as well as for its growth inhibitory 
activity (Gu et al. , 1993). Gu et al. (1993) also demonstrate that the sequences in pRb that bind 
MyoD overlap with those known to bind to SV40 large T antigen and E1A (Decaprio et al., 1988; 
Whyte et al. , 1988; Kaelin et al., 1990). 
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In apparent contradiction to the above results, mice that are genetically deficient in RB1 (RB_,_) 
have a histologically normal skeletal musculature (Clarke et al. , 1992). A possible explanation for 
this is that a different molecule, for example, the structurally related pocket protein p107, may 
have substituted for the myogenic function of pRb. Indeed, Schneider et al. (1994) have 
demonstrated, using western blot analysis, that nuclear p107 was induced during myogenic 
development in Rb_,_ mouse skeletal cells, much like pRb in developing wild-type muscle cells. 
They also show by northern blot analysis, that there is a reciprocal pattern of p107 and RB1 
expression in these skeletal muscle cells. The compensatory pattern of p107 expression in Rs-'-
mouse skeletal cells suggested that, like pRb in wild-type myotubes, this pocket protein might 
associate with the myogenic bHLH factors present in RB_,_ myotubes. Schneider et al. (1994) 
showed, using different binding analysis, that p107 binds to myogenin which suggests that p107 
might function in place of pRb as a partner of myogenic bHLH factors in differentiated RB_,_ 
myotubes. Furthermore, they provide data to show that myogenin and p107 can together 
mediate the activation of muscle genes in RB1-deficient cells which might therefore explain the 
myogenic differentiation of RB_,_ mouse embryos. 
The observation that pRb interacts with the transcription factors, NF-IL6, C/EBPJ3 and MyoD, 
through its SV40 large T antigen-binding domains raises the possibility that one way in which the 
large T antigen and related molecules can interfere with cellular differentiation is through 
disrupting pRb interactions with other regulatory molecules. 
1.10 pRb and melanocyte differentiation 
When growth-regulatory molecules such as basic fibroblast growth factor (bFGF) or the 
dominantly acting oncogenes ras, myc, adenovirus E1A, polyoma middle T antigen, or SV40 
large T antigen, are aberrantly expressed in melanocytes they frequently lose their pigmented 
dendritic phenotype. This would suggest that there may be a common factor controlling 
melanocyte differentiation and a subset of genes essential to growth control. If one considers 
the role that pRb plays in controlling growth and differentiation of other cell types, it is possible 
that it has a similar role in melanocytes. Conclusive proof of such a role for pRb in melanocyte 
differentiation and growth could serve as a major breakthrough in our understanding of 
melanocyte differentiation and melanoma formation . Recent investigations have provided 
preliminary evidence to suggest that pRb might indeed play a role in melanocyte differentiation. 
Valente et al. (1996) transfected B16F10 mouse melanoma cells with a human RB1 cDNA under 
the control of the human !3-actin promoter. The resulting cells highly overexpress RB1 mRNA 
and its product, pRb, show reduced growth rate and increased expression of the differentiation 
marker melanin (melanogenesis) in vitro. While the above data suggest that pRb may be 
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involved in melanocyte differentiation, one cannot exclude the possibility that induction of 
differentiation was solely a result of the negative effect of pRb over-expression on cell 
proliferation. 
In a different approach, Yavuzer et al. (1995) used the oncoprotein, E1A, as a probe for factors 
controlling melanocyte-specific gene expression and differentiation. They showed that 
expression of the E1A protein in a highly pigmented melanocyte cell line results in a non-
pigmented phenotype. Loss of pigmentation was shown to be a consequence of the 
transcriptional repression of the tyrosinase and TRP-1 genes. The same investigators explored 
the possibility that the interaction between pRb and E 1 A was required for repression of the TRP-
1 promoter. To this end, wild-type (YYT) E1A or E1A mutants that are unable to bind pRb or p300 
or both were co-transfected with a TRP-1-CAT reporter gene into 816 mouse melanoma cells. 
They showed that while the wild-type E1A repressed TRP-1 expression efficiently (32-fold), a 
E1A protein with a mutation affecting both p300 and pRb binding failed to do so. These results 
demonstrated that repression of TRP-1 expression by E1A required the sequestration of p300 
and/or pRb. Interestingly, a mutant that was able to bind pRb but not p300 repressed TRP-1 
expression sixfold less than WT E1A. Repression by the E1A mutant that was able to bind p300 
but not pRb, was only twofold lower than WT E1A. While these results suggest that both pRb 
and p300 are important targets for E1A repression of melanocyte-specific gene expression, it 
would appear that the p300:E1A interaction is more important. 
Moreover, Yavuzer et al. (1995) using reverse transcribed polymerase chain reactions (PCR), 
showed that mi gene expression was reduced around 50-fold in the E1A-expressing 
melanocytes. They reported that a residual amount of mi expression could be detected in E1A-
expressing melanocytes if the PCR reactions were allowed to proceed for a further six rounds. 
Based on their results that showed that tyrosinase and TRP-1 expression was undetectable in 
E1A-expressing melanocytes, they suggested that the residual amount of Mi present in these 
cells might be rendered inactive by E1A. Since in muscle cells MyoD requires interaction with 
pRb for transcription activation, Yavuzer et al. (1995) considered the possibility that a similar 
interaction between Mi and pRb might be disrupted by E1A. They therefore investigated whether 
Mi could interact with pRb and showed that in vitro, Mi does bind pRb. Yavuzer et al. (1995), 
therefore, proposed that one mechanism by which E1A can repress transcription of melanocyte-
specific gene expression is by disrupting Mi:pRb complexes which may be required for 
transactivation of these genes. While this speculation seems feasible, there is no evidence that 
Mi binds pRb in vivo nor has it been demonstrated that a Mi:pRb complex can transactivate 
melanocyte-specific gene expression. 
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It is also worth noting that in a similar study, Halaban et al. (1996) found that melanocyte
s 
expressing an E1A mutant which was unable to bind p300 induced the amelanotic phenotype
. 
This suggested that sequestration of p300 by E1A was not responsible for abrogation of th
e 
melanocyte differentiated phenotype and therefore contrasts with the results of Yavuzer et a
l. 
(1995). Interestingly, Halaban et al. (1996) showed that melanocytes transfected with an E1A
 
mutant (p60", pRb·, p107+, p300") that bound p107 were morphologically normal and pigmented
. 
These results would suggest that inactivation of p107 by E1A does not result in de
-
differentiation. However, for some unknown reason these transfectants expressed very low
 
levels of the E1A protein which might explain why this E1A variant was unable to induce the de
-
differentiated phenotype. 
Taken together the results of the above studies suggest, but do not directly and unequivocall
y 
show, a role for pRb in melanocyte differentiation. Further investigations are therefore clearl
y 
required to confirm a role for pRb in melanocyte differentiation and growth. 
1.11 General and specific aims of study 
Over the last decade, the development of culture conditions for normal mouse melanocytes ha
s 
facilitated the establishment of immortal (spontaneously) and transformed cell lines. These ce
ll 
lines have contributed enormously to our understanding of melanocyte differentiation an
d 
transformation. However, despite several important advances, very little is understood about th
e 
molecular mechanisms regulating the pigmentation process and the mechanism by whic
h 
normal melanocytes become malignant in vivo remains poorly understood. Moreover, whil
e 
several studies have provided compelling evidence in support of a connection between th
e 
transformation process and the loss of pigmentation, the precise role of transforming agents i
n 
the depigmentation process is still unclear. In vitro systems are therefore required to establish 
a 
more direct link between melanocyte transformation and differentiation. 
Because the primary interest of this study was the molecular mechanism(s) regulatin
g 
melanocyte-specific gene expression and differentiation, the experimental approach adopte
d 
was to establish novel conditionally immortalised mouse melanocyte lines with a temperature
-
sensitive mutant SV40 large T antigen. It was hypothesised that such cell lines will contribut
e 
towards the understanding of the molecular mechanisms regulating and de-regulatin
g 
differentiation in normal and transformed melanocytes respectively by: 
i) providing a system in which melanocytes can be induced to differentiate, which can serve a
s 
an invaluable resource for studying the molecular mechanisms regulating this process; 
ii) providing a system which allows cellular and molecular comparisons between transforme
d 
melanocytes (at the permissive temperature) and their equivalent 'normal' cells (at the non-
permissive temperature) , which could lead to the identification of genes that are differentially 
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expressed during melanocyte differentiation and transformation and therefore shed light on 
the mechanism(s) regulating these processes; 
iii) allowing identification of a possible factor/mechanism controlling melanocyte differentiation 
and a subset of genes essential to growth control. 
The specific aims of this study were therefore: 
i) to establish primary cultures of normal melanocytes from newborn mouse skin ; 
ii) to infect the cultures in i) with a murine recombinant retrovirus containing a temperature-
sensitive mutant SV40 large T antigen in order to establish conditionally immortalised 
melanocyte lines; 
iii) to characterise these T antigen-expressing melanocyte lines with regard to features of 
melanocyte differentiation and growth; 
iv) to dete.rmine the effect of TPA on melanocyte differentiation; 
v) to Gompare the expression of · melanocyte-specific markers in T antigen-expressing 
melanocytes cultured at the permissive and non-permissive temperatures in order to 
determine the direct effect of the oncoprotein on melanocyte differentiation; 
vi) to investigate whether pRb and/or its relatives, p130 and p107, have a role in melanocyte 
differentiation. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Cell cultures 
Primary cultures of mouse epidermal and dermal melanocytes were obtained from the skins of 
0.5-day-old C57BU6 mice by a procedure described previously for the culture of dermal 
melanocytes (Tamura et al. , 1987). All processing was carried out with sterile instruments under 
sterile conditions. Briefly, newborn mice were sacrificed by gassing with chloroform. They were 
then immersed in 70% ethanol and then transferred to petri dishes containing sterile phosphate 
buffered saline (PBS). The skins were removed from the dorsolateral side of the trunk between 
the limbs and then cleaned of subcutaneous tissues. The samples were then incubated 
epidermis side up in a 0.25% solution of trypsin in Ca2+/Mg2+-free PBS (pH 7.2) for 16 hours (hrs) 
at 4°C. 
The epidermis and dermis were mechanically separated with fine forceps and placed separately 
in 60 mm culture dishes (the dermis of each skin per dish and the epidermis of two skins per 
dish). Each dish contained 1 ml of melanocyte-specific medium (MSM) which contains Ham's 
F1 O (Highveld Biological) supplemented with 20% heat inactivated (30 minutes 56°C) fetal calf 
serum (FCS, Highveld Biological), 48 nM 12-0-tetradecanoyl-phorbol-13-acetate (TPA, Sigma), 
0.1 mM isobutylmethyl xanthine (IBMX, Sigma), 50 µg protein/ml human placental extract (see 
Appendix to this chapter) , 1 mM L-glutamine (Highveld Biological), 200 units/ml penicillin and 
100 µg/ml streptomycin (Highveld Biological) . In order to obtain a cell suspension the tissues 
were teased apart with jeweler's forceps and incubated in a total of 3 ml MSM, to allow for 
optimal attachment, in a 37°C incubator (95.0% air/5% C02, 65% humidity) overnight. The 
following day an additional 2 ml of MSM was added to each dish. Two days after plating, tissue 
debris was removed and the medium changed and supplemented with 100 µg/ml Geneticin 
(G418, Sigma) which selectively kills off rapidly dividing cells and has therefore been suggested 
as a means of eliminating contaminating fibroblasts (Halaban and Alfano, 1984). After 2 days of 
Geneticin treatment and in all cultures thereafter, cells were grown in MSM without G418. 
Mouse 816 melanoma and 3T3 fibroblast cells were grown in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% FCS, 200 units/ml penicillin and 100 µg/ml 
streptomycin. The mouse melanocyte cell lines, melan-a (black), melan-b (brown) and melan-c 
(albino) (Bennett et al. , 1987, 1989), obtained from Dr. Dorothy Bennett, were grown in Eagle's 
minimum essential medium supplemented with 5% FCS, 1 % sodium pyruvate, 100 µM 2-
mercaptoethanol, 200 units/ml penicillin and 100 µg/ml streptomycin and 200 nM TPA. Primary 
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melanocyte cultures as well as the above cell lines were maintained in a 37°C incubator (95.0% 
air/5% C02, 65% humidity). 
2.2 Preparation of retroviral lysate 
2.2.1 Maintenance of the '1'2 producer cell line 
The '1'2 cell line producing the ecotropic helper-free retrovirus was provided by R.D.G. McKay 
(National Institute of Neurological Disorders, NIH, Bethesda). This producer cell line, packaging 
the retrovirus encoding tsA58/U19 T antigen and neomycin resistance, was grown in DMEM 
(Highveld Biological) supplemented with 5% FCS, 200 units/ml penicillin and 100 µg/ml 
streptomycin in a 33°C incubator (95.0% air/5% C02, 65% humidity). 
2.2.2 Collection of.retroviral supernatant 
The retroviral producer cells were grown to confluency and then incubated overnight in fresh 
medium containing 10% FCS. The next day the supernatant was collected, centrifuged at 1000 
g to remove debris and then filtered through a 0.45 µm filter to remove living producer cells from 
the retrovirus stock. The retroviral containing supernatant was stored in 10 ml aliquots at -80°C. 
2.2.3 Virus titration using NIH 3T3 cells 
NIH 3T3 mouse fibroblasts were cultured in DMEM supplemented with 10% FCS, 200 units/ml 
penicillin and 100 µg/ml streptomycin in a 37°C incubator (95.0% air/5% C02, 65% humidity). 
The day before infection with retroviral-containing supernatant, equal numbers of the cells were 
plated in 6 X 35 mm dishes. The following day each dish was incubated at 37°C for 2 hrs with 2 
mis of one of the following dilutions of retroviral supernatant containing 8 µg/ml polybrene: 10°, 
10-1, 10-2, 10-3, 10-4 or 10-5. After the 2 hr incubation the medium was replaced with DMEM + 
10% FCS. The next day, Geneticin, the neomycin analogue, was included in the medium at 
1000 µg/ml to begin neomycin-resistance selection. The selective medium was changed every 3-
4 days over a period of 10 days and then the number of resistant colonies was counted visually; 
this count is presented below. 
Table 2.1. Calculation of retrovirus titre 
Dilution Factor No. of colonies 
10v Completely confluent 
10-1 Completely confluent 
10-~ Completely confluent 




The titre was calculated as follows: 
Number of colonies X virus dilution = cfu/ml 
virus inoculum volume (ml) 
Thus the titre was calculated to be 2 X 105 = 1 x 105 cfu/ml. 
2ml 
2.3 Retroviral infection of primary mouse epidermal and dermal melanocyte cultures 
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Seven days after plating, the primary cultures of mouse melanocytes were infected with the 
retrovirus supernatant in the presence of 8 µg/ml polybrene under the following conditions to 
ensure successful integration of the retrovirus: at 33°C or 37°C for 2 or 4 hrs. Polybrene was 
included because it increases the efficiency of infection. After infection, fresh medium was 
added and 48 hrs later the cultures were subjected to neomycin selection using the neomycin 
analogue, G418 (Geneticin, Sigma, Gibco) at 200 µg/ml for one month. As opposed to 3T3 cells 
that are robust and, therefore, require 1000 µg/ml Geneticin for neomycin selection, primary 
cultures are generally subjected to only 200 µg/ml of the drug. The selection medium was 
changed every 3-4 days. 
After one month, colonies of pigmented cells appeared and they were isolated with the use of 
cloning rings as follows: The colonies were marked by encircling individual pigmented areas with 
a pen on the bottom of the culture dish. The medium was aspirated and the cells rinsed with 
PBS. Sterile cloning rings containing sterile vacuum grease were placed over the marked areas 
and cells surrounded by the cloning rings were trypsinized and immediately placed into a 96 well 
tissue culture dish containing MSM. Once confluent the cells were expanded into a 24 well 
tissue culture dish; then 35 mm dishes; then 60 mm dishes and finally into 10 cm dishes. Clones 
that grew were cultured at 33°C (unless stated otherwise) in MSM, as described earlier for 
primary melanocytes, and expanded into cell lines. Cells were frozen in MSM with 10% DMSO 
before any further analysis. 
2.4 lmmunodetection of the SV 40 large T antigen 
Cells were washed with PBS (pH 7.4), fixed in 2% paraformaldehyde at room temperature (RT) 
for 15 min and permeabilised in 100% methanol at -20°C for 15 min. T antigen was detected 
with a mouse monoclonal antibody (PAb 101 , ATCC, Gurney et al. , 1980) directed against the 
C-terminus of the SV 40 large T antigen. Fixed cells were incubated with a 1 :1 dilution of 
hybridoma supernatant for 5 hrs at RT and then overnight at 4°C. This was followed by 
incubation with biotinylated rabbit anti-mouse immunoglobulins (1 :200, DAKO) for 1 hr at RT. 
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The cells were then incubated with a streptavidin biotinylated horseradish peroxidase complex 
(streptABComplex/HRP, 1:1000, DAKO) and the reaction visualised with the peroxidase 
substrate, 3,3-diaminobenzidine tetrahydrochloride (DAB). Negative controls were prepared 
following the same procedure but substituting the primary antibody with 1 % FCS in PBS. 
2.5 Southern blot hybridisation of genomic DNA 
Genomic DNA was isolated from T antigen-expressing melanocytes and from \j/2 and NIH 3T3 
cells according to a rapid DNA isolation method (Davis et al., 1986 pp42-43). Samples were 
subsequently treated with 40 µg/ml of DNAse-free RNase A for 30 min at 37°C to remove 
contaminating RNA, followed by extraction with phenol:chloroform:isoamyl alcohol. The DNA 
was precipitated, resuspended in TE (10 mM Tris, pH 7.6; 0.1 mM EDTA, pH 8) and quantified. 
Twenty micrograms of genomic DNA was digested with a total of 2 units Eco R1 restriction 
enzyme/µg DNA at 37°C. Steps were taken to ensure even digestion of the high molecular 
weight DNA, as suggested by Sambrook et al. (1989, pp 9.32). Digested DNA was separated on 
a 0.8% agarose gel in TBE buffer, run overnight at 6.5 V/cm. The DNA was denatured and 
transferred onto a nylon membrane (Hybond-N+, Amersham) by capillarity, according to the 
manufacturer's instructions. Hybridisation was carried out in a hybridisation oven (Hybaid). The 
blot was prehybridised in 10% dextran sulphate; 6 X SSC; 5 X Denhardt's; 0.5% SOS and 100 
µg/ml denatured salmon sperm DNA for 2 hrs at 65°C. An 808 bp Xba 1-Bgl 11 fragment, 
specific for the sequence conferring resistance to neomycin, was released from a pGK-lacZ 
plasmid (obtained from R Jaenisch, Massachusetts Institute of Technology, Cambridge) and 
labelled with [a-32P]-dCTP using a Random-primed DNA labeling kit (Boehringer Mannheim) for 
use as a probe. Radiolabelled probe was separated from unincorporated label on a Sephadex 
G-50 column. Denatured probe was added to a final concentration of 1 X 106 cpm/ml and 
hybridisation was carried out at 65°C overnight. Post-hybridisation washes included two low 
stringency washes in 2 X SSC, 0.1 % SOS at RT for 20 min, followed by a higher stringency 
wash in 0.1 X SSC, 0.1 % SOS at 65°C for 10 min. The blot was then exposed to 
autoradiographic film (AGFA CURIX RP1) at -80°C. 
2.6 Melanogenic Assays 
Cells were washed three times with cold PBS (pH 7.4), scraped from the dishes into Nonidet P-
40/SDS buffer (1% Nonidet P-40, 0.01% SOS, 0.1 M Tris-Cl, pH 7.2, 100 µM 
phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin), vortexed and incubated at 4°C overnight. 
Following centrifugation at 14 000 g at 4°C for 15 min, the supernatants were recovered and the 
protein concentration of each sample was determined by the BCA protein assay system (Pierce 
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Chemicals). The supematants were stored at ~70°C until use for melanogenic assays. All 
melanogenic enzyme assays were carried out at pH 6.8, 37°C, for 1 hr. 
2.6.1 Tyrosinase is an unusual enzyme in that it has tyrosine hydroxylase, DOPA- and OHi 
oxidase activity. In this study, tyrosine hydroxylase activity was assayed by a method which 
measures tritiated water produced during the hydroxylation of L-[3,5-3H]tyrosine to DOPA 
(Hearing and Ekel, 1976; Hearing, 1987). Briefly, the reaction mixture was set up in round 
bottom 96 well plates and consisted of 30 µI cell protein, 10 µI of a solution containing antibiotics 
and the L-DOPA cofactor (1 M KPO ... buffer, pH 7.2, 1 mg/ml chloramphenicol, 1 mg/ml 
cycloheximide, 0.1 mg/ml bovine serum albumin, 1000 U/ml penicillin G and 0.25 mM L-DOPA) 
and 10 µI L-[3H]tyrosine (40 - 50 Ci/mmol, NEN-DuPont, Boston, MA adjusted to 1 Ci/mmol 
before use). The reaction was incubated for 1 h at 37°C. Forty microliters of each sample was 
then added to a charcoal slurry (approximately 100 mg charcoal in 1 ml of 0.1 N HCI) and the 
samples vortexed intermittently over a 1 h period. The charcoal, which is used to adsorb excess 
(
3H]tyrosine, was pelleted by centrifugation (1000 g, 5 min) and a 100 µI aliquot of the 
supernatant counted for the production of radioactive water. 
2.6.2 DOPAchrome tautomerase activity was measured by high performance liquid 
chromatography (HPLC) as the disappearance of DOPAchrome substrate and the production of 
5,6-dihydroxyindole-2-carboxylic acid (DHICA) rather than 5,6-dihydroxyindole (DHl)(Palumbo et 
al. , 1987; Tsukamoto et al. , 1992). Calculations of substrate and product concentrations in these 
reactions are based on comparison of eluting peaks with calibrated curves of known OHi and 
DHICA standards. DOPAchrome was prepared using the silver oxide method originally 
described by Komer and Pawelek (1980) . 
2.6.3 DHICA oxidase activity was measured by HPLC as the disappearance of DHICA above 
background auto-oxidation. Again , reaction rates are calculated from comparison of eluting 
peaks with calibrated curves of known DHICA standards. DHICA was a generous gift of Prof. 
Shosuke Ito (Fujita Health Sciences University). 
The results of the above assays are expressed as pmol of product per µg protein per hour at 
37°C. Pmol product are calculated from the radioactive measurements or, in the HPLC assays, 
by comparison with known standards. Extracts of melan-a cells solubilized in extraction buffer 
were used as positive controls for each assay. All HPLC analysis were performed on a Beckman 
model 344 instrument with a C18 5 µm-pore column (4.6 mm X 250 mm). 
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2.7 Melanin Synthesis Assay 
The assay that measures melanin synthesis was adapted from that published by Hearing and 
Ekel (1976) and measures the amount of radioactive melanin formed as [1 4C]tyrosine is 
converted to the acid-insoluble melanin biopolymer. This assay therefore reflects the combined 
melanogenic activities of tyrosinase, TRP-1, TRP-2, and inhibitory factors. Briefly, the cells were 
harvested with trypsin:EDTA (0.05%:0.02%), solubilised with an equal volume of 0.1% Triton X-
100 in 0.1 M phosphate buffer and centrifuged for 5 min at 10000 g. The supematants were 
adjusted to equal protein concentrations by the Biuret test (Bradshaw, 1966) or SCA assay 
(Pierce). A 10 µI aliquot of each supernatant was mixed with 5 µI 14C tyrosine (25 µCi/ml, specific 
activity 513 mCi/mmol, Amersham), 5 µI L-dopa (0.05 mM in 0.1 M phosphate buffer) and 5 µI of 
an antibiotic mix containing chloramphenicol (1 mg/ml}, cyclohexamide (1 mg/ml), bovine serum 
albumin (0.1 mg/ml) and penicillin (1000 units/ml). This reaction mix was incubated for 3 hrs at 
37°C. Controls were assays in which the supernatants were replaced with phosphate buffer (to 
determine non-enzymatic incorporation levels). Samples were individually spotted onto 
Whatman glass-fibre filter discs in 20 µI aliquots and washed in 10% trichloroacetic acid for 15 
min and then for 10 min to remove unincorporated 14C-tyrosine. The discs were dehydrated by 
washing for 5 min in 95% ethanol and then dried overnight in scintillation vials at RT. 200 µI 
Soluene-350 tissue solubiliser (Packard) was added to lift the reaction products out of the filter 
and 8 ml toluene scintillation fluid (Packard) was added prior to counting. Samples were counted 
in a Beckman scintillation counter set for 10 min counts on the 14C channel. Each assay was 
carried out in triplicate and the results presented as the mean of 3 samples. 
2.8 Northern Blot Hybridisation 
2.8.1 Northern blot hybridisation of total RNA samples 
Expression of tyrosinase, TRP-1, TRP-2, mi, c-kft, SV40 large T antigen, Pax3 and /3-actin 
mRNA was determined by standard northern blot hybridisation procedures (Davis et al. , 1986). 
Probes included: 
(i) A 1.9-kb Eco R1 fragment of pmcTyr1, specific for murine tyrosinase (Muller et al., 1988). 
(ii) A 1.7-kb Hind Ill fragment of pMT4, which is specific for murine TRP-1 (Shibahara et al. , 
1986). 
(iii) A 1.8-kb Eco R1 fragment of TRP-2a, which is specific for murine TRP-2 (Jackson et al. , 
1992). 
(iv) A 1.3-kb Eco R 1 fragment of the mouse mi cDNA Cf avuzer et al., 1995) or a 1. 7-kb Xba 1-
Hind 111 fragment of the mouse mi cDNA (provided by M. Tachibana, Maryland, USA). 
(v) A 1.0-kb Barn H1-Eco R1 fragment of the mouse c-Kft cDNA (provided by J-J. Panthier, 
lnstitut National de la Recherche Agronomique, France) was used as probe to c-Kit. 
(vi) A 2.0-kb Pvu 11 fragment of the SV40 large T anti.gen cDNA (provided by P. Jat, Ludwig 
Institute for Cancer Research, London, UK). 
(vii) A 0.35-kb Pvu 11 fragment of the mouse Pax3 cDNA (provided by Y. Furuta , Vanderbilt) . 
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Total RNA was extracted from T antigen-expressing melanocytes, from 816 melanoma, melan-
a, and \Jl2 fibroblast cells according to Sambrook et al. (1989). Twenty micrograms of RNA from 
each sample was separated on a 1.1 % denaturing, formaldehyde agarose gel at 5 V/cm for 1 hr, 
stained for 2.5 min with 0.01 % ethidium bromide and photographed on a Spectroline 
transilluminator. The gel was rinsed twice in 10 X SSC for 20 min and then the RNA transferred 
onto a nitrocellulose membrane (Hybond C, Amersham) by capillarity using 10 X SSC as blotting 
buffer. The gel was blotted overnight, after which the towelling was replaced and the blotting 
continued for a further 3 hr. Transfer onto the membrane was checked by transillumination and 
the position of the rRNA bands marked with pin-pricks. The RNA was then fixed onto the 
membrane by baking at 80°C for 2 hrs. For northern blot analyses using a 1.7-kb Xba 1-Hind 
. 111 fragment of the mouse mi cDNA and a 1.0-kb Barn H1-Eco R1 fragment of the mouse c-kit 
cDNA as probes, a nylon membrane was used and the RNA was ultraviolet crosslinked. 
Prehybridisations and hybridisations were carried out according to Davis et al (1986) in a 
hybridisation oven (Hybaid) overnight at 47°C. After prehybridisation, the blots were hybridised 
with a probe labelled with [a-32P]-dCTP using a Random-primed DNA labeling kit (Boehringer 
Mannheim). Radiolabelled probe was separated from unincorporated label on a Sephadex G-50 
column. Denatured probe was added to the hybridisation bottle (at a final concentration of 1 x 
106 cpm/ml) and the blots were hybridised, stripped and then rehybridised with other probes as 
described later in the results. Blots were washed under high stringency conditions (0.1 X SSC at 
68°C for 2 X 1 O min) and exposed to autoradiographic film at -80°C. The blots were reprobed 
with P-actin DNA under the identical conditions to control for comparable loading and transfer of 
RNA. RNA from 816 melanoma cells was included as a positive experimental control because 
these cells have been shown to express high levels of the melanocyte-specific genes. RNA from 
\j/2 fibroblast cells was included as a negative control on all blots. 
2.8.2 Northern blot hybridisation of poly(Ar RNA samples 
Expression of pRB, p130 and p107 mRNA was determined by northern blot hybridisation of 
poly(Af enriched RNA from DMEL-3 cells cultured at 33°C and 37°C for 4, 16 and 30 days, 
mouse 816 melanoma cells, melan-a cells and mouse brain tissue. Four to six 15 cm petri-
dishes of subconfluent cells were rinsed in chilled phosphate-buffered saline (PBS) and 
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trypsinised. The cells were resuspended in cold culture medium with serum to stop the trypsin 
action and the cell suspensions were collected in 50 ml sterile tubes. The cells were pelleted in a 
refrigerated centrifuge at 1500 RPM for 5 min, the supernatant was removed and the pellets 
resuspended in 40 ml of chilled PBS. After the cells were pelleted again in a refrigerated 
centrifuge at 1500 RPM for 5 min, the supernatant was removed and the cell pellets were 
immersed in liquid N2 for 1 min and then transferred onto dry ice and stored at -70°C. Brain 
tissue was removed from adult mice and immediately placed in 50 ml sterile tubes in liquid N2. 
The tissue was minced with the use of a pestle and mortar and then stored at -70°C. Total RNA 
was extracted from these frozen cell pellets and minced brain tissue according to Sambrook et al 
(1989, pp 7.12-7.13). To check the integrity of the RNA, 5 µg of each sample was run on a 1% 
formaldehyde gel. Poly(Af RNA was then further purified from total RNA with the 'Fast-track' 
mRNA isolation kit (lnvitrogen) according to the manufacturer's instructions. 
Five micrograms of poly(Af RNA from each sample was separated on a 1 % denaturing 
formaldehyde agarose gel at 5 V/cm for approximately 4 hours. The gel was rinsed in 1 X MOPS 
for 30 min followed by a 45 min rinse in 20 X SSC. The poly(Af RNA was transferred onto either 
nitrocellulose (Hybond C, Amersham) or nylon membrane (Hybond N+, Amersham) by capillarity 
· using 20 X SSC as blotting buffer. The gel was blotted overnight after which the towelling was 
replaced and the blotting continued for a further 3 hours. Following transfer the blots were rinsed 
briefly in 6 X SSC and then 2 X SSC. The blot was air-dried for 2 hours and then the RNA was 
fixed onto the membrane by baking at 80°C for 2 hours. After prehybridisation, the blots were 
hybridised with a probe labelled with [a-32P]-dCTP by random priming (Amersham), stripped and 
then rehybridised with other probes as described later in the results. Probes included a 848-bp 
Hind 111 fragment of the mouse p130 cDNA (provided by E. Lam, Ludwig Institute of Cancer 
Research, St Mary's, London, UK), a 2.88-kb Eco R1-Hind 111 fragment of the mouse pRB 
cDNA and a Barn H1-Sal 1 fragment of the human p107 cDNA (provided by S. Mittnacht, ICR, 
London, UK). Prehybridisation, hybridisation and post-hybridisation washes were carried out as 
described in section 2.8.1. 
The membranes containing total RNA or poly(Af RNA were autoradiographed at -80°C. After 
autoradiography, the probe was removed by treating the membranes in 0.1% SOS at 100°C, 
allowed to cool to room temperature, then reprobed with ~actin DNA. 
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2.9 Western immunoblotting analysis of tyrosinase, TRP-1, TRP-2, SV40 large T antigen, c-
Kit, pRb, p130 and p107 
Cells were harvested and solubilized overnight at 4°C in lysis buffer (1 % NP-40, 0.01 % SDS, 0.1 
M Tris-HCI, pH 7.2, 100 µM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, 1 mM sodium 
orthovanadate and 1 mM sodium fluoride), then centrifuged at 12 000 g for 15 min at 4°C, and 
the supematants were recovered. Protein concentrations were determined by the BCA assay 
(Pierce), with bovine serum albumin as the standard. Equal amounts of protein were loaded in 
each lane and separated on 7 .5% SDS gels, and then transferred electrophoretically to Hybond 
ECL nitrocellulose membranes (Amersham). Equal protein loading was verified by staining the 
gels with Coomassie brilliant blue after transfer of proteins to membranes. For Western blot 
analysis of tyrosinase, TRP-1, TRP-2, SV40 large T antigen and c-Kit, blots were blocked for 1 
hr at RT in 5% non-fat dry milk powder in TBS/Tween (0.05% Tween-20 in Tris buffered saline), 
then they were incubated with the following rabbit antisera (all obtained from Dr V. Hearing, 
National Cancer Institute): aPEP7 (carboxy terminus of tyrosinase, 1 :2000), aPEP1 (carboxy 
terminus of TRP-1 , 1 :2000) and aPEP8 (carboxy terminus of TRP-2, 1 :2000). Mouse 
monoclonal antibodies to SV40 large T antigen (Pab 101, Santa Cruz Biotechnology) and c-Kit 
(ACK2, Nishikawa et al., 1991) were employed at dilutions of 0.5 µg/ml and 1 µg/ml respectively. 
For detection of pRb, p130 and p107, blots were blocked for 1 hour in 5% non-fat dry milk 
powder in TBS/Tween (0.1 % Tween-20 in Tris buffered saline), and then they were incubated 
with rabbit polyclonal antibodies to pRb, p107 and p130 (C-15, C-18 and C-20 respectively, 
Santa Cruz) at dilutions 1 :2000 (kind gifts from E Lam, Ludwig Institute for Cancer Research, 
London, UK). The membranes were then incubated with either horseradish peroxidase-
conjugated anti-rabbit lgG (1: 1500 dilution) or anti-mouse lgG (1 :2000 dilution) and the 
immunoreactive proteins were detected by Enhanced Chemiluminescence (Amersham) 
according to the manufacturer's instructions. 
2.10 Assessment of the growth characteristics of T antigen-expressing melanocytes 
Short-term growth was determined in medium without TPA, or without human placental extract, 
or with only 2% serum and compared with growth in melanocyte-specific medium which contains 
TPA, human placental extract and 20% serum. Cells were seeded in triplicate in 12-well plates 
(4x104 cells/well), collected by trypsinization and counted on a hemocytometer at intervals of 2-3 
days. 
2.11 Melanin content measurement 
To determine the effect of individual growth-promoting additives on the melanin content of T 
antigen-expressing melanocytes, cells were grown in experimental and control media for two 
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weeks. Medium was renewed twice weekly. Cells were harvested separately from each plate by 
trypsinization and counted by hemocytometer. Melanin contents were determined by heating 
pellets of 106 cells in 1 ml 0.1 M NaOH at 95°C for 90 min (Zepter et al.1 1995). Each sample 
was prepared in duplicate and their optimal density was measured at 475 nm with a Shimadzu 
spectrophotometer UV-120. Relative values were obtained by comparing absorption values 
obtained for experimental samples to that of fibroblast samples. 
2.12 Hormonal stimulation 
To determine the effect of alpha-melanocyte-stimulating hormone (a-MSH) on the DMEL-3 cell 
line, the following procedures were followed . Cells were seeded at 4000 cells/cm
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in 10 cm 
dishes in standard culture medium and left to adhere overnight. The following day the regular 
medium was replaced with fresh medium with or without a-MSH. Appropriate media were 
changed daily thereafter for 4 days. MSH used was synthetic bovine a-MSH (Sigma) at 0.2 µM, 
since this concentration was shown to be the most effective in previous studies (Aroca et al. , 
1993). Cells were harvested with trypsin-EDTA (0.25% trypsin, 0.05% ethylenediamine 
tetraacetic acid) and processed for protein and RNA extractions. 
2.13 Transfection assays 
The transfection experiments to determine if ectopic expression of mi can rescue the expression 
of tyrosinase, TRP-1 and TRP-2 genes were carried out using the FuGENE 6 transfection 
reagent (Boehringer and Mannheim) according to manufacturer's instructions. DMEL-3 cells 
grown at the permissive temperature (33°C) were passaged 24 hours before transfection and 
plated at 1 X 105 cells per 35 mm dish. Co-transfections were carried out using a 20: 1 molar 
ratio of an mi cDNA under the control of the CMV IE promoter (Yavuzer et al., 1995) to 
selectable DNA (pBabepuro) in a total of 5.5 µg DNA. Forty-eight hours after transfection, cells 
were selected in 2.5 µg/ml of puromycin (Sigma). Untransfected DMEL-3 cells and DMEL-3 cells 
transfected with pBabepuro alone served as negative controls. 
To determine the regions of SV40 large T antigen involved in repressing melanocyte-specific 
gene expression, approximately 2 X 106 passage 8 DMEL-3 cells (grown at the permissive 
temperature, 33°C), were co-transfected with plasmid DNA, using the lipofection reagent 
DOTAP (Boehringer Mannheim) according to manufacturer's instructions. Cotransfections were 
carried out using a 20:1 molar ratio of non-selectable DNA to selectable DNA (pBabepuro) in a 
total of 18 µg DNA. The pBabepuro plasmid which encodes the puromycin resistance gene was 
used to facilitate the selection of stable transfectants. The three T antigen mutants (non-
selectable DNA), d/1135, 3213 and 5041 , were provided by P .S. Jat (Ludwig Institute for Cancer 
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Research, London, UK) and are delineated in Table 2.2. Untransfected passage 8 DMEL-3 cells 
and passage 8 DMEL-3 cells transfected with pBabepuro alone served as negative controls. 
Forty-eight hours after transfection, cells were selected in 2.5 µg/ml of puromycin (Sigma). 
Twenty-four hours later, half of the plates were shifted to the non-permissive temperature 
(37°C). During this time the growth medium was changed every 3-4 days. 
Table 2.2. T antigen-encoding plasmids and their protein 
binding specificities 
T antigen derivatives Specific Protein binding ability 
p53 pRB, p130, p107 p300 
5041 - + + 
3213 + - + 
dl1135 + + -
Appendix 
Preparation of human placental extract 
Full-term human placenta was washed extensively with sterile PBS, a portion was minced and 
homogenized in PBS using a Polytron ultra-homogenizer. The homogenate was centrifuged at 
13 000 g for 20 min at 4°C and the supernatant was passed through a 0.45 µm filter. The protein 
content of the supernatant was determined using the Biorad protein assay and bovine serum 
albumin as a standard. The supernatant was frozen at -20°C. 
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CHAPTER3:RESULTS 
3.1 Establishment of primary epidermal and dermal melanocyte cultures 
The skins from neonatal (0.5-day-old) C57816 mice were used as a source of both epidermal 
and dermal melanocyte cultures. After two days in culture, the keratinocytes and fibroblasts 
dominated the epidermal and dermal cultures, respectively, and melanocytes were distributed 
sparsely among them. Figure 3.1 a,b shows the typical appearance of a two day old epidermal 
culture. The light-appearing patches that are not in focus, are clumps of epidermal tissue (see 
arrows). When examined by phase contrast microscopy, single melanocytes (see arrowheads) 
were randomly distributed among sheets of keratinocytes (Fig. 3.1 a). These melanocytes 
appeared as small dendritic cells with dark cytoplasm and melanin pigment was visible within 
them by bright field microscopy (Fig. 3.1 b). 
The keratinocytes and fibroblasts were gradually killed by Geneticin treatment and within 7 days, 
individual melanocytes could be seen attached to the dishes. In both epidermal and dermal 
cultures, melanocytes appeared as bipolar or polydendritic cells when examined by phase 
contrast microscopy (Fig . 3.1 c) and melanin was observed both in their cytoplasm and dendrites 
by bright field microscopy (Fig . 3.1d). Cells continued to proliferate and confluent or 
subconfluent cultures enriched, for either epidermal or dermal melanocytes, were obtained at 
about 3 weeks. At this stage, the cultures contained only melanocytes and they were 
predominantly polygonal or epithelioid in shape (Fig. 3.1e) and pigment granules were clearly 
seen in them by bright field microscopy (Fig. 3.1 f) . 
3.2 Establishment and isolation of clonal pigmented melanocyte lines expressing the SV40 
large T antigen 
At the time at which this study was initiated, there was no published procedure for the retroviral 
infection of primary mouse melanocyte cultures and therefore suitable infection conditions had 
to be established. A brief account of the approaches attempted is given in chronological order 
because this clarifies why particular directions were followed at different stages. 
The first approach was to infect 3-week old epidermal cultures enriched for melanocytes. After 3 
months, no drug-resistant colonies were obtained and only single, senescent-appearing 
melanocytes were visible. It was concluded that the 3-week old cultures of epidermal 
melanocytes had probably reached a crisis before infection and were therefore not susceptible 
to retroviral infection. This experiment was abandoned. To overcome the problem encountered 
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Fig. 3.1. Primary cultures of mouse melanocytes, derived from epidermal cell suspensions, in melanocyte-
specific medium. (a,c,e) are phase contrast photomicrographs. (a) A typical mixture of keratinocytes and 
epidermal melanocytes after two 2 days in culture. Note sheet of keratinocytes and relative paucity of 
black, dendritic melanocytes (arrowheads). Retractile masses are clumps of epidermal tissue (arrows). (c) 
After 7 days in culture, melanocytes appear as single bipolar or polydendritic cells. (e) After 3 weeks, 
subconfluent cultures consisted entirely of bipolar to polygonal melanocytes. (b,d,f) are bright field 
photomicrographs of the same fields as (a,c,e) respectively, to show colour due to black melanin granules. 
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dermal cultures. Within 3-4 weeks, 22 unpigmented drug-resistant colonies were obtained and 
expanded into cell lines. Four cell lines were analysed, at both the permissive (33°C) and non-
permissive (37°C) temperatures, for the expression of a set of melanocyte-specific markers, 
including TRP-2. None of these clones displayed any known features associated with 
·melanocytes. This experiment was therefore also abandoned. 
In view of the problems experienced above, the third approach was to infect 7-day old cultures 
enriched for either proliferating epidermal or dermal melanocytes. Because it was not obvious 
what the optimal conditions would be for infecting melanocytes, these dishes were incubated 
with the retroviral supernatant at 33°C or 37°C for either 2 or 4 hrs. Infected cells were grown at 
the permissive temperature of 33°C in the presence of 200 µg/ml G418 for a minimum of 3 
weeks, until drug-resistant colonies were observed. The average number of clones obtained per 
dish under the different infection conditions is presented in Table 3.1. The dermal cultures gave 
rise to more clones than the epidermal cultures. The duration of infection at 37°C did not seem 
to influence the number of clones obtained but infection at 33°C for 4 hrs yielded significantly 
more clones than the.2 hr infections at this temperature. 
Table 3.1. Summary of results obtained under different infection conditions of 
7-day old cultures 
Source of Average no. of Average no. of Average no. of Average no. of 
cultures clones/dish at clones/dish at clones/dish at clones/dish at 
37°C for 2 hrs 37°C for 4 hrs 33°C for 2 hrs 33°C for 4 hrs 
Epidermis 0.7 1 1.5 3 
Dermis 5 6 2.8 5.3 
After 4 weeks, 78 pigmented and 4 unpigmented colonies were picked from 18 dishes of primary 
dermal cultures, and expanded into cell lines. Nine dishes of epidermal cultures gave rise to 6 
pigmented and 6 unpigmented clones that were also picked and expanded into cell lines. At the 
time of picking, these unpigmented clones were thought to be contaminating keratinocytes or 
fibroblasts. Subsequently, however, several of the pigmented clones became either completely 
unpigmented (Fig. 3.2a,b}, or contained a mixture of pigmented and unpigmented cells (Fig . 
3.2c,d), or consisted of cells that contained small amounts of pigment restricted to their 
perinuclear regions (Fig. 3.2e,f). After expansion, only three epidermal (termed EMEL-1, 2 and 
3) and three dermal (termed DMEL-1, 2 and 3) cell lines retained their pigmented phenotype and 
were selected for further analysis. 
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Fig. 3.2. Morphology of clones of melanocytes that have lost their pigmented phenotype during expansion 
into cell lines. (a) A clone of melanocytes that had completely lost their pigmented phenotype (phase 
contrast). (b) Bright field photomicrograph of the same field as (a) showing absence of the melanin 
pigment. (c) A clone consisting of a mixture of pigmented and unpigmented melanocytes (phase contrast) . 
(d) Same field as (c) showing only the pigmented cells (bright field) . (e) Melanocytes of a clone that 
contain melanin restricted to their perinuclear regions (phase contrast). (f) Same field as (e) showing the 
pigment (bright field) . 
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To confirm that the six selected cell lines expressed the SV40 large T antigen, the cell lines were 
cultured at 33°C and T antigen expression was detected with a monoclonal antibody directed 
against the C-terminus of T antigen. The presence of the nuclear T antigen was detected in all 
six cell lines. An example of the nuclear localization of T antigen in one of the cell lines is shown 
in Fig. 3.3a. Figure 3.3b shows the absence of nuclear staining in the negative control which 
was prepared following the same procedure but in which the primary antibody was substituted 
with 1 % FCS in PBS. The presence of T antigen was confirmed by western blot analysis using 
the same antibody. Figure 3.4 shows that while the dermal lines, DMEL-1 , 2 & 3 appeared to 
have comparable levels of T antigen, these levels were higher than that found in the epidermal 
lines, EMEL-1, 2 & 3. Interestingly, compared to the EMEL-1 & 3 cell lines, the EMEL-2 cell line 
had much lower levels of the T antigen. 
Southern blotting was used to determine whether the six selected cell lines were clonal. 
Genomic DNA prepared from the cells was digested with Eco R1 and blots hybridised to a cDNA 
sequence of the neomycin resistance gene. Since Eco R1 cuts once in the provirus and yields a 
fragment containing an intact neomycin resistance gene (Fig. 3.Sa), analysis of the Eco R1 
digest with a probe specific for the neomycin resistance gene should indicate the number of 
· proviral inserts. A single hybridisation band in each cell line indicated that all six cell lines 
contained a single integrated retroviral genome (Fig. 3.Sb) and confirmed that they were clonal. 
As expected, DNA from the \j/2 cells had a single hybridisation band while DNA from the NIH 
3T3 cells (negative control) showed no hybridisation. These results confirmed that the EMEL-1 , 
2 & 3 and DMEL-1, 2 & 3 cell lines each arose from a single pigmented melanocyte and not a 
mixture of melanocytes and other cell types. 
3.3 T antigen-expressing melanocytes retain the characteristics of fully differentiated 
melanocytes 
To determine the effect of the SV40 large T antigen on melanocyte differentiation, EMEL-1, 2 & 
3 and DMEL-1, 2 & 3 cells were cultured at the permissive temperature (33°C) and assessed for 
their ability to express melanocyte-specific markers. 
3.3.1 Epidermal and dermal-derived melanocytes are morphologically normal and actively 
synthesize melanin 
To ascertain the effect of the T antigen on melanocyte morphology, all six cell lines were 
examined by phase contrast and bright field microscopy. The epidermal melanocyte lines 
exhibited a morphology typical of cultured epidermal melanocytes: the cells were bipolar, tripolar, 
or dendritic with dark cytoplasm when examined by phase contrast microscopy (Fig. 3.6a,c,e). 
Under bright field microscopy, pigment granules were visible within the cytoplasm and dendrites 
Fig. 3.3. lmmunocytochemical detection of the SV40 large T antigen. (a) Shows a bright field 
photomicrograph of DMEL-2 cells immunostained with the monoclonal antibody Pab 101 , specific for the 
large T antigen. Staining was observed in the nuclei of all the cells. (b) Staining was not observed in the 










































Fig. 3.4. Comparison of levels of T antigen protein in T antigen-expressing melanocytes. T antigen-
expressing melanocyte cell lines cultured at 33°C at no more than 10 passages were solubilised in lysis 
buffer and 12.45 µg of protein from each extract was separated on a 7.5% polyacrylamide gel. After 
electrotransfer to a nitrocellulose sheet the proteins were stained with the monoclonal anti-SV40 large T 
antigen antibody (0.5 µg/ml) and visualised by enhanced chemiluminescence (Amersham). NIH 3T3 
fibroblasts were used as a negative control. 
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Fig. 3.5. Detection of proviral insertion by Southern blot hybridisation to a radiolabelled 
neomycin-resistance cDNA probe. (a) A schematic representation of the integrated proviral 
DNA. Since Eco R1 cuts once in the provirus, hybridisation of the Eco R1 digest with the 
neomycin-resistance (neo) probe should reveal a single band. (b) Southern blot analysis 
shows that all cell lines contain a single retroviral insert. Twenty micrograms of genomic DNA 
was digested with Eco R1 , transferred onto a Nylon+ membrane and hybridised to a 
32P-
labelled probe covering the neo sequence. 
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Fig. 3.6. Morphology of semiconfluent cultures of T antigen-expressing epidermal melanocytes. Phase 
contrast (a,c,e) and bright field (b,d,f) photomicrographs depict the typical appearance of the epidermal 
melanocyte lines. (a) EMEL-1 at passage 12, (c) EMEL-2 at passage 11 and (e) EMEL-3 at passage 13. 
(b,d,f) are the same fields as (a,c,e) showing pigment granules in the cytoplasm and dendrites of the cells. 
Arrowheads depict the elongated appearance of cells at confluence. 
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of all the cells (Fig. 3.6b,d,f}. At confluence, the cells were homogeneous in shape with an 
elongated appearance (see arrowheads in Fig. 3.6a,b) and although they were closely 
juxtaposed, they never formed multiple layers. 
The dermal melanocyte lines had a morphology different from the epidermal cell lines: the cells 
were mainly bipolar, typical of dividing melanocytes (Fig. 3.7a,c,e) and visibly pigmented (Fig . 
3.7b,d,f}. Cell bodies of the dermal cell lines were much smaller than those of the epidermal cell 
lines (compare Fig. 3.6a & 3.7a). At confluence, they became tripolar and epithelioid (Fig . 
3.7g,h) but never formed foci. After six months in culture (approximately passage 10), the EMEL-
1, 2 & 3 and DMEL-1 , 2 & 3 retained the highly melanotic phenotype of their original 
counterparts. The above results indicate that at this stage, T antigen expression had no effect 
on the pigmented phenotype of these cell lines. This was confirmed by assays for melanin 
synthesis (Table 3.2). 
Table 3.2. Melanin synthesis in T antigen-expressing melanocytes at no 
later than passage 10 
Cell lines 14C-Tyrosine incorporation/100 µg 
protein 
lj/2 400.00 ± 52.0 
816 2577.00 ± 16.7 
EMEL-1 1580.00 ± 20.3 
EMEL-2 2060.00 ± 12.0 
EMEL-3 2639.00 ± 16.4 
DMEL-1 1825.00 ± 42.0 
DMEL-2 1672.00 ± 0.6 
DMEL-3 1326.00 ± 39.3 
Epidermal cell lines (EMEL-1, 2 & 3) appeared, on average, to be synthesizing melanin at a 
higher rate than the dermal cell lines (DMEL-1 , 2 & 3). Compared to the EMEL-1 & 2 and DMEL-
1, 2 & 3 cell lines, the 816 melanoma cells had a higher rate of melanin formation. This result 
was interesting because the visual examination of the pellets of all the pigmented cell lines used 
in this assay indicated that 816 melanoma cells were the least pigmented. This suggests that 
there was no direct correlation between visible pigmentation and melanin synthesis. 
3.3.2 Epidermal and dermal melanocytes express tyrosinase, TRP-1, TRP-2 and mi genes 
The next aim was to examine the effect of the T antigen on the expression of melanocyte-
specific genes known to be involved in melanin biosynthesis. Northern blots were prepared and 
hybridised with specific cDNA probes for mouse tyrosinase, TRP-1 and TRP-2 genes. The same 
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Fig. 3.7. Morphology of cultures of T antigen-expressing dermal melanocytes. Phase contrast (a,c,e,g) and 
bright field (b,d,f,h) photomicrographs depict the typical appearance of the dermal melanocyte lines at 
passage 5. (a) DMEL-1, (c) DMEL-2 and (e) DMEL-3. (g) Typical appearance of dermal melanocytes at 
confluence. (b,d,f,h) are the same fields as (a,c,e,g) showing pigment granules in the cytoplasm and 
dendrites of the cells. 
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filters were stripped and reprobed for all the genes. RNA from 816 melanoma cells and RNA 
from the '1'2 fibroblast cell line were included on all blots as positive a~d negative controls and 
hybridisation with a j3-actin cDNA served as a loading control. The results from these 
experiments are presented in Fig. 3.8. 
When hybridised with a mouse tyrosinase cDNA, two transcripts of approximately 2.5 kb and 8.0 
kb were detected in all six T antigen-expressing melanocyte cell lines (see arrowheads) and both 
signals were present even after very high stringency washing. The 2.5 kb and 8.0 kb transcripts 
were first detected after 9 and 14 days, respectively, of autoradiographic exposure. This 
suggested that the 8.0 kb transcript was expressed at lower levels than the 2.5 kb transcript. 
The detection of more than one transcript is consistent with a previous report showing that 
multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing (Ruppert 
et al. , 1988). As can be seen in Fig. 3.8, the expression of the tyrosinase gene appeared to be 
highest in the epidermal cell lines and the 816 melanoma cells expressed levels similar to the 
dermal cell lines. The expression of tyrosinase was melanocyte-specific since no bands were 
observed in the '1'2 fibroblast RNA. 
For TRP-1 , a single transcript of approximately 3. 7 kb was observed in all six cell lines as well as 
in the 816 melanoma cells. The TRP-1 transcript could be detected as early as 1 day after 
autoradiographic exposure indicating that TRP-1 is significantly more abundant than tyrosinase. 
Similarly, the autoradiographs for TRP-2 were exposed for 1 day and clearly showed a very 
intense 2.4 kb transcript in all six cell lines indicating a higher prevalence of TRP-2 mRNAs. 
TRP-2 expression was higher in epidermal than in the dermal cell lines and the 816 melanoma 
cells expressed TRP-2 mRNAs at levels similar to the dermal cell lines. 
To determine whether there was a correlation between the expression of the tyrosinase gene 
family and mi in T antigen-expressing melanocytes, the above northern blots were hybridised 
with a mouse mi cDNA. After 11 days of exposure, a single band of approximately 7.0 kb was 
obtained in all six cell lines, as well as in 816 melanoma cells (See Fig. 3.8) . The long exposure 
time for the mi result could indicate low prevalence of the mi mRNA in the above cell lines. 
Alternatively, it could indicate that stripping the blots repeatedly resulted in some RNA being lost. 
The expression of the tyrosinase, TRP-2 and mi genes in Fig . 3.8 appeared to be highest in the 
epidermal melanocyte cell lines. To determine whether this was indeed the case, the levels 
reflected by these autoradiographs needed to be corrected for (1) RNA loading and (2) the use 
of separate blots for the epidermal and dermal cell lines. This was estimated as follows: (1) Less 
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Fig. 3.8. Northern blot analysis of melanocyte-specific gene expression in pigmented T 
antigen-expressing melanocytes. Total RNA (20 µg) from each sample was separated on a 
formaldehyde gel followed by electrophoretic transfer onto nitrocellulose membranes. The 
same blots were repeatedly hybridised to probes specific for tyrosinase, TRP-1 , TRP-2, mi or 
for P-actin as a loading control. Arrowheads indicate two tyrosinase transcripts. 
51 
52 
exposed autoradiographs were scanned densitometrically and the levels of tyrosinase, TRP-1 , 
TRP-2 and mi were calculated relative to ~-actin. (2) Each blot contained RNA that was prepared 
from the same 816 melanoma cells so that values were calculated relative to the respective 
level of B16melanoma cells in each blot. Bar graphs of these values for EMEL-1 , 2 & 3 and 
DMEL-1 , 2 & 3 are shown in Fig . 3.9. The results suggested that, on average, the epidermal cell 
lines express higher levels of the tyrosinase, TRP-1 , TRP-2 and mi genes. 
3.3.3 Melanocyte-specific proteins are present in T antigen-expressing melanocytes 
To determine whether the levels of message correlated to levels of tyrosinase, TRP-1 and TRP-
2 proteins in EMEL-1 , 2 & 3 and DMEL-1, 2 & 3 cell lines, western immunoblotting was carried 
out. Extracts from all six cell lines were analyzed using the anitibodies a.PEP?, a.PEP1 and 
a.PEPS which recognise tyrosinase, TRP-1 and TRP-2 proteins, respectively (Tsukamoto et al. , 
1992). NIH 3T3 fibroblasts were included as non-melanocytic negative control cells. The results 
from these experiments are presented in Fig. 3.10. 
lmmunoblotting using antibodies specific for the tyrosinase protein revealed an immunoreactive 
band of approximately 75 kDa in the EMEL-1 , 2 & 3 and DMEL-1 & 2 cell lines which was not 
detected in the DMEL-3 cell line. This band represents the glycosylated form of tyrosinase (Chen 
et al. , 1995; Hearing and Tsukamoto, 1991 ; Halaban and Moellmann, 1990). The 75 kDa protein 
was not detected in the NIH 3T3 fibroblasts. 
As for the tyrosinase result, antibodies specific to the TRP-1 protein recognised the glycosylated 
form of TRP-1 , which was detected as a major band of approximately 80 kDa band, in the 
EMEL-1 , 2 & 3 and DMEL-1 & 2cell lines but not in the DMEL-3 cell line. It is worth noting that a 
minor background band of 69 kDa was also detected in the NIH 3T3 fibroblasts. This result is 
occasionally seen (in NIH 3T3 cells and other non-melanocytes) in other laboratories and it has 
been suggested that it represents a nonspecific reaction (personal communication, V. Hearing). 
Antibodies to TRP-2 identified a major band of approximately 64 kDa in all 6 melanocyte lines. A 
faint band of approximately 75 kDa was present in the EMEL-1 , 2 & 3 and DMEL-1 cell lines but 
was undetectable in the DMEL-2 and 3 cell lines. Since the 64 kDa protein probably represents 
the de novo form of TRP-2, these results suggest that all 6 cell lines contain high levels of the 
TRP-2 protein. Shorter exposures of the autoradiograms revealed that this protein was absent in 
NIH 3T3 fibroblasts. However, longer exposures of the autoradiograms indicated that this protein 


























































Fig. 3.9. Expression of tyrosinase, TRP-1 , TRP-2 and mi in epidermal (EMEL-1 , EMEL-2 and EMEL-3) and 
dermal (DMEL-1, DMEL-2 and DMEL-3) cell lines. Densitometric scans of the autoradiographs in Fig. 3.8 















































Fig. 3.10. Western immunoblot analysis of levels of melanocyte-specific proteins. T antigen-
expressing melanocyte cell lines cultured at 33°C were solubilised in lysis buffer and 20 µg 
protein from each extract was separated on SDS gels. After electrotransfer to nitrocellulose 
membranes, the blots were probed with antisera specific to tyrosinase (a.PEP?), TRP-1 (a.PEP1) 
or TRP- 2 (a.PEPS) and the bands were visualised by chemiluminescence. Molecular weight 




3.4 Proliferation of T antigen-expressing melanocytes is stimulated
 by, but not dependent 
onTPA 
Previous studies have shown that in general, normal mouse melanoc
ytes in culture have 
obligatory growth requirements for TPA and a natural growth factor p
rovided by serum. In 
contrast, transformed melanocytes proliferate independently of TPA and g
rowth factors required 
by normal melanocytes. When the EMEL-1, 2 & 3 and DMEL-1, 2 & 3 ce
ll lines were originally 
established from primary melanocyte cultures, they were grown in melan
ocyte-specific medium 
(MSM) which contained TPA, human placental extract and 20% fetal calf s
erum. To evaluate the 
effect of these individual growth-promoting additives on T antigen-expres
sing melanocytes, the 
growth of DMEL-2 cells was assessed in the following media: 
i) MSM = basic medium (Ham's F10 and IBMX) + 48 nM TPA + 50 µg protein/ml human 
placental extract + 20% FCS 
ii) MSM - HPE = MSM without human placental extract 
iii) MSM - TPA = MSM without TPA 
iv) MSM2% = MSM with 2% instead of 20% FCS 
DMEL-2 cells were selected for detailed analysis since all six cell lines w
ere shown to exhibit 
similar melanocyte-specific characteristics. The results of this experiment
 are illustrated in Fig. 
3.11. When the growth of the cells was compared in MSM and MSM 
- HPE, there was no 
difference in the proliferation rate of the cells. HPE was, however, retained
 in the culture medium 
to ensue consistency in experimental conditions. Cells grown in MSM - T
PA revealed that the 
absence of TPA did not lead to quiescence of the cells but it did result in d
ecreased proliferation 
as compared to cells grown in MSM. This result suggested that while TPA
 was not an obligatory 
mitogen for T antigen-expressing melanocytes, it was able to stimulate the
 growth of these cells. 
To determine the relative importance of serum in the culture medium, t
he growth of DMEL-2 
cells was compared in MSM and MSM2%. Lowering the serum concentrati
on in the medium from 
20% to 2%, reduced cell numbers by almost 50%. Since MSM2% contain
s TPA, it can only be 
concluded that 2% serum was sufficient for growth (albeit slower growth) w
hen TPA was present 
in the culture medium. 
3.5 TPA stimulates melanogenesis 
3.5.1 TPA enhances the dendritic pigmented phenotype of melanocy
tes 
While investigating the growth of the DMEL-2 cells in different media 
(as described above), 
differences in the morphology of the cells were noticed: Cells grown in med
ium without TPA 
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Fig 3.11. Growth kinetics of DMEL-2 cells cultured at 33°C in MSM (blue line), MSM-
HPE (red line), MSM-TPA (orange line) and MSM2% (green line). Each value is the 
average of duplicate wells. The standard error between duplicate wells ranged 
between 5 and 15%. 
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became polygonal, lost their dendritic morphology (Fig. 3.12a) and exhibited minimal 
pigmentation when examined by bright field microscopy (Fig. 3.12b). In contrast, cells grown in 
medium with TPA were dendritic and pigmented (Fig. 3.12c,d). Furthermore, the removal of TPA 
from the medium resulted in a 5.3-fold decrease in melanin content of these cells (Table 3.3). 
There was only a slight decrease of 1. 7- and 1.4-fold in melanin content when either human 
placental extract was excluded from the medium or, when the serum concentration was dropped 
from 20% to 2%, respectively. 
Table 3.3. Effect of TPA, HPE and FCS on melanin content in DMEL-2 cells 
Samples 00475 Fold increase above 3T3 
fibroblasts 
3T3 fibroblasts 0.028 ± 0.001 1.0 
MSM 0.403 ± 0.005 14.4 
MSM - HPE 0.296 ± 0.003 10.6 
MSM - TPA 0.076 ± 0.003 2.7 
MSM2% 0.278 ± 0.005 9.9 
3.5.2 TPA treatment results in increased levels of tyrosinase, TRP-1 and TRP-2 protein 
levels 
To further explore the effect of TPA on pigmentation, the levels of the melanogenic proteins 
were measured in TPA-treated and untreated DMEL-2 cells. Western immunoblotting of extracts 
of DMEL-2 cells, grown at 33°C in either the presence or absence of 48 nM TPA for 24 days, 
was carried out using the antibodies, a.PEP?, aPEP1 and aPEP8. Protein extracts from melan-a 
cells were included on all blots as positive experimental controls. The results are presented in 
Fig. 3.13. 
lmmunoblotting, using antibodies specific for tyrosinase, revealed the presence of two 
immunoreactive proteins of approximately 60 kDa and 75 kDa in TPA-treated DMEL-2 cells (lane 
3). These two proteins, which were also detected in melan-a cells (lane 1) represent the de novo 
and mature glycosylated forms of the protein, respectively. When TPA was removed from the 
medium, the 60 kD protein was detected at similar levels to those found in TPA-treated DMEL-2 
cells but the 75 kDa protein was completely absent (lane 4). These results suggest that TPA 
stimulated the synthesis of tyrosinase (because the total amount of tyrosinase protein was 
higher in TPA-treated cells) . 
Similarly, using antibodies specific to the TRP-1 protein, two immunoreactive proteins (69 kDa 
and 80 kDa) were detected in TPA-treated DMEL-2 cells (lane 3) and in melan-a cells (lane 1). 
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Fig. 3.12. Morphology of DMEL-2 cells cultured in the absence (a,b) or presence (c,d) of TPA. Phase 
contrast micrographs of DMEL-2 cells grown in medium in which TPA was withdrawn for 14 days (a) and in 
medium containing 48 nM TPA (c). (b,d) are bright field micrographs of the same fields as (a,c) showing 
the absence or presence of pigment granules, respectively. 





Fig. 3.13. Western immunoblot analysis of levels of melanocyte-specific proteins in TPA 
treated and untreated DMEL-2 cells. The cells were solubilized in lysis buffer and 30 µg 
protein from each extract was separated on 7.5% SOS gels. After electrotransfer to 
nitrocellulose membranes, the blots were probed with antisera specific to tyrosinase 
(aPEP7), TRP-1 (aPEP1) or TRP-2 (aPEP8) and the bands visualised by 
chemiluminescence. Lane 1, melan-a cells (positive control) ; lane 2, NIH 3T3 fibroblasts 




The glycosylated form of TRP-1 was dramatically lower in cells cultured in TPA-free medium 
(lane 4). Likewise, TPA-treated and untreated cells expressed similar levels of a 69 kDa protein 
that reacted with antibodies specific for TRP-2 (compare lanes 3 and 4). The glycosylated form 
of the TRP-2 protein was detected very faintly in TPA-treated cells and was not detectable in 
untreated cells. These results suggest that TPA was able to stimulate the synthesis of the TRP-1 
and TRP-2 proteins. Interestingly, unlike the T antigen-expressing DMEL-2 cells, a very intense 
band corresponding to the glycosylated form of TRP-2 was detected in melan-a cells (lane 1 ). 
3.5.3 The effect of TPA on tyrosinase, TRP-1 and TRP-2 protein levels is not dose-
dependent 
Previously, it was reported that TPA caused a dose-related stimulation of tyrosinase activity in 
normal human melanocytes (Chao-Hsing, 1991 ; Abdel-Malek et al. , 1992). Western blot analysis 
was therefore used to compare the levels of tyrosinase, TRP-1 and TRP-2 proteins in DMEL-2 
cells grown at 33°C in either 48 nM TPA or 200 nM TPA. These two concentrations were 
selected because they are the most. frequently used in procedures published for the culture of 
primary and immortalised mouse melanocytes. Figure 3.14 shows that there was no appreciable 
difference in the amount of tyrosinase, TRP-1 and TRP-2 proteins present in DMEL-2 cells 
grown in either 48 nM TPA (lane 1) or 200 nM TPA (lane 4). These results suggest that 48 nM 
TPA is possibly a saturating dose. 
3.5.4 T antigen does not modulate the effect of TPA on tyrosinase, TRP-1 and TRP-2 
protein levels 
Because oncoproteins are known to alter the differentiation programme of melanocytes, the next 
question asked was whether the T antigen could modulate the effect of TPA on levels of 
tyrosinase and TRP-1 proteins. To answer this question DMEL-2 cells were grown at the 
permissive (33°C) and non-permissive (37°C) temperatures for 3 and 5 days in either 48 nM TPA 
or 200 nM TPA. As can be seen in Fig. 3.14, DMEL-2 cells grown in 48 nM TPA at either 33°C 
(lane 1) or 37°C for 3 and 5 days (lanes 2 & 3 respectively) produced similar levels of tyrosinase, 
TRP-1 and TRP-2 proteins. Similarly, a comparison of the levels of tyrosinase, TRP-1 and TRP-
2 protein in cells grown in 200 nM TPA at 33°C (lane 4) or 37°C for 3 and 5 days (lanes 5 & 6 
respectively) revealed that there were no appreciable differences in the levels of these proteins. 
Therefore, the T antigen did not appear to alter the responsiveness of DMEL-2 cells to TPA. 




Fig. 3.14. Western immunoblot analysis of levels of melanocyte-specific proteins in DMEL-2 
cells cultured at 33°C and 37°C in either 48 nM TPA or 200 nM TPA. The cells were 
solubilized in lysis buffer and 38 µg protein from each sample was separated on 7.5% SOS 
gels. After electrotransfer to nitrocellulose membranes, the blots were probed with antisera 
specific to tyrosinase (cxPEP7), TRP-1 (cxPEP1) or TRP-2 (cxPEP8) and the bands were 
visualised by chemiluminescence. Lanes 1, 2 and 3, DMEL-2 cells grown in 48 nM TPA at 
either 33°C or, 37°C for 3 and 5 days, respectively; lanes 4, 5 & 6, DMEL-2 cells grown in 




3.5.5 Expression of tyrosinase, TRP-1 and TRP-2 genes are co-ordinately up-regulated by 
TPA 
Northern blot analysis was performed to determine whether the increase in the levels of 
tyrosinase, TRP-1 and TRP-2 proteins in response to TPA treatment resulted from an increase 
in the levels of the encoding mRNA. A northern blot was prepared using total RNA from DMEL-2 
cells cultured in the presence or absence of 48 nM TPA at 33°C for 10 and 17 days. Figure 3.15 
(lanes 2 and 4) shows that DMEL-2 cells, grown in the presence of TPA, expressed both 
tyrosinase transcripts of approximately 2.5 kb and 8.0 kb, whereas no detectable tyrosinase 
mRNA was found in cells grown in the absence of TPA for 10 (lane 3) and 17 (lane 5) days. 
Similarly, a 3.7 kb TRP-1 transcript was observed in DMEL-2 cells grown with TPA (lane 2 and 
lane 4) and this signal decreased the longer the cells were grown without TPA (lane 3 (10 days) 
and lane 5 (17 days)). Likewise, an intense 2.4 kb TRP-2 transcript was detected in lanes 
containing RNA from TPA-treated DMEL-2 cells (lanes 2 and 4). When the cells were cultured 
without TPA, the amount of TRP-2 mRNA decreased after 10 days (lane 3) and was further 
lowered to undetectable levels after 17 days (lane 5). 
3.5.6 TPA increases mi expression 
To investigate the mechanism by which TPA increased tyrosinase, TRP-1 and TRP-2 mRNA 
levels, the level of expression of the mi gene was determined. As can be seen in Fig . 3.15, 
DMEL-2 cells treated with TPA expressed high levels of mi (lanes 2 and 4) and there was no 
detectable expression in untreated cells (lanes 3 and 5). These results indicate that TPA could 
be stimulating melanin synthesis by stimulating mi expression and consequently increasing the 
expression of the tyrosinase, TRP-1 and TRP-2 genes. To explore the possibility that TPA is 
acting via Pax3 to increase mi expression, northern blot analysis was performed. A northern blot 
containing the same samples as described in section 3.5.5 was probed with a mouse Pax3 
cDNA and no detectable Pax3 transcripts were found in cells cultured in either the presence or 
absence of TPA (results not shown). 
3.6 The SV40 large T antigen induces loss of melanocyte-specific markers in DMEL-3 cells 
which are re-expressed at the non-permissive temperature 
3.6.1 DMEL-3 cells gradually acquire morphological features typical of transformed 
melanocytes 
Following six months of continual passage (approximately passage 10) at 33°C, the DMEL-3 
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Fig. 3.15. Northern blot analysis of melanocyte-specific gene expression in DMEL-2 cells 
cultured at 33°C with or without 48 nM TPA. Total RNA (20 µg) from each sample was 
separated on a formaldehyde gel followed by electrophoretic transfer onto nitrocellulose 
membranes. The same blot was repeatedly hybridised to probes specific for tyrosinase, TRP-
1, TRP-2 or mi. Ethidium bromide staining of the 28S and 18S rRNAs shows the quality and 
quantity of the RNAs loaded. Lane 1, 816 melanoma cells (positive control); lanes 2 and 4, 
TPA-treated DMEL-2 cells; lanes 3 and 5, DMEL-2 cells cultured without TPA for 10 and 17 
days, respectively; lane 6, \j/2 fibroblasts (negative control). 
63 
64 
passage 10, the DMEL-3 cells were much less pigmented and dendritic (Fig . 3.16a,b) than cells 
of the same cell line at earlier passages (see Fig. 3.7e,f). Eventually, at passage 17, the cells 
displayed the characteristic morphology of a transformed cell line: that is, they were mostly 
unpigmented and larger with fewer dendrites (Fig. 3.16c,d). However, they did not form colonies 
in soft agar assays nor did they form foci in culture. 
To ascertain whether the T antigen was directly involved in the de-differentiation process, it was 
investigated whether reversion to the normal melanocyte morphology could be achieved by 
inactivating the oncoprotein at the non-permissive temperature. The approach was thus to 
culture passage 1 O and 17 DMEL-3 cells at both the permissive (33°C) and non-permissive 
(37°C) temperatures and to compare the morphology of the cells using light microscopy. After 3 
days of incubation at 37°C, the morphology of passage 10 cells had visibly changed. The cells 
reverted to a more dendritic and visibly pigmented phenotype and some of the cell bodies 
became smaller in size (Fig. 3.16e,f). When passage 17 cells were transferred to 37°C, the cells 
became more dendritic but, in contrast to passage 10 cells, they did not visibly repigment (even 
after 21 days at this temperature). It is possible, however, that partial reversion had occurred but 
that the changes were not detectable microscopically. To explore this question further, a more 
detailed biochemical and molecular analysis was carried out on DMEL-3 cells, and by way of 
comparison, on DMEL-2 cells. (The DMEL-2 cell line was selected as a representative of the five 
cell lines which did not depigment). 
3.6.2 Depigmentation in DMEL-3 cells results from the co-ordinate down-regulation of 
tyrosinase, TRP-1 and TRP-2 gene expression 
Passage 13 or 14 DMEL-2 cells grown at 33°C and at 37°C for 2 and 4 days, and passage 15 or 
17 DMEL-3 cells grown at 33°C and at 37°C for 2, 4 and 21 days, were assayed for their ability 
to synthesize melanin. The assay was carried out on three separate occasions in triplicate with 
different passages and are therefore presented separately as cpm/100 µg protein and as a 
percentage of 816 melanoma cell activity (Table 3.4). 
Results showed that, compared to 816 melanoma cells, DMEL-3 cells cultured at 33°C had low 
levels of melanin synthesis activity. At 37°C, however, melanin synthesis was stimulated in a 
time-dependent manner. Compared to DMEL-3 cells, the DMEL-2 cells showed much higher 
melanin synthesis activity at 33°C which also increased at 37°C. The above results indicate that 
although DMEL-3 cells did not visibly repigment within 21 days at 37°C, they did regain the 
ability to synthesize melanin at this temperature. A similar pattern of results was obtained when 
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Fig. 3.16. Morphology of DMEL-3 cells cultured at 33°C and 37°C. Figures a,c,e are phase contrast 
photomicrographs and b,d,f are the equivalent bright field photomicrographs. They show DMEL-3 cells 




Table 3.4. Melanin fonnation in DMEL-2 and 3 cells cultured at 33°C and 37°C 
Cell lines Assay 1 Assay 2 Assay 3 
cpm/100 µg % activity cpm/100 µg % activity cpm/100 µg % activity 
protein of 816 cells protein of 816 cells protein of 816 cells 
\V2 Fibroblasts 1066 ± 171 31 893 ± 252 63 1146 31 
816 melanoma cells 3428 ± 324 100 1421± 62 100 3700 100 
DMEL-2 (33°C) ND ND 1043 ± 27 74 2238 61 
DMEL-2 (37°C for 2 days) ND ND 1310 ± 5 92 2406 65 
DMEL-2 (37°C for 4 days) ND ND 859 ± 17 61 2422 66 
DMEL-3 (33°C) 1333 ± 219 39 624 ± 41 44 1242 34 
DMEL-3 (37°C for 2 days) 1550 ± 72 45 721±3 51 1341 36 
DMEL-3 (37°C for 4 days) 2246 ± 324 66 1092 ±44 77 1752 47 
DMEL-3 (37°C for 21 1998 ± 181 58 1213 ± 68 85 2049 55 
days) 
ND Not determined 
DMEL-3 cells were cultured at 33°C and 37°C for 4 and 21 days and then assayed for 
tyrosinase (tyrosine hydroxylase), TRP-1 (DHICA oxidase) and TRP-2 (DOPAchrome 
tautomerase) activity. The results of the tyrosine hydroxylase and DOPAchrome tautomerase 
assays are shown in Table 3.5 and are expressed in pmol/µg protein/hour. The results for 
DHICA oxidase activity was too low to be detected by this assay and they were therefore 
considered unreliable for analysis. 
Table 3.5. Melanogenic activities of DMEL-3 cells at 33°C and 37°C 
TYROSINE DOPACHROME 
CELLS HYDROXYLASE TAUTOMERASE 
pmol/µg protein/hr pmol/µg protein/hr 
DMEL-3 (33°C) 1.0 1.6 
DMEL-3 (37°C for 4 days) 1.7 4.9 
DMEL-3 (37°c for 21 days) 2.0 30.2 
melan-a (37°C) 6.1 14.7 
Taken together, the above results suggest that the inhibition of melanin synthesis in passage 17 
DMEL-3 cells cultured at 33°C results from low levels of tyrosinase, TRP-1 and TRP-2 activity. 
To determine whether these decreases were due to down-regulation of gene activity, northern 
blot analyses were carried out to compare tyrosinase, TRP-1 and TRP-2 expression in passage 
17 DMEL-3 cells cultured at the permissive (33°C) and non-permissive (37°C) temperatures. 
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DMEL-2 cells grown at 33°C and 37°C were also included for comparative analyses. Fig. 3.17A 
(lane 2) shows that the DMEL-2 cells grown at 33°C expressed two tyrosinase transcripts of 
approximately 2.5 kb and 8.0 kb. The level of both tyrosinase transcripts increased slightly when 
DMEL-2 cells were grown at 37°C for 2 days (lane 3) and 4 days (lane 4). In contrast, Fig. 3.178, 
lane 2, shows that no detectable tyrosinase mRNA was found in DMEL-3 cells grown at 33°C 
but a faint signal corresponding to a 2.5 kb transcript was detected in DMEL-3 cells cultured at 
37°C for 2 days (lane 3). The intensity of the signal increased the longer the cells were cultured 
at 37°C (lane 4 (4 days) and lane 5 (21 days)). A comparison of the TRP-2 gene expression in 
DMEL-2 and 3 cells at 33°C and 37°C is shown in Fig . 3.17 A and 8, respectively. A very intense 
2.4 kb transcript was obtained in DMEL-2 cells at 33°C (lane 2) and the intensity of this transcript 
increased slightly when DMEL-2 cells were cultured at 37°C for 2 days (lane 3) and 4 days (lane 
4). In contrast, DMEL-3 cells showed a weak signal at 33°C (lane 2) and the intensity of the 
signal increased with time when the cells were cultured at 37°C for 2 days (lane 3), 4 days (lane 
4) and 21 days (lane 5). An analysis of TRP-1 gene expression in DMEL-2 cells at 33°C and 
37°C is shown in Fig. 3.17 A. A single transcript of 3. 7 kb was observed in DMEL-2 cells grown at 
33°C (larie 2) and this signal increased slightly when the cells were grown at 37°C for 2 days 
(lane 3) and 4 days (lane 4). While TRP-1 expression was not determined for DMEL-3 cells at 
33°C, Fig. 3.17C. (lane 3) shows a faint signal corresponding to a 3. 7 kb transcript in DMEL-3 
cells cultured at 37°C for 2 days. The intensity of this signal increased, the longer the cells were 
cultured at 37°C (lanes 4 (4 days) and 5 (21 days)) . 
Tyrosinase, TRP-1 and TRP-2 transcripts were detected in 816 melanoma cells but were 
completely absent in the w2 fibroblast cell line. 
3.6.3 mi expression is down-regulated in depigmented DMEL-3 cells 
To shed light on the mechanism by which the downregulation of melanocyte-specific genes 
might occur at the permissive temperature (33°C), the level of expression of the microphthalmia 
gene was determined. Given the possibility that stripping blots repeatedly could be resulting in 
loss of RNA (as mentioned on page 50) and thus inaccurately reflecting low levels of mi 
expression, new northern blots were prepared using the same batch of RNA that was probed for 
the expression of the tyrosinase, TRP-1 and TRP-2 genes. As can be seen in Fig. 3.18A, the 
DMEL-2 cells expressed high levels of mi at 33°C and, as with tyrosinase, TRP-1 and TRP-2, 
there was only a slight increase at 37°C. A comparison of the level of mi expression obtained in 
this experiment (for DMEL-2 and 816 melanoma cells) to that obtained in Fig 3.8 would indeed 
suggest that large amounts of RNA are lost during stripping of northern blots. In contrast, Fig. 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































33°C. After only 4 days of culture at 37°C, mi message began to increase. The ratio of mi 
expression relative to !3-actin expression was calculated from the phospho-analyzer readings 
and the following ratios were obtained: at 33°C, 1: 1; at 37°C for 2, 4 and 21 days, 1: 1.1; 1: 1.2 
and 1 :2.4, respectively. These results show that mi gene expression is down-regulated in DMEL-
3 cells cultured at 33°C and that the level of its expression begins to increase after 4 days at 
37°C. There was therefore a direct correlation between the re-expression of the mi gene at 37°C 
and that of the tyrosinase, TRP-1 and TRP-2 genes. 
The above results raised the possibility that one mechanism whereby the T antigen might 
downregulate expression of the tyrosinase gene family is by repressing mi expression. If this 
was the case, then ectopic expression of mi in DMEL-3 cells cultured at 33°C should rescue the 
expression of endogenous tyrosinase, TRP-1 and TRP-2 genes. DMEL-3 cells were therefore 
transfected with an expression vector encoding a mi cDNA. To facilitate the selection of stable 
transfectants, a plasmid encoding the puromycin resistance gene (pBabepuro) was co-
transfected into the cells. DMEL-3 cells transfected with only the pBabepuro plasmid and 
untransfected DMEL-3 cells, served as controls. A week after the cells were grown in medium 
supplemented with 2.5 µg/ml puromycin, a significant percentage of cells detached from the 
culture surfaces of all dishes and died. This mortality was initially most noticeable in 
untransfected dishes. However, puromycin-resistant colonies of cells soon appeared in both 
transfected and untransfected dishes. A similar pattern of results was obtained for 
concentrations of puromycin ranging from 2.5 µg/ml to 7.5 µg/ml. Since the survival of 
untransfected and "transfected" DMEL-3 cells was similar in medium supplemented with various 
concentrations of puromycin, this experiment was abandoned. 
It should be pointed out that before the above transfection experiments were performed, a dose-
curve was constructed to determine what concentration of puromycin was required to kill 
untransfected DMEL-3 cells (results not shown). The cells were plated in 35 mm dishes at a 
density of 6 X 104 cells/dish and duplicate dishes were treated with the following concentrations 
of puromycin over a period of 1 O days (media containing the appropriate concentration of 
puromycin were renewed every 3 days): 0 µg/ml; 0.625 µg/ml; 1.25 µg/ml; 2.5 µg/ml; 5.0 µg/ml 
and 10 µg/ml. Results from the dose curve suggested that the cells were sensitive to puromycin 
at concentrations above and including 2.5 µg/ml. It would therefore appear that DMEL-3 cells, 
cultured for prolonged periods in the presence of puromycin, developed drug resistance. 
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3.6.4 Pax3 expression is not detected in DMEL-2 and 3 cells 
To investigate the mechanism by which mi expression is down
-regulated at the permissive 
temperature (33°C), northern blot analysis was performed to dete
rmine the level of Pax3 gene 
expression. Northern blots were prepared using the same batch of
 RNA that was probed for the 
expression of the microphthalmia gene. Pax3 expression could no
t be detected in DMEL-3 cells 
cultured at either the permissive or non-permissive temperatures 
(results not shown). Similarly, 
Pax3 transcripts were completely absent in pigmented DMEL-2 a
nd melan-a cells (results not 
shown). These results suggested that Pax3 was not expressed
 in "normal" and T antigen-
expressing melanocytes and that there was therefore no dir
ect correlation between the 
expression of the mi gene and that of the Pax3 gene. 
3. 7 Melanogenesis is not favoured at 37°C 
At this stage of the study it was considered important to confirm
 that DMEL-3 cells were re-
expressing melanocyte-specific markers at the non-permissive te
mperature (37°C) due to the 
inactivation of the T antigen and not because melanogenesis is fa
voured at this temperature. If 
the latter was the case, one would predict that the levels of the m
elanogenic proteins and their 
enzymatic activities would 9e higher at 37°C than at 33°C. To tes
t this hypothesis, a study was 
done using melan-a cells, an immortalised mouse melanocyte ce
ll line in which properties of 
normal melanocytes are retained. The cells were grown at 37
°C and 33°C for 18 days, 
solubilized, and the proteins used for both western blot analys
is and enzymatic assays for 
tyrosinase and TRP-2 activity. 
Western blots showed that the levels of tyrosinase and TRP-1 
proteins were higher in cells 
grown at 33°C (Fig. 3.19). In contrast, the levels of TRP-2 protei
n were not influenced by the 
temperature at which the cells were cultured. Furthermore, the c
ells grown at 33°C exhibited 
almost twice the tyrosine hydroxylase activity of cells grown at
 37°C (Table 3.6). Similarly, 
DOPAchrome tautomerase activity was stimulated 1.5 fold in m
elan-a cells grown at 33°C 
compared to 37°C. These results demonstrate that, if anything, me
lanogenic activity was higher 
at 33°C than at 37°C. 
Table 3.6. Melanogenic activities of melan-a cells at 33°C and
 37°C 
TYROSINE DOPACHROME 
CELLS HYDROXYLASE TAUTOMERASE 
pmol/µg protein/hr pmol/µg protein/hr 
melan-a cells (33°C) 11 .9 
22.0 






Fig. 3.19. Western blot analysis of levels of melanocyte-specific proteins in melan-a cells cultured for 18 
days at 33°C and 37°C. The cells were solubilized in lysis buffer and 25 µg of protein from each sample was 
separated on 7.5% SDS gels. After electrotransfer to nitrocellulose membranes, the blots were probed with 
antisera specific to tyrosinase (aPEP7), TRP-1 (aPEP1) or TRP-2 (aPEP8) and the bands visualised by 
chemiluminescence. 
A 1 2 3 4 5 B 1 2 3 4 5 
Fig. 3.20. Northern blot analysis of c-kit expression in DMEL-2 and 3 cells cultured at 33°C and 37°C. In A: 
lane 1, 816 melanoma cells; lanes 2, 3 & 4, passage 13 DMEL-2 cells cultured at 33°C, and 37°C for 2 and 4 
days, respectively; lane 5, '1'2 fibroblasts. In B: lane 1, melan-a cells; lanes 2, 3, 4 & 5, passage 17 DMEL-3 
cells cultured at 33°C and, 37°C for 2, 4 and 21 days, respectively. 
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3.8 Does T antigen expression affect signalling pathways known to regulate 
melanogenesis? 
3.8.1 c-kit is expressed in pigmented DMEL-2 cells but not in unpigmented DMEL-3 cells 
To establish whether the T antigen affects c-kit expression in DMEL-2 and DMEL-3 cells, blots 
previously probed with mi were rehybridised to a c-kit cDNA. Fig. 3.20A shows the results of a 
blot containing total RNA from DMEL-2 cells grown at 33°C and 37°C, probed for c-kit 
expression. Two transcripts of approximately 8.2 kb and 5.8 kb were detected in DMEL-2 cells 
grown at 33°C (lane 2) and the levels of both transcripts increased slightly when these cells were 
grown at 37°C for 2 days (lane 3) and 4 days (lane 4). A single transcript of approximately 6 kb 
was detected in melan-a cells only (lane 1, Fig. 3.208) and no signal was obtained for DMEL-3 
cells grown at either 33°C or 37°C. 
In a repeat experiment, a northern blot of poly(Af RNA from DMEL-3 cells grown at 33°C and at 
37°C for 4, 16 and 30 days revealed once again an absence of c-kit transcripts in DMEL-3 cells 
in all cases (even after 30 days at 37°C when the cells had visibly repigmented) (not shown). 
Consistent with this result, c-Kit protein was not detected by western blot analysis with the 
monoclonal antibody, ACK2, which recognises c-Kit (not shown). These results suggest that c-kit 
expression is repressed in DMEL-3 cells grown at the permissive temperature (33°C) and that it 
is not re-expressed when the T antigen is inactivated at 37°C. 
3.8.2 a-MSH stimulates melanogenic activities in DMEL-3 cells grown at 33°C and 37°C 
To determine whether DMEL-3 cells were able to respond to a-MSH and whether such 
responsiveness was altered by T antigen expression, passage 14 DMEL-3 cells were grown at 
33°C and 37°C in melanocyte-specific medium in the presence and absence of 0.2 µM a-MSH 
for 4 days, with daily changes of the medium. The cells were then harvested and their 
melanogenic activities measured. 
Following MSH treatment of DMEL-3 cells at 33°C and 37°C, it was noticed that morphological 
changes had occurred. At 33°C, both untreated control cells and treated cells were visibly 
unpigmented. However, unlike the untreated cells, some MSH-treated cells became dendritic 
(compare Figs 3.21a & b). This observation was interesting because it suggested that even at 
the permissive temperature (33°C), MSH was able to induce dendrite formation , a key feature of 
melanocyte differentiation. As expected, both treated and untreated dishes cultured at 37°C 
contained pigmented cells. There was, however, a significant increase in the number of 
pigmented cells after MSH treatment (compare Figs 3.21c & d). This observation suggested that 
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Fig. 3.21. Phenotype of DMEL-3 cells cultured at 33°C and 37°C in either the absence or presence of u-
MSH for 4 days. Phase contrast photomicrographs show the morphology of DMEL-3 cells cultured at 33°C 
in the absence (a) or presence (b) of a-MSH. Bright field photomicrographs show colour due to black 
melanin granules in DMEL-3 cells cultured at 37°C in the absence (c) or presence (d) of a-MSH. 
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MSH was able to stimulate pigment synthesis in OMEL-3 cells grown at the non-permissive 
temperature (37°C}. 
To assess more accurately the effect of MSH on melanin synthesis in OMEL-3 cells, the melanin 
, formation assay was carried out on two separate occasions and each sample was assayed in 
triplicate. The results, expressed as cpm/100 µg protein are presented in Table 3.7. 
Table 3.7. Effect of MSH on melanin synthesis in DMEL-3 cells at 33°C and 37°C 
Samples Experiment 1 Experiment 2 
cpm/100 µg protein cpm/100 µg protein 
Control + MSH MSH/ Control + MSH MSH/ 
Control Control 
DMEL-3 at 33°C 1053 ± 86 1389 ± 36 1.3 382 ± 78 473 ± 10 1.2 
DMEL-3 at 37°C 1104 ± 102 1407 ± 36 1.3 1581 ± 50 1912 ± 59 1.2 
In experiment 1, when OMEL-3 cells were exposed to 0.2 µM a-MSH for 4 days, there was only 
a 1.3-fold stimulation of melanin synthesis at both the permissive (33°C} and non-permissive 
(37°C} temperatures. This suggests that the T antigen did not effect the responsiveness of 
OMEL-3 cells to MSH. However, in this experiment, MSH treatment was initiated only one day 
after the cells had been transferred to 37°C and it has been reported that the ts mutant large T 
antigen is inactivated at the non-permissive temperature after 2-4 days (Almazan and McKay, 
1992). In experiment 2, therefore, OMEL-3 cells were cultured at 37°C for 21 days before MSH 
treatment was initiated. A comparison of melanin synthesis in untreated OMEL-3 cells at 33°C 
and 37°C confirmed that inactivation of the T antigen at 37°C resulted in increased melanin 
synthesis. However, both at 33°C and 37°C, MSH induced a proportionately equal increase in 
melanin synthesis. These results were therefore similar to those obtained in experiment 1. 
Results of the above experiments indicated that the OMEL-3 cells were only slightly responsive 
to the melanogenic stimulatory effect of MSH and that T antigen expression did not affect this 
responsiveness. To confirm these results, and to investigate the effect of MSH on the activity of 
individual melanogenic enzymes, assays measuring tyrosine hydroxylase and OOPAchrome 
tautomerase (OCT) activities of tyrosinase and TRP-2, respectively, were carried out. The results 
of these assays are presented in Table 3.8 and are expressed in pmol/µg protein/hour. Tyrosine 
hydroxylase activity was stimulated around 1.6- and 1.4-fold after MSH treatment at 33°C and 
37°C, respectively. As in the case of the results obtained for the melanin formation assay, there 
was no significant difference in stimulation between cells that were treated at 33°C and 37°C. 
MSH did not stimulate OCT activity in OMEL-3 cells at either 33°C or 37°C, although a slight 
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stimulation was observed in melan-a cells. OCT activity was, however, 10-fold more in DMEL-3 
cells cultured at 37°C than at 33°C. 
Table 3.8. Effect of MSH on melanogenic activities of DMEL-3 cells at 33°C and 37°C 
Melanogenic activities Samples Control +MSH Stimulation 
pmol/µg prcxein/hr pmol/µg prcxeinlhr MSH/Control 
Tyrosine hydroxylase DMEL-3 at 33°C 0.55 0.88 1.6 
DMEL-3 at 37°C 1.51 2.04 1.4 
melan-a 4.32 5.05 1.2 
DOPAchrome tautomerase DMEL-3 at 33°C 6 6 1.0 
DMEL-3 at 37°C 60 60 1.0 
melan-a 12 18 1.5 
3.9 The growth of DMEL-2 and DMEL-3 cells is temperature-sensitive but not TPA-
dependent 
Since DMEL-3 cells gradually lost several features of differentiated melanocytes, whereas 
DMEL-2 cells did not, the effect of TPA on the growth of the DMEL-2 and DMEL-3 cell lines was 
compared. This is important because transformed melanocytes become TPA-independent. 
Short-term growth of the cells was compared at 33°C and 37°C in melanocyte-specific medium 
(MSM) with and without 48 nM TPA (Fig . 3.22a,b). 
It was found that over a period of nine days, DMEL-3 cells grew about nine times faster than the 
DMEL-2 cells when cultured at 33°C in medium with TPA. As expected, at 37°C in MSM with 
TPA, both cell lines grew much more slowly than their counterparts at 33°C. Removal of TPA 
resulted in a 40-50% decrease in proliferation of both DMEL-2 and 3 cells cultured at 33°C. 
Similarly, at 37°C the removal of TPA resulted in a 67% decrease in proliferation of DMEL-3 
cells. It was not possible to determine the effect of TPA on the growth of DMEL-2 cells at 37°C 
because the cells showed very little potential to proliferate at this temperature. This analysis 
indicated that at the permissive temperature (33°C), melanocyte cell lines in this study did not 
senesce after removal of TPA, confirming the results from a previous experiment (Fig. 3.11) that 
expression of the T antigen in these cells induced growth autonomy from TPA. Furthermore, the 
decline in proliferation when the cells were grown at the non-permissive temperature (37°C) 
demonstrated that the cells were conditionally immortalised by the ts mutant T antigen. 
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Fig 3.22. T antigen-expressing melanocytes show reduced dependence on TPA 
for growth. Growth kinetics of (a) DMEL-2 cells and (b) DMEL-3 cells cultured at 
33°C (green) and 37°C (red) in MSM with (solid line) or without (broken line) 
TPA. Each value is the average of duplicate wells. The standard error between 





3.10 Loss of pigmentation and an increase in proliferation rate in DMEL-3 cells is not 
associated with increased levels of T antigen 
The results of the experiments described above raise two interesting questions. Firstly, why did 
the differentiation and growth characteristics of late passage DMEL-3 cells cultured at 33°C 
differ from earlier passages and from the pigmented cell lines established in this study? 
Secondly, when cultured at the non-permissive temperature (37°C), why were passage 17 
DMEL-3 cells not able to revert to the fully differentiated state of earlier passages? 
It was hypothesized that late passage DMEL-3 cells become de-differentiated and proliferated 
faster because they contain higher levels of the T antigen. To test this hypothesis, western blot 
analysis was performed to compare the levels of T antigen in early passage pigmented DMEL-3 
cells and late passage unpigmented DMEL-3 cells, as well as to assess how these levels 
compared to those in DMEL-2 cells. This analysis was carried out on three separate occasions, 
using protein from DMEL-3 cells at passages 9 and 16 and from DMEL-2 cells at passages 11 
and 18. Similar results were obtained on each occasion and an example of one of these 
experiments is shown in Fig. 3.23A. A 94 kDa band representing the large T antigen was seen in 
DMEL-3 cells (lanes 2 and 3) and DMEL-2 cells (lanes 4 and 5) but not in melan-a cells (lane 1 ). 
A visual comparison of the intensity of the bands in passage 9 (lane 2) and 16 (lane 3) DMEL-3 
cells revealed that they contained similar levels of the T antigen indicating that late passage 
DMEL-3 cells do not contain higher levels of T antigen than earlier passages. Similarly, passage 
11 DMEL-2 cells (lane 4) and passage 18 DMEL-2 cells (lane 5) contain similar levels of the T 
antigen. Furthermore, DMEL-2 and 3 cells contained equal amounts of T antigen. As expected, 
the levels of message for the T antigen (Fig . 3.238) were similar in passage 9 (lane 2) and 
passage 16 (lane 3) DMEL-3 cells (see arrowhead). 
The present study used 37°C as the non-permissive temperature instead of the recommended 
non-permissive temperature of 39°C. It was hypothesized that the inability of DMEL-3 cells to 
revert to their fully differentiated state at 37°C was due to incomplete inactivation of the T 
antigen at this temperature. To test this hypothesis, western blot analysis was used to compare 
the levels of T antigen in passage 8 and 15 DMEL-3 cells cultured at 33°C, 37°C and 39°C for 4 
days. The 4-day period was selected because previous studies have reported that the T antigen 
is not detected in cells expressing the temperature-sensitive mutant large T antigen after 2 to 4 
days at 39°C (Almazan and McKay, 1992). The results from this experiment are shown in Fig. 
3.24. 
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Fig. 3.23. A, Levels of T antigen protein in DMEL-2 and 3 cells at 33°C. Each lane of a 7.5% 
polyacrylamide gel was loaded with 30 µg of soluble intracellular protein obtained by detergent lysis. After 
electrotransfer to nitrocellulose sheets the proteins were stained with the monoclonal anti SV40 large T 
antigen antibody (0.5 µg/ml) and visualised by enhanced Chemiluminescense (Amersham). Lane 1, 
melan-a cells; lanes 2 and 3, passage 9 and 16 DMEL-3 cells, respectively; lanes 4 and 5, passage 11 and 
18 DMEL-2 cells respectively. B, Northern blot analysis of T antigen expression (see arrowhead) in 
passage 9 (lane 2) and passage 16 (lane 3) DMEL-3 cells. Ethidium bromide staining of the 28S and 18S 
rRNAs show the quantity and quality of the RNA loaded. Lane 1, 816 melanoma cells (negative control); 
lane 4, '1'2 fibroblasts (positive control). 
1 2 3 4 5 6 7 
Fig. 3.24. Levels of T antigen in passage 8 and 15 DMEL-3 cells cultured at 33°C, 37°C and 39°C. Each 
lane of a 7.5% polyacrylamide gel was loaded with 30 µg of soluble intracellular protein obtained by 
detergent lysis. After electrotransfer to nitrocellulose sheets the proteins were stained with the monoclonal 
anti SV40 large T antibody (0.5 µg/ml) and visualised by enhanced Chemiluminescense. Lanes 1, 2 & 3, 
passage 8 DMEL-3 cells cultured at 33°C, 37°C and 39°C, respectively; lanes 4, 5 & 6, passage 15 DMEL-
3 cells cultured at 33°C, 37°C and 39°C respectively; lane 7, NIH 3T3 fibroblasts (negative control). 
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lmmunoblotting using the Pab101 antibody specific for the T antigen protein revealed an 
immunoreactive band of approximately 94 kDa in all lanes containing protein from DMEL-3 cells 
(lanes 1 to 6). The intensity of the band obtained in passage 8 DMEL-3 cells cultured at 33°C 
(lane 1 ), 37°C (lane 2) and 39°C (lane 3) decreased as the temperature at which the cells were 
cultured increased. Similar results were obtained for passage 15 DMEL-3 cells cultured at 33°C · 
(lane 4), 37°C (lane 5) and 39°C (lane 6). No signal was obtained in the NIH 3T3 fibroblasts 
(lane 7). These results show that: (1) although the levels of T antigen were lower at the 
recommended temperature of 39°C, T antigen was still detectable and (2) the levels of T antigen 
present in the two passages of DMEL-3 cells were similar at the different temperatures. 
3.11 Mechanism by which SV40 large T antigen inhibits differentiation in DMEL-3 cells 
3.11.1 T antigen does not affect the expression of the RB gene family 
To determine whether any of the RB family members is involved in melanocyte differentiation, 
this study investigated whether there were any correlative changes in the expression pattern of 
RB1 , p130 and p107 mRNA when DMEL-3 cells were induced to differentiate at the non-
permissive temperature of 37°C. Passage 15 DMEL-3 cells were cultured at 33°C and 37°C for 
4, 16 and 30 days. As reported earlier, DMEL-3 cells cultured at 33°C and 37°C for 4 and 16 
days were unpigmented, whereas after 30 days at 37°C, melanin was clearly visible (Fig. 
3.25a,b), confirming that the cells had re-differentiated. To determine whether there was any 
correlation between this re-differentiation and expression of the RB gene family, a northern blot 
of poly(Af RNA from DMEL-3 cells cultured at 33°C and at 37°C for 4, 16 and 30 days as well 
as poly(Af RNA from melan-a cells, 816 melanoma cells and adult mouse brain tissue was 
probed with cDNAs for RB 1, p 130 and p 107. 
When probed with a mouse RB1 cDNA, a 4.7 kb band of equal intensity was obtained in all 
lanes (Fig. 3.26A). When this blot was stripped and reprobed with a mouse p130 cDNA a 4.8 kb 
band was detected in all lanes (Fig . 3.26A). These results indicate that there were no significant 
changes in RB1 and p130 expression in DMEL-3 cells induced to differentiate by inactivation of 
the T antigen. Interestingly, the signal was strongest in melan-a and 816 melanoma cells. 
Finally, the above blot was probed with a human p107 cDNA. Two bands of 4.9 kb and 2.4 kb 
were detected in DMEL-3 cells cultured at 33°C and 37°C but not in melan-a cells, 816 
melanoma cells or brain tissue (Fig. 3.26A). There was no change in the intensity of these bands 
when DMEL-3 cells were induced to re-differentiate. The absence of p107 in melan-a cells, 816 
melanoma cells and brain tissue suggests that p107 is up-regulated in T antigen-expressing 
melanocytes. To test the validity of this conclusion , a northern blot containing total RNA from 







Fig. 3.25. Morphology of passage 15 DMEL-3 cells induced to differentiate at 37°C. (a) Phase contrast 
photomicrograph of DMEL-3 cells at 37°C for 30 days. (b) Bright field photomicrograph of the same field 









Fig. 3.26. Expression of the RB gene family members. Northern blot hybridisation analysis was performed 
on DMEL-3 cells cultured at 33°C and 37°C. Poly(At RNA (5 µg) from each sample was separated on a 
formaldehyde gel followed by electrophoretic transfer onto nylon membranes. A, The same blot was 
repeatedly hybridised to a mouse RB1 cDNA, a mouse p130 cDNA and a human p107 cDNA. In A: lanes 
1, 2, 3 & 4, passage 15 DMEL-3 cells cultured at 33°C and, 37°C for 4, 16 and 30 days, respectively; lane 
5, melan-a cells; lane 6; 816 melanoma cells and lane 7, adult mouse brain tissue. B, Northern blot 
containing total RNA (20 µg) from DMEL-2 cells cultured at 33°C and 37°C, probed with a human p107 
cDNA. Lane 1, 816 melanoma cells; lanes 2, 3 & 4, DMEL-2 cells cultured at 33°C and, 37°C for 2 and 4 
days, respectively; lane 5, \Jl2 fibroblasts. 
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pigmented DMEL-2 cells cultured at 33°C and 37°C as well as 816 melanoma and '1'2 fibroblast 
cells was also probed with p107. Figure 3.268 shows that while DMEL-2 and '1'2 cells express 
the p107 gene, no detectable expression was observed in 816 melanoma cells. The signals 
obtained in DMEL-2 cells grown at 33°C and 37°C was of equal intensity. 
3.11.2 Changes in the levels and phosphorylation status of the pRb protein family in DMEL-
3 cells induced to differentiate 
To investigate whether phosphorylation of any of the pRb family proteins is modulated during 
melanocyte differentiation, the phosphorylation status of these proteins was examined in 
unpigmented DMEL-3 cells at 33°C and in DMEL-3 cells , induced to re-differentiate, at 37°C. 
Since the more highly phosphorylated forms of the pRb family proteins have slower mobilities 
upon SOS-PAGE than the least phosphorylated forms, immunoblotting could be employed to 
gauge the phosphorylation status of these proteins. Cell extracts were prepared from passage 
16 DMEL-3 cells cultured at 33°C and 37°C for 19 days, as well as from melan-a, melan-b, 
melan-c and 816 melanoma cells. Figure 3.27 shows immunoblot analyses with antibodies 
specific to pRb, p130 and p107. 
Both the hypo- and hyper-phosphorylated forms of the pRb protein can be seen in DMEL-3 cells 
cultured at 33°C (lane 1) and 37°C (lane 2) , as well as in melan-a (lane 4), melan-b (lane 5) and 
melan-c (lane 6) cells. No detectable pRb protein was found in 816 melanoma cells (lane 7). A 
visual comparison of the levels and phosphorylation status of the pRb protein in DMEL-3 cells 
cultured at 33°C and 37°C, revealed that there was a moderate increase in both forms of the 
protein at 37°C. Melan-a, melan-b and melan-c cells contained comparable levels of both forms 
of the pRb protein. 
When blots were probed with antibodies specific to the p130 protein, two bands were detected 
in all lanes. The lower band corresponded to approximately 130 kDa suggesting that these 
bands probably represent the hypo- and hyper-phosphorylated forms of the p130 protein. The 
hyperphosphorylated band was equally intense in all lanes suggesting that all the samples 
contained equal levels of this form of p130. Interestingly, judging from the intensity of the lower 
band in all the lanes, the hypophosphorylated form of the protein was present at much lower 
levels in DMEL-3 cells cultured at 33°C (lane 1) and 37°C (lane 2) compared to melan-a (lane 4), 
melan-b (lane 5) and melan-c (lane 6) cells. 




Fig. 3.27. Levels and phosphorylation status of the pRb protein family in DMEL-3 cells at 
33°C and 37°C. Passage 16 DMEL-3 cells were induced to differentiate at 37°C for 19 days 
and differentiation was assessed by visible pigmentation. The cells were solubilized in lysis 
buffer and approximately 60 µg of protein from each sample was separated on 7.5% SDS 
gels. After electrotransfer to nitrocellulose membranes, the blots were probed with antisera 
specific to pRb, p130 and p107 and the bands visualised by chemiluminescence. Lane1 , 
DMEL-3 cells at 33°C; lane 2, DMEL-3 cells at 37°C; lane 3 (for pRb and p107), senescent 
melanocytes; lanes 4, 5 & 6, melan-a, melan-b & melan-c cells, respectively. 
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By using antibodies specific to the p107 protein, a broad band of approximately 107 kDa, which 
probably represents a mixture of different phosphorylated forms of the protein, was detected in 
all samples. The intensity of the band was slightly stronger in DMEL-3 cells cultured at 33°C 
(lane 1) compared to those at 37°C (lane 2). Interestingly, melan-a (lane 4), melan-b (lane 5) , 
melan-c (lane 6) and 816 melanoma cells (lane 7) contained significant levels of the p107 
protein. These results therefore did not correlate with the results obtained from northern blot 
analysis. 
3.11 .3 Identification of the regions of T antigen required for inhibiting melanocyte-specific 
gene expression and differentiation 
To determine which regions of T antigen were required for inhibiting melanogenesis in DMEL-3 
cells at 33°C, the cells were transfected with the T antigen mutants, dl1135, 5041 and 3213, 
described in Table 2.2. These T antigen mutants have previously been used to determine the 
region(s) of the T antigen required for transformation of cells. The advantage of using the 
DMEL-3 cell line to assay T antigen mutants is that it should allow the identification of regions 
required to maintain the de-differentiated state at the non-permissive temperature. Cells from 
each transfection were incubated at both the permissive and non-permissive temperatures. 
Since passage 10 DMEL-3 cells were previously shown to visibly re-pigment at the non-
permissive temperature, these cells were used in this experiment. To detect which mutants were 
able to inhibit re-pigmentation at the non-permissive temperature, paired dishes of transfected 
cells that were cultured at the permissive and non-permissive temperatures, were examined by 
light microscopy. Mutants that were able to bind the cellular proteins that are required for 
pigmentation, were expected to yield colonies of cells that were unpigmented at the non-
permissive temperature. Over a period of several weeks, re-pigmentation was not detected in 
any of the transfected dishes at the ·non-permissive temperature (results not shown) . However, 
the untransfected control cells also did not visibly re-pigment (results not shown). Since analysis 
of these results was dependent on the repigmentation of the control cells at 37°C, it was not 
possible to make any conclusive deductions from the above experiments. The following 
observations are, however, worth noting: (1) Cells from all dishes were unpigmented and 
fibroblast-like at the permissive temperature (33°C). At the non-permissive temperature (37°C), 
however, cells transfected with the T antigen mutant 5041 which encodes a protein that is 
unable to bind p53, were dendritic. The morphology of these cells was indistinguishable from 
cells transfected with only the control pBabepuro plasmid, and from untransfected DMEL-3 cells 
at the non-permissive temperature. In contrast, cells transfected with the two other mutants, 
dl1 135 and 3213 that encode proteins that bind p53 but are defective in binding p300 and the 
RB family members, respectively, resembled their counterparts at the permissive temperature. 
(2) At the non-permissive temperature, untransfected cells, cells transfected with pBabepuro 
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alone and cells transfected with the mutant 5041 grew much slower than cells transfected with 
either the 3213 or dl1135 mutants. This would suggest that the two mutants, 3213 and dl1135, 
were able to complement the growth defect of DMEL-3 cells at 37°C. Due to time limitations on 
the present study, this transfection experiment could not be further analysed nor could it be 
repeated. 
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CHAPTER 4: DISCUSSION 
The stepwise progression from a normal melanocyte to malignant melanoma involves a series of 
poorly understood genotypic and phenotypic alterations. One of the reasons for this poor 
understanding, particularly about the molecular events and controls that are altered during this 
progression, is that there are very few models in which all the steps in this progression are 
represented. Several groups have attempted to establish in vitro models of melanoma formation 
by transforming mouse melanocytes with exogenous oncogenes. These studies have resulted in 
a growing understanding of the alterations in the growth characteristics of transformed 
melanocytes. In addition, although this was not the prime aim of most of these studies, they also 
reported on concurrent changes in differentiation. A consistent finding in all these studies was 
that when melanocytes became transformed, there was always a change from TPA dependence 
to independence and at the same time, the cells became unpigmented. At face value these 
results would suggest that the exogenously introduced transforming oncogenes are directly 
involved in the changes observed in both proliferation and differentiation. Interestingly, in most 
instances these transformation-related changes were reported to occur immediately following 
oncogene expression, suggesting that in vitro at least, the transformation process occurs in a 
single step. However, clinical and pathological observations have defined cutaneous lesions 
which represent steps in melanoma progression, clearly indicating that the transformation 
process is not a single step process. One can therefore conclude that the cell lines established 
in the above studies do not mirror the sequential manner in which melanoma occurs in vivo. Why 
is it then that melanoma progression in vivo is clearly a multistep process involving a number of 
different changes, whereas in vitro it can be brought about by the introduction of a single 
oncogene? The most likely reason for this is that in all of the above in vitro studies, the 
investigators have introduced oncogenes into already immortal melanocyte lines. Thus the cells 
had already passed through the first steps of transformation and undergone some of the earliest 
changes characteristic of tumor cells. It would therefore appear that these proposed in vitro 
models are not entirely suitable for delineating the key events in early melanoma progression. 
The hypothesis that an oncogene alone is unable to bring about complete transformation in a 
single step could be tested by introducing oncogenes into primary (non-immortal) melanocytes. 
This approach was adopted by Albino et al. (1992), who infected normal human melanocytes 
with a retrovirus containing the viral Ha-ras oncogene. They reported that the resulting cells 
acquired transformation-related changes in a minimum of two phases. In the early phase, the 
oncogene induced limited alterations, including changes in morphology and anchorage-
dependent growth. At this stage, the cells remained pigmented and TPA-responsive for 
approximately six months. Subsequently, in what appeared to be a second phase of 
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transformation (associated with spontaneous chromosomal changes), the cells became TPA 
independent, depigmented and acquired tumorigenic potential. Transformation therefore 
occurred in a sequential manner. In a similar type of experiment, Zepter et al. (1995) introduced 
the SV40 large T antigen into normal human melanocytes but obtained somewhat different 
results. The growth rate of these T antigen-positive cells increased and the cells proliferated in 
the absence of TPA. Similar to the results obtained in the early phase by Albino et al. (1992), 
however, their cells were pigmented and tyrosinase-positive. The cells of Zepter et al. (1995) 
were unable to initiate tumors in nude mice and eventually underwent senescence. 
Although Albino et al. (1992) were able to establish an in vitro model of time-dependent 
tumorigenesis, the transforming oncoprotein could not be inactivated and therefore their model 
made it difficult, if not impossible, to study the following questions: Is de-differentiation a direct 
effect of oncogene expression and, if so, is it mechanistically related to the transforming activity 
of the oncoprotein? Secondly, what is· the role of the oncogene in maintaining the transformed 
phenotype over time? Because the cell lines produced in the present study were derived from 
primary melanocytes, and because the oncoprotein could be inactivated by a temperature 
alteration, it was possible to address the above questions. 
The first issue addressed in the present study was to determine whether the temperature-
sensitive (ts) mutant SV40 large T antigen, that was expressed in primary mouse melanocytes, 
was directly and immediately able to bring about changes both in proliferation and 
differentiation. The six clonal cell lines established in the present study were therefore 
characterised fully with regard to fe~tures of melanocyte differentiation and growth dependence 
on TPA. It was established that during continued passage over at least six months at the 
permissive temperature, these cell lines expressed the T antigen and retained several features 
of normal differentiated melanocytes. They remained pigmented, dendritic, actively synthesizing 
melanin and expressed the tyrosinase, TRP-1 and TRP-2 genes and the proteins encoded by 
them. In addition, they expressed the mi gene and the c-kit receptor. These results demonstrate 
that alterations in the differentiation programme of melanocytes is not necessarily an early event 
induced by the T antigen. This is similar to studies that show that differentiated cell types 
expressing the SV40 large T antigen can maintain a proliferative state while the differentiated 
phenotype is retained. For example, Greenwood et al. (1996) infected primary cultures of rat 
brain and retinal endothelial cells with a recombinant retrovirus encoding the SV40 large T 
antigen. The cell lines derived expressed the T antigen and retained the morphology and 
markers characteristic of the primary culture cells. Similarly, transfection of primary testicular 
cells with a plasmid containing the SV40 large T antigen gave rise to immortalised peritubular, 
Leydig and Sertoli cell lines that retained their morphology and differentiated properties 
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(Hoffman et al. , 1992). It is also worth noting that melanocytes derived from skin explants of 
transgenic mice carrying a recombinant gene compos.ed of DNA coding for a ts mutant SV40 
large T antigen under the control of the human vimentin promoter were also pigmented at the 
permissive temperature and their growth was TPA-dependent (Vicart et al. , 1994) 
To determine whether the growth of the pigmented T antigen-expressing melanocytes in the 
present study showed alterations in TPA-dependence, a representative cell line, the DMEL-2, 
was assessed for its ability to proliferate with and without TPA. Over the 9-day growth period 
tested, cells grown in TPA proliferated almost 50% more than those deprived of TPA. 
Importantly, the cells grown without TPA continued to proliferate and did not senesce. The 
growth of DMEL-2 cells was therefore stimulated by, but not dependent on, TPA. The cell lines 
established in the present study thus differ from all other melanocyte cell lines that have been 
established to date because the cells remained pigmented but were TPA-independent. These 
results suggest that an early event induced by the SV40 large T antigen in primary cultures of 
normal mouse melanocytes is release from TPA dependence, without loss of TPA-
responsiveness and without alterations in the differentiation programme of the cells. 
During the course of the above investigations, one of the six cell lines, the dermal melanocyte 
cell line DMEL-3, acquired a more fibroblastic morphology, grew very rapidly and became 
depigmented at the permissive temperature. Even though they were unpigmented, low levels of 
mi and TRP-2, though not tyrosinase, transcripts were detected by northern blot hybridisation 
(levels of TRP-1 were not examined). Because the oncoprotein could be inactivated, this 
provided an ideal tool for investigating the question of whether the T antigen plays a direct role 
in the de-differentiation process. Proliferation ceased on inactivation of the large T antigen and 
the DMEL-3 cells re-expressed melanocyte-specific markers, including the tyrosinase gene 
family , as well as mi message, in a time-dependent manner. These results convincingly 
demonstrate that (1) the T antigen initially had a role in suppressing the pigmented phenotype; 
(2) this suppression is directly linked to alterations in mi expression and function; and (3) this 
process is reversible at this stage. If Mi is acting as a melanocyte master gene one might predict 
that other melanocyte-specific markers are also altered as a consequence of alterations in mi 
expression. 
To explore this hypothesis, this study also examined the question of whether the expression of 
the a-MSH and c-kit receptors is altered by the changes in mi expression. When paired cultures 
of DMEL-3 cells were treated with a-MSH at the permissive and non-permissive temperatures, 
melanin synthesis and tyrosinase activity increased by the same magnitude at both 
temperatures. This suggested that DMEL-3 cells have a-MSH receptors which are responsive to 
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a.-MSH. Because levels of mi expression did not correlate to responsiveness to a.-MSH at 
permissive and non-permissive temperatures, it suggested that the MSH receptor gene is not 
regulated by Mi. 
However, this data should be interpreted with caution because responsiveness of DMEL-3 cells 
to a.-MSH was very low at both temperatures. This low response of DMEL-3 cells may be related 
to the culture conditions used in this study. For example, the experimental medium used in the 
present study contained TPA which has been shown to block or reduce pigmentation by the 
POMC peptides (Hunt et al. , 1994; Mcleod et al. , 1995). In addition, in several earlier reports 
where melanocytes failed to show a pigmentary response to a.-MSH (De Luca et al., 1993; 
Friedmann et al. , 1990; Halaban et al., 1983; Hedley et al. , 1998; Ranson et al., 1988), TPA was 
present as a mitogen in the culture media. It is, therefore, quite possible that the inclusion of 
TPA masks potential melanogenic responses to POMC peptides. An alternative explanation for 
the poor response of DMEL-3 cells to MSH may be related to early changes at the MSH 
receptor. It is possible, for example, that the T antigen could alter expression of the MSH 
receptor and that re-expression of this receptor was not obtained at the non-permissive 
temperature. The most plausible cause for the poor response of DMEL-3 cells to a.-MSH, 
however, may relate to the presence of IBMX in the culture medium. It is very possible that high 
levels of cAMP induced by IBMX maximises the melanogenic response of the cells and that 
further addition of a.-MSH was not able to increase melanogenesis. The above speculations 
remain to be tested. 
When DMEL-3 cells were examined for c-kit expression, no message could be detected at either 
the permissive or non-permissive temperatures. c-Kit transcripts were, however, present in 
DMEL-2 and melan-a cells. These results were confirmed by western blot analysis and suggest 
that, at the very least, Mi homodimers do not regulate c-kit expression. This is in agreement with 
the results of Askan and Goding (1998) who demonstrated that Mi homodimers were unable to 
bind the atypical E-box element in the c-kit promoter either in vitro or in the yeast one-hybrid 
assay. However, as pointed out by the authors, their experiments used Mi homodimers and 
therefore the possibility that Mi heterodimers might be involved in regulating c-kit expression 
cannot be ruled out. Similarly, the results of the present study do not exclude the possibility that 
the SV40 large T antigen could be disrupting formation of such heterodimers. 
The inability of DMEL-3 cells to re-express c-kit at the non-permissive temperature at a stage 
when they were able to re-express mi, suggested that the irreversible loss of c-kit expression is 
an early irreversible change induced by the SV40 large T antigen. This is in line with evidence 
that c-kit expression is lost in tumorigenic primary melanomas and metastases. While the 
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functional relevance of this modulation remains to be evaluated, it is possible that signalling 
pathways that normally regulate growth are bypassed during transformation of melanocytes and 
that more efficient pathways are mobilized. This might lead to eventual loss of the molecules 
that convey signals that normally regulate cell growth. 
With increased passage of DMEL-3 cells at the permissive temperature, loss of differentiation 
and enhanced growth (results not shown) became more pronounced and more difficult to 
reverse at the non-permissive temperature. Eventually, it was not possible to induce the cells to 
re-express mi and the tyrosinase gene family at all. There is a number of possible explanations 
for these findings. The first possibility is that over a period of time, the levels of T antigen 
increased, resulting in increased suppression of differentiation as was shown by Larue et al. 
(1993). Western blot analyses in the present study, however, showed that early passage 
(pigmented) and late passage (unpigmented) DMEL-3 cells contained similar levels of the T 
antigen. This correlated to the results of northern blot analysis which showed that equal levels of 
large T mRNA were present in early and late passage DMEL-3 cells. Furthermore, it might be 
argued that DMEL-3 cells originally contained higher levels of T antigen than the other 
pigmented cell lines. However, a comparison of levels of T antigen in DMEL-2 and 3 cells 
showed that they express similar levels of the T antigen protein. Therefore the depigmented 
phenotype of DMEL-3 cells at the permissive temperature was not associated with increased 
levels of the T antigen. In addition, a comparison of T antigen levels in DMEL-3 cells at the 
permissive and non-permissive temperature revealed that the difference in the ability of early 
and late passage DMEL-3 cells to re-differentiate at the non-permissive temperature was not 
due to higher levels of the T antigen in the late passage cells at this temperature. 
A second possible explanation for ultimate irreversibility of the de-differentiated state of DMEL-3 
cells is that the large T antigen acts as a primary transforming stimulus which, over time, triggers 
a cascade of changes that prohibit reversal of oncogene-induced phenotypic alterations in the 
DMEL-3 cells. Inactivation of the oncoprotein in late passage DMEL-3 cells cultured at the non-
permissive temperature would therefore not be sufficient to reverse this process. This theory is 
supported by experiments with transgenic mice in which the SV40 large T antigen could be 
conditionally expressed in the salivary gland (Ewald et al. , 1996). In this system, the oncogene is 
transcribed in the absence of tetracycline and is silent in the presence of tetracycline. The 
temporal progression of T antigen-induced morphological changes in the submandibular gland, 
and their potential reversibility were investigated over a 7-month period after birth. Expression of 
T antigen in the submandibular gland of transgenic mice from the time of birth induced cellular 
transformation and extensive ductal hyperplasia by 4 months of age. The hyperplasia was 
reversed when T antigen expression was silenced by exposing the mice to tetracycline for 3 
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weeks. When T antigen expression was silenced after 7 months, however, the hyperplasia 
persisted even though the T antigen was absent. Interestingly, epithelial cells from the 
submandibular tissue of the transgenic mice were polyploid and this polyploidy could be 
reversed at 4 months of age but not at 7 months in the absence of T antigen. These results 
support a model of time-dependent, multistep tumorigenesis, in which virally transformed cells 
eventually lose their dependence on the viral oncoprotein for maintenance of the transformed 
state. 
An interesting question that remains to be answered is why did the DMEL-3 cells, but not the 
other five cell lines analysed in the present study, depigment? It should be pointed out that while 
all six cell lines analysed in the present study contain a single retroviral insert, Southern blot 
analysis show that the insert has been incorporated into a different part of the host genome. 
This might have important implications on how these melanocytes behave because the site of 
insertion could differentially affect the expression of genes that regulate melanocyte proliferation 
or melanogenesis. 
Mechanism by which T antigen causes depigmentation in DMEL-3 cells 
Having established that there is a window period in which the T antigen directly but reversibly 
affects melanocyte differentiation, the next question was to explore the mechanism whereby the 
T antigen inhibits the melanogenic process. The first indication that the T antigen could be 
altering pigmentation in the DMEL-3 cells was the failure to detect the glycosylated forms of the 
tyrosinase, TRP-1 and TRP-2 proteins in this cell line. A possible explanation is that T antigen 
was interfering with either their post-translational processing or synthesis. It is interesting to note 
that the cytosolic heat shock protein, hsp 70, known to influence protein folding in the 
endoplasmic reticulum (ER) is bound by the T antigen (Sawai and Butel, 1989). It is therefore 
possible that incorrect folding of the tyrosinase, TRP-1 and TRP-2 proteins as a result of 
inactivated hsp 70 prevents them from exiting the ER and this results in their degradation and/or 
the retardation of their maturation. The latter possibility is supported particularly by the 
observation that the pigmented cell lines, established in the present study, express high levels of 
the TRP-2 gene and the de novo TRP-2 protein, but frequently had undetectable or low levels of 
the glycosylated TRP-2 protein. This alteration was clearly not due to an experimental artefact 
because under the same conditions, the melan-a cells were shown to contain low levels of de 
novo TRP-2 protein and high levels of glycosylated TRP-2 protein. 
Some investigators have used the oncoprotein E1A as a tool for understanding the control of 
melanocyte-specific gene expression and differentiation (Halaban et al. , 1996; Yavuzer et al. , 
1995). Yavuzer et al. (1995) demonstrated that E1A induced loss of pigmentation in immortal 
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murine melanocytes and this correlated to loss of expression of the TRP-1 and tyrosinase 
genes. They also showed that repression of TRP-1 by E1A correlated to E1A binding to pRb and 
p300. The demonstration that Mi binds pRb in vitro suggested that the pRb:Mi interaction may 
be essential for the ability of Mi to activate transcription of the melanocyte-specific genes . The 
authors proposed that since E1A binds pRb, repression of melanocyte-specific gene expression 
by this viral oncogene may result, in part, from the disruption of Mi:pRb complexes. Since the 
SV40 large T antigen also binds pRb, the above mechanism may, in part, provide an 
explanation for the depigmentation in the DMEL-3 cells. To address the possible role of pRb in 
melanocyte differentiation, the present study investigated whether melanocyte differentiation is 
accompanied by an increase in transcription of the RB1 gene and increased levels of the pRb 
protein (as has been shown by Copolla et al. (1990) and Chen et al. (1989) respectively). 
Because p107 and p130 are structurally similar to pRb and may also possibly play a role in 
differentiation, an analysis of these two proteins was also included. 
Northern blot analysis showed that unpigmented DMEL-3 cells , cultured at the permissive 
temperature (33°C), express similar levels of RB1 mRNA as DMEL-3 cells induced to pigment at 
the non-permissive temperature (37°C). Western blot analyses, however, revealed that the 
hypophosphorylated form of pRb increased when the DMEL-3 cells were induced to differentiate 
at 37°C and that there was also a slight increase in the hyperphosphorylated form of pRb at this 
temperature. Similar results were obtained for p130. This would suggest that either the levels of 
pRb and p130 increased during differentiation or that these proteins are less stable in the 
presence of the SV40 large T antigen. Since the mRNA levels of pRb and p130 did not increase 
during differentiation, the former possibility seems unlikely. With regard to the latter possibility, it 
is of interest to note that the N terminus of the SV40 large T antigen shares sequence homology 
with the J domain of the DnaJ (heat shock protein 40) family of molecular chaperones (Kelley 
and Landry, 1994). This J domain of T antigen is required for cellular transformation and has 
been reported to mediate a perturbation of the phosphorylation status of p130 and p107 and to 
promote the degradation of the p130 protein (Stubdal et al. , 1997). Such a mechanism could 
possibly account for lower levels of pRb and p130 proteins at the permissive temperature. 
As with RB1 and p130, there was no alteration in p107 gene expression. Overall , the results 
therefore show that there are no alterations in the expression of the pRb gene family in the 
presence or absence of the large T antigen. However, unlike the pRb and p130 proteins, 
differentiation was not associated with an increase in levels of the p107 protein. These western 
blot analyses are, however, difficult to interpret because the Rb-related proteins are bound and 
presumably inactivated by the SV40 large T antigen at the permissive temperature. At the non-
permissive temperature, the SV40 large T antigen is degraded, thereby liberating the active form 
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of the proteins. Release of this form of the proteins at the non-permissive temperature alone 
might therefore be sufficient for their activity. Thus a comparison of the levels of the Rb-related 
proteins at the permissive and non-permissive temperatures by western blot analyses does not 
necessarily reflect the functioning of these proteins at the two temperatures. 
Additional information on the role of the Rb family in melanocytes can be deduced from the 
comparisons of their expression in melanocytes with and without T antigen. The present study 
shows that although melan-a and 816 melanoma cells express the R81 gene at levels similar to 
those found in DMEL-3 cells, they expressed higher levels of the p130 gene and no detectable 
p107 message. These results possibly suggest that the T antigen down-regulates p130 and up-
regulates the p107 genes. To test the hypothesis that the T antigen up-regulates p107 
expression, a northern blot containing RNA from DMEL-2 melanocytes, 816 melanoma cells and 
'1'2 fibroblasts (cell line producing T antigen) was probed for p107 expression. The results 
revealed that the DMEL-2 and '1'2 fibroblast cell lines, both of which express T antigen, express 
p107, whereas 816 cells , which do not contain T antigen, do not express p107. If the differences 
between the T antigen-expressing melanocytes established in the present study, and the melan-
a and 816 melanoma cells can be believed, then they might provide important clues about the 
changes brought about during oncogene-mediated transformation of melanocytes. For example, 
it is possible that in response to constitutive expression of the SV40 large T antigen, 
melanocytes up-regulate the tumor-suppressor p107 in an attempt to control growth. A possible 
explanation for the observation that melan-a cells do not express any detectable levels of p107 
mRNA transcripts but contained high levels of p107 protein might be that p107 mRNA is 
unstable in spontaneously immortalised melan-a cells. Further studies are clearly necessary to 
determine whether pRb and its relatives play a role in melanocyte-specific gene expression and 
differentiation. 
Down-regulation of mi expression 
Depigmentation in the DMEL-3 cell line at the permissive temperature was shown to be a 
consequence of the down-regulation of the tyrosinase, TRP-1 and TRP-2 genes and this 
correlated to reduced levels of mi mRNA transcripts. At the non-permissive temperature, mi 
expression increased in a time-dependent manner in a pattern similar to that observed for the 
tyrosinase gene family. These results are consistent with the possibility that Mi is the central 
regulator of melanocyte-specific gene expression and suggests that it is the potential target for T 
antigen-mediated de-differentiation in melanocytes. These results are similar to studies which 
show that mi expression is also reduced in E1a-transformed melanocytes (Halaban et al. , 1996; 
Yavuzer et al., 1995) and that ectopic expression of Mi was able to prevent repression of the 
tyrosinase and TRP-1 promoters in the presence of E1A (Yavuzer et al. , 1995). 
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To date, there have been no investigations directed at understanding how mi is down-regulate
d 
in E1A or SV40 transformed melanocytes. This is a challenging question because, so far, onl
y 
the human microphthalmia promoter sequence has been cloned and there is limited informatio
n 
on the regulation of mi expression (see section 1.5). One possibility is that mi is autoregulate
d 
and that oncoproteins interfere with this autoregulation either by directly binding to an
d 
inactivating Mi or by preventing complexing with a necessary transcription partner. Thi
s 
possibility however appears unlikely since there are no CA TGTG motifs in the publishe
d 
sequence of the MITF promoter and co-transfection of human melanoma cells with an MIT
F 
cDNA did not lead to an increase in expression of MITF-luciferase fusion genes (Fuse et al
. , 
1996). However, it is possible that the cloned promoter fragment does not represent the fu
ll 
regulatory sequence or that Mi may bind either upstream or intronic enhancer sequences. Thu
s 
the possibility of autoregulation cannot be excluded. 
Another possible mechanism for mi downregulation could be via the inactivation/repression of 
a 
positive transcriptional regulator of the mi gene. A potential candidate is, the paired-bo
x 
homeodomain transcription factor, Pax3. Mutations in Pax3 cause hypopigmentation an
d 
hearing impairment in individuals suffering from Waardenburg Syndrome 1 and 3 which possibl
y 
results from a fault in melanocyte differentiation. Interestingly, very recent evidence provided b
y 
Watanabe et al. (1998) suggest that Pax3 may be an upstream regulator of the mi gene. Th
e 
present study therefore explored the possibility that Pax3 may be a potential target for 
T 
antigen-mediated repression of mi gene expression. Northern blot analysis of DMEL-3 cells
, 
cultured at the permissive and non-permissive temperatures, revealed that there was n
o 
detectable levels of Pax3 transcripts at either temperature. In addition, Pax3 expression wa
s 
also absent in the highly pigmented DMEL-2 and melan-a cell lines. 
The inability to detect Pax3 expression in pigmented melanocyte cell lines that express hig
h 
levels of mi would suggest that Pax3 is not expressed in fully differentiated melanocytes an
d 
that it is unlikely to be a target for T antigen-mediated repression of mi expression in DMEL-
3 
cells. It is, however, possible that the onset of mi expression during melanocyte developmen
t 
may be dependent on Pax3 but that once the initial expression of mi is established, it
s 
subsequent expression becomes independent of Pax3. This possibility is similar to the role o
f 
Pax3 in muscle development. Pax3 expression has been reported to be required for myogeni
c 
cell specification but appears to be repressed as precursors cells activate expression of th
e 
myogenic gene cascade (Williams and Ordahl, 1994). Given the results of Watanabe et a
l. 
(1998) and the fact that mutations in Pax3 give rise to hypopigmentation, it is clear that Pax
3 
must play a role in the melanocyte lineage. However, reports on the expression of Pax3 durin
g 
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melanocyte development are inconclusive. For example, Goulding et al. (1991) examined mouse 
embryos at various stages of development for Pax3 expression and they reported, although the 
results were not shown, that "at no time was Pax3 expression detected in melanocytes". 
Furthermore, they concluded that Pax3 is only expressed during embryogenesis because no 
adult tissues contained detectable levels of Pax3 mRNA. In contrast, it appears that in keeping 
with their origins in the neural crest, premelanoblast cell lines, as well as melanocytes at later 
stages of development, do express Pax3 (D.C. Bennett, unpublished, personal communication). 
Similarly, Watanabe et al. (1998) reported on the presence of Pax3 protein in a melanoma cell 
line, although, again, the data was not shown. It is worth noting that unlike the present study in 
which total RNA was used to detect Pax3 expression, Bennett reportedly used poly(At RNA. It is 
therefore possible that differentiated melanocytes do express Pax3 but at levels too low to be 
detected on blots containing total RNA. More sensitive assays, such as quantitative RT-PCR, 
are currently underway and it is hoped that the results from these experiments would clarify this 
issue. 
Another possibility that should be explored is whether the SV40 large T antigen activates a 
negative transcriptional regulator of the mi gene. However, only a single candidate negative 
regulator, the POU domain transcription factor Brn-2, has been identified and it is still not clear 
whether it indeed acts as a repressor or activator of the mi gene. Further work is clearly 
necessary before the precise role of oncoproteins in melanocyte de-differentiation is 
established. 
While there is substantial evidence that Mi activates transcription of the tyrosinase and TRP-1 
genes through specific E-box elements, most notably the highly conserved M-box, the role of Mi 
in the regulation of the TRP-2 gene remains in dispute. Halaban et al. (1996) report that, unlike 
the tyrosinase and TRP-1 genes, TRP-2 gene expression is not altered in E1A-transformed 
melanocytes. However, examination of their published Figures shows that, compared with the 
pigmented clones transfected with the pSVneo control plasmid, there does appear to be a 
reduced level of TRP-2 protein and mRNA in the amelanotic melanocytes. Their observation that 
TRP-2 expression is down-regulated but not shut down in the absence of mi expression would 
suggest that Mi, even if not essential, may have a role in TRP-2 gene expression. It is possible 
that in the present study, either the large T antigen itself is somehow directly responsible for 
down-regulating TRP-2 expression, or that the large T antigen is inactivating another, as yet 
unidentified, factor involved in TRP-2 transcription. These last two alternatives might explain the 
differences between the results in this study and those of Halaban et al. (1996). It is possible, at 
the very least, that E1A and large T antigen do not exert the same effect on TRP-2 expression. 
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TPA stimulates melanogenesis by regulating microphthalmia expression 
In vitro studies have shown that TPA not only acts to regulate melanocyte progenitor cell number 
but is also essential for inducing pigment in pluripotent mouse neural crest cells (Murphy et al. , 
1992). These findings suggest that TPA stimulates differentiation of the melanocyte progenitors 
into fully mature melanocytes. Since TPA is not a physiological agent, its action is clearly 
mimicking some in vivo pathway involved in the melanogenic process. Subsequent studies in the 
same mouse neural crest system have shown that endothelins can substitute for this role of TPA 
(Reid et al. , 1996). Further evidence for the role of TPA in melanogenesis have also come from 
studies that have shown an increase in tyrosinase activity (Abdel-Malek et al., 1992; Chao-Hsing 
and Hsin-Su, 1991 ; Halaban et al., 1983) and melanin synthesis (Melber et al., 1989) in normal 
melanocytes treated with TPA. However, the study of the stimulatory effect of TPA on 
melanogenesis has, in part, been hindered because normal melanocytes in culture frequently 
require TPA as an obligatory growth factor. To date, there have been no reports on the effect of 
TPA on the expression of the pigmentation genes in normal melanocytes and the mechanism by 
which TPA stimulates melanogenesis has not been elucidated. The pigmented cell lines 
established in the present study provided a unique opportunity to address this issue because, as 
described earlier, the cells become TPA-independent but continue to be TPA-responsive. 
In this investigation it was found that the levels of tyrosinase, TRP-1 and TRP-2 proteins and 
mRNAs were increased during TPA-induced melanogenesis in DMEL-2 cells. This study also 
shows, for the first time, that mi gene expression is up-regulated by TPA and that this directly 
correlates with the increase in tyrosinase, TRP-1 and TRP-2 gene expression. This suggests 
that the TPA signalling pathway is stimulating melanogenesis by increasing mi expression. 
Interestingly, Hemesath et al. (1998) obtained a somewhat different result when they treated 
human melanoma cells with TPA. They demonstrated that TPA stimulation results in activation 
of MAP kinase which in turn phosphorylates Mi. This phosphorylated form of Mi was shown to 
increase transactivation of a tyrosinase gene promoter reporter construct. Taken together, the 
results of the present study and that of Hemesath et al. (1998) would suggest that TPA 
regulates the expression of the tyrosinase-gene family by increasing Mi activity through both 
transcriptional and post-translational mechanisms (see blue and black arrows in Fig 4.1). The 
following possible models, also depicted in Fig 4.1 , could explain this dual effect. 
Firstly, in theory, it is possible that the mi gene is autoregulated and that the increase in mi 
expression seen in the present study may be due to TPA increasing the affinity of Mi for its 
target sequences in the mi promoter (as demonstrated by Hemesath et al. (1998) for tyrosinase 
(see A in Fig 4.1)). Cloning and expression studies of mi promoter sequences from other species 

























































































































































































































































Secondly, the presence of TPA-responsive DNA elements, AP1 and AP2, in the mi promoter 
would provide a mechanistic link between TPA signalling and stimulation of tyrosinase, TRP-1 
and TRP-2 via regulation of mi expression (see B in Fig 4.1). However, analysis of the cloned 
fragment from the human MITF promoter reveals that there are no AP1 and AP2 binding 
consensus sequences. Another alternative is that TPA may be altering the functioning of a 
transcriptional regulator of the mi gene, such as Brn-2 or Pax3 (see C in Fig 4.1). 
Thirdly, the endothelin 1 (ET-1) gene has been shown to contain a TPA-responsive element 
and, as has been suggested by Reid et al. (1996), TPA may be stimulating melanogenesis by 
inducing endogenous endothelin production (see D in Fig 4.1). This endothelin (ET) would act 
on its own endothelin receptor, thus creating an autocrine and/or paracrine loop which mediates 
the effects observed in the present study (see E in Fig 4.1). Interestingly, several of the effects 
observed for TPA in the present study are similar to the reported effects for endothelins on 
normal melanocytes (Hara et al. , 1995; lmokawa et al. , 1995, 1996, 1997; Lahav et al. , 1996; 
Nataf et al. , 1996; Yada et al. , 1991); for example, stimulation of melanocyte proliferation, 
melanin synthesis, dendrite formation and increased tyrosinase and TRP-1 mRNA gene 
expression. In the light of the results in the present study it would be interesting to establish 
whether endothelins also have an effect on mi expression. Finally, to further explore the 
mechanism by which TPA stimulates melanogenesis will require a more detailed understanding 
of its effects on the various PKC isoforms. This should lead to a clearer understanding of the 
role of PKC in pigmentation. 
Future considerations 
A number of questions has arisen from the investigations carried out in the present study. A few 
of these questions, and possible directions for future studies, are briefly discussed below. 
Pax3 has recently emerged as a potential regulator of mi expression. It is therefore of interest 
that Pax3 expression could not be detected in any of the melanocytes tested in the present 
study, data which conflicts with unpublished reports that Pax3 is expressed in premelanoblasts 
and is indeed up-regulated during melanocyte differentiation. In view of the key role that Mi plays 
Fig. 4.1. Possible models for mechanism(s) by which TPA stimulates melangenesis. A, B, C, D 
& E (red arrows) represent possible mechanisms by which TPA stimulates melanogenesis. 
Black arrows, data provided by Hemesath et al. , (1998); blue arrows, data provided by present 
study; green arrows, data proposed by Reid et al. , (1996) . 
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in melanocyte development, the question of what regulates mi expression is of paramount 
importance. One possible approach to confirming the results of the present study would be to 
carry out a more sensitive assay, such as quantitative RT-PCR, for investigating Pax3 
expression. In addition, detailed investigations into the expression pattern of the Pax3 and mi 
genes in melanocytes at various stages of development would be most valuable. 
One theory put forward in the present study is that the T a~tigen derails pigmentation by 
inactivating cellular proteins that are required for regulating melanogenesis. To test this theory, 
an initial approach could be to repeat the experiment which was designed to establish the 
domain(s) of the T antigen that are involved in inducing the depigmented phenotype. This would 
involve stably transfecting DMEL-3 cells with T antigen mutants that are unable to bind either the 
pRb-related proteins, or p53, or p300, and to assess whether any of these mutants is able to 
maintain the de-differentiated phenotype at the non-permissive temperature. To overcome the 
problem experienced in the present study, where the untransfected control cells did not visibly 
re-pigment at the non-permissive temperature, much earlier passages of the DMEL-3 cells 
should be used. It is important to note that in the present study the results were analysed by 
assessing the visible "re-pigmentation" of the cells. However, as has been shown earlier in this 
study, certain passages of DMEL-3 cells do re-express melanocyte-specific genes at the non-
permissive temperature even though visible pigmentation was not evident. An alternative 
approach may, therefore, be to carry out molecular analyses of the stable transfectants obtained 
in the present experiment. 
One of the most interesting findings of the present study was that TPA regulates expression of 
the mi gene. An obvious line of investigation would be to carry out transient transfection assays 
in which mi promoter reporter constructs are introduced into DMEL-2 cells treated with and 
without TPA. This would lead to the identification of key promoter elements required for 
mediating the effect of TPA on mi expression which could reveal potential upstream regulators 
of mi gene regulation. Such studies await the cloning of the mouse mi regulatory sequences. 
In conclusion, the unique feature of the DMEL-3 cells generated in this study is that the 
differentiation process can be reversibly controlled by regulating the activity of the temperature-
sensitive oncoprotein. These cells therefore provide an ideal tool for carrying out differential 
display analyses or microchip searches for identifying and cloning genes specifically involved in 
melanocyte transformation and differentiation. It should, however, be emphasised that given the 
irreversible changes that occur in the DMEL-3 cells , the power of this cell line in the use of 
melanocyte differentiation is limited to early passages. 
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